var title_f9_17_9488="Common warts PI";
var content_f9_17_9488=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F78884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F78884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Common warts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD, and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9488=[""].join("\n");
var outline_f9_17_9488=null;
var title_f9_17_9489="Oxitropium: International drug information";
var content_f9_17_9489=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Oxitropium: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4324023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Oxivent (BE, CH, DE, GB, IE, IT, LU);",
"     </li>",
"     <li>",
"      Tersigan (JP);",
"     </li>",
"     <li>",
"      Tersigat (DE, FR);",
"     </li>",
"     <li>",
"      Ventilat (DE);",
"     </li>",
"     <li>",
"      Ventox (FI)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1979882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Oxitropium Bromide",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1979884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anticholinergic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1979887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD)",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1979883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Inhalation: 100-200 mcg (2 puffs) 2-3 times/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1979886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aerosal for oral inhalation, as bromide: 100 mcg/metered inhalation",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10424 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.1.191.153-863D5741FF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9489=[""].join("\n");
var outline_f9_17_9489=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4324023\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979882\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979884\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979887\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979883\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821132\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979886\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10424\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10424|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_17_9490="Patient information: Complex regional pain syndrome (The Basics)";
var content_f9_17_9490=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?23/12/23746\">",
"         Patient information: Chronic pain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/20/7491\">",
"         Patient information: Common wrist injuries (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?24/17/24854\">",
"         Patient information: Fibromyalgia (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Complex regional pain syndrome (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/complex-regional-pain-syndrome-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H14925240\">",
"      <span class=\"h1\">",
"       What is complex regional pain syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Complex regional pain syndrome (CRPS) is a condition that causes pain, swelling, and other symptoms. It usually happens in just 1 part of the body, such as an arm or leg.",
"     </p>",
"     <p>",
"      Both adults and children can get CRPS. In adults, it often starts after an injury, surgery, heart attack, or stroke. Doctors are not sure how or why it starts. People who have CRPS have worse pain than doctors would expect from the injury, surgery, or other medical problem. CRPS can also start without any injury or medical problem happening first.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14925255\">",
"      <span class=\"h1\">",
"       What are the symptoms of complex regional pain syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms of CRPS are different depending on how long it lasts. The symptoms are also different for adults and children.",
"     </p>",
"     <p>",
"      Adult symptoms of CRPS can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Pain -- The pain can be burning, tingling, throbbing, or aching. It can also be severe. &nbsp;",
"       </li>",
"       <li>",
"        Being sensitive to touch or cold",
"       </li>",
"       <li>",
"        Swelling in the body part with CRPS",
"       </li>",
"       <li>",
"        Skin changes, such as getting thick, rough skin &nbsp;",
"       </li>",
"       <li>",
"        Losing muscle size and strength",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If CRPS lasts longer than 3 to 6 months, it can cause worse symptoms. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Trouble moving the body part that has CRPS",
"       </li>",
"       <li>",
"        Fingers, toes, hands, or feet that curl in",
"       </li>",
"       <li>",
"        More skin changes, such as skin that looks shiny or changes color",
"       </li>",
"       <li>",
"        Fingernails that break easily. They can have lines or ridges on them.",
"       </li>",
"       <li>",
"        Sweating when a person is not exercising or hot",
"       </li>",
"       <li>",
"        Changes in hair on the head or body &nbsp;",
"       </li>",
"       <li>",
"        Coldness of the body part with CRPS",
"       </li>",
"       <li>",
"        Urinary problems, such as having to urinate more often or not being able to urinate when you want to",
"       </li>",
"       <li>",
"        Sore, tight places in muscles, called &ldquo;tender points.&rdquo; (These are common if CRPS affects the shoulder or upper body.)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In children, CRPS is most common in the legs. Children with CRPS can have the following symptoms:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Pain, even from something that does not normally cause pain. For example, a child with CRPS might feel pain from a light, gentle touch or just from wearing clothes on the affected body part. &nbsp;",
"       </li>",
"       <li>",
"        Being sensitive to touch or cold",
"       </li>",
"       <li>",
"        Trouble moving the affected body part",
"       </li>",
"       <li>",
"        Sleep problems",
"       </li>",
"       <li>",
"        Coldness, changes in skin color, swelling, or sweating in the body part with CRPS &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      A child with CRPS might hold the body part that hurts in a strange position.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14925272\">",
"      <span class=\"h1\">",
"       Is there a test for complex regional pain syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. There is not just 1 test doctors can do to find CRPS.",
"     </p>",
"     <p>",
"      The doctor or nurse will do an exam and ask questions. He or she can usually tell if a person has CRPS from the symptoms, medical history, and exam.",
"     </p>",
"     <p>",
"      If a doctor is not sure if a person has CRPS, he or she might order imaging tests such as a bone scan, X-ray, or MRI. These tests create pictures of the inside of the body. They can show changes to the bones, joints, or skin caused by CRPS.",
"     </p>",
"     <p>",
"      Doctors can also do tests that measure skin temperature, sweating, and nerve sensitivity. These tests are not usually needed. The doctor might do them if he or she needs extra information.",
"     </p>",
"     <p>",
"      For children with CRPS, doctors might do blood tests and imaging tests to make sure a different condition is not causing the symptoms. Once the doctor or nurse knows a child has CRPS, other tests are not usually needed. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14925289\">",
"      <span class=\"h1\">",
"       How is complex regional pain syndrome treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment for CRPS is different for each person. Doctors can try different treatments to see what works best.",
"     </p>",
"     <p>",
"      For adults, treatments for CRPS include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Learning about CRPS -- For example, it is important to know that even though CRPS hurts, it does not damage the body part. Joining a support group can help a person with CRPS deal with symptoms. &nbsp;",
"       </li>",
"       <li>",
"        Talking with a counselor -- This can help reduce stress. Stress at work or home can be part of CRPS or make it worse.",
"       </li>",
"       <li>",
"        Physical therapy to learn exercises and stretches, and keep the body part with CRPS working.",
"       </li>",
"       <li>",
"        Stopping smoking &nbsp;",
"       </li>",
"       <li>",
"        Taking medicines to relieve pain -- These can be prescription or over-the-counter medicines, depending on what the doctor or nurse thinks might work best.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If CRPS does not get better with these treatments, doctors can try other things. These include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Injections (shots) of numbing or pain-relieving medicines",
"       </li>",
"       <li>",
"        Pain-relieving medicine given in the spine",
"       </li>",
"       <li>",
"        Devices to help stop nerve signals of pain",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People with severe CRPS should see a doctor who specializes in treating pain.",
"     </p>",
"     <p>",
"      The main treatments for children with CRPS include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Physical therapy",
"       </li>",
"       <li>",
"        Counseling to reduce stress. Working with a counselor is also important to treat mental or emotional problems that could be part of CRPS.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14925304\">",
"      <span class=\"h1\">",
"       Can complex regional pain syndrome be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes. In adults who have a stroke, heart attack, or injury, keeping a body part moving can help prevent CRPS. For example, if someone with a stroke is partly paralyzed, a nurse or physical therapist can gently move the paralyzed parts of his or her body. This can be done even if the person cannot get out of bed.",
"     </p>",
"     <p>",
"      Breaking a wrist can raise the chance of getting CRPS. If you break your wrist, move it as soon as the doctor says it is safe to do so. This can help prevent CRPS. A physical therapist can teach you exercises and stretches to help the wrist get better. Taking Vitamin C can also help prevent CRPS after a broken wrist. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14925321\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23746?source=see_link\">",
"       Patient information: Chronic pain (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/20/7491?source=see_link\">",
"       Patient information: Common wrist injuries (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/17/24854?source=see_link\">",
"       Patient information: Fibromyalgia (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?9/17/9490?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82943 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.117.136.88-C2C11C53A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9490=[""].join("\n");
var outline_f9_17_9490=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14925240\">",
"      What is complex regional pain syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14925255\">",
"      What are the symptoms of complex regional pain syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14925272\">",
"      Is there a test for complex regional pain syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14925289\">",
"      How is complex regional pain syndrome treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14925304\">",
"      Can complex regional pain syndrome be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14925321\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23746?source=related_link\">",
"      Patient information: Chronic pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/20/7491?source=related_link\">",
"      Patient information: Common wrist injuries (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/17/24854?source=related_link\">",
"      Patient information: Fibromyalgia (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_17_9491="Patient information: Esophageal cancer (The Basics)";
var content_f9_17_9491=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16832\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/22/29024\">",
"         Upper digestive tract",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/39/37490\">",
"          Upper endoscopy",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?19/50/20258\">",
"         Patient information: Achalasia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/29/13778\">",
"         Patient information: Barrett's esophagus (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/27/17842\">",
"         Patient information: Hair loss from cancer treatment (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/40/1667\">",
"         Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/36/579\">",
"         Patient information: Managing pain when you have cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/57/19346\">",
"         Patient information: Nausea and vomiting with cancer treatment (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/32/40450\">",
"         Patient information: Radiation therapy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/41/33426\">",
"         Patient information: Upper endoscopy (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?2/55/2934\">",
"         Patient information: Achalasia (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/39/2676\">",
"         Patient information: Barrett's esophagus (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/0/21506\">",
"         Patient information: Upper endoscopy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Esophageal cancer (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/esophageal-cancer-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H26549577\">",
"      <span class=\"h1\">",
"       What is esophageal cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Esophageal cancer happens when normal cells in the esophagus change into abnormal cells and grow out of control. The esophagus is the tube that moves food from the mouth to the stomach (",
"      <a class=\"graphic graphic_figure graphicRef55616 \" href=\"UTD.htm?28/22/29024\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26549591\">",
"      <span class=\"h1\">",
"       What are the symptoms of esophageal cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Early on, people might not notice any symptoms. They might find out they have esophageal cancer after a test for another condition.",
"     </p>",
"     <p>",
"      When people have symptoms from esophageal cancer, they might have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Trouble swallowing, especially solid foods &ndash; This gets worse over time.",
"       </li>",
"       <li>",
"        Weight loss",
"       </li>",
"       <li>",
"        Pain or a burning feeling in the chest",
"       </li>",
"       <li>",
"        Hoarse voice",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      All of these symptoms can also be caused by conditions that are not cancer. But if you have these symptoms, tell your doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26549606\">",
"      <span class=\"h1\">",
"       Is there a test for esophageal cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If your doctor suspects you have esophageal cancer, he or she will do 1 or more of the following tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?18/37/19028?source=see_link\">",
"         Barium",
"        </a>",
"        swallow &ndash; Your doctor will give you a drink called &ldquo;barium.&rdquo; Then he or she will take X-rays as the barium moves down your esophagus.",
"       </li>",
"       <li>",
"        Upper endoscopy &ndash; This is a procedure in which your doctor puts a thin tube with a camera and light on the end (called an endoscope) into your mouth and down into your esophagus (",
"        <a class=\"graphic graphic_figure graphicRef75392 \" href=\"UTD.htm?36/39/37490\">",
"         figure 2",
"        </a>",
"        ). He or she will look at the lining of your esophagus.",
"       </li>",
"       <li>",
"        Biopsy &ndash; For this test, your doctor will take a small sample of tissue from your esophagus. Another doctor will look at the sample under a microscope to see if it has cancer. Your doctor will probably do a biopsy during an upper endoscopy. A biopsy is the only way to know for sure if you have esophageal cancer.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26549620\">",
"      <span class=\"h1\">",
"       What is cancer staging?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Cancer staging is a way in which doctors find out if a cancer has a spread past the layer of tissue where it began, and, if so, how far.",
"     </p>",
"     <p>",
"      The right treatment for you will depend a lot on the stage of your cancer and your other medical problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26549634\">",
"      <span class=\"h1\">",
"       How is esophageal cancer treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people with esophageal cancer have 1 or more of the following treatments:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Surgery &ndash; Esophageal cancer can be treated with surgery to remove the cancer. If your doctor needs to remove part of your esophagus during surgery, he or she will reconnect your esophagus and stomach so that you can swallow food.",
"       </li>",
"       <li>",
"        Radiation therapy &ndash; Radiation kills cancer cells.",
"       </li>",
"       <li>",
"        Chemotherapy &ndash; Chemotherapy is the term doctors use to describe a group of medicines that kill cancer cells.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Esophageal cancer can sometimes be cured with treatment. This is most likely when the cancer is found at an early stage. If your cancer cannot be cured, your doctor might do other treatments to help improve your symptoms. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Using a laser beam or electric current to kill the cancer cells",
"       </li>",
"       <li>",
"        Doing a procedure to widen the blocked part of your esophagus",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26549649\">",
"      <span class=\"h1\">",
"       What happens after treatment?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After treatment, you will be checked every so often to see if the cancer comes back. Regular follow-up tests usually include exams, blood tests, and imaging tests. Some people also have follow-up upper endoscopy or",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?18/37/19028?source=see_link\">",
"       barium",
"      </a>",
"      swallow tests.",
"     </p>",
"     <p>",
"      You should also watch for the symptoms listed above. Having those symptoms could mean the cancer has come back. Tell your doctor or nurse if you have any symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26549664\">",
"      <span class=\"h1\">",
"       What happens if the cancer comes back or spreads?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If the cancer comes back or spreads, you might have more radiation therapy or chemotherapy. You might also have other treatments to help improve your symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26549679\">",
"      <span class=\"h1\">",
"       What else should I do?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It is important to follow all your doctor&rsquo;s instructions about visits and tests. It&rsquo;s also important to talk to your doctor about any side effects or problems you have during treatment.",
"     </p>",
"     <p>",
"      Getting treated for esophageal cancer involves making many choices, such as what treatment to have.",
"     </p>",
"     <p>",
"      Always let your doctors and nurses know how you feel about a treatment. Any time you are offered a treatment, ask:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        What are the benefits of this treatment? Is it likely to help me live longer? Will it reduce or prevent symptoms?",
"       </li>",
"       <li>",
"        What are the downsides to this treatment?",
"       </li>",
"       <li>",
"        Are there other options besides this treatment?",
"       </li>",
"       <li>",
"        What happens if I do not have this treatment?",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26549694\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/29/13778?source=see_link\">",
"       Patient information: Barrett's esophagus (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/50/20258?source=see_link\">",
"       Patient information: Achalasia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/41/33426?source=see_link\">",
"       Patient information: Upper endoscopy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/32/40450?source=see_link\">",
"       Patient information: Radiation therapy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/27/17842?source=see_link\">",
"       Patient information: Hair loss from cancer treatment (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/40/1667?source=see_link\">",
"       Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/36/579?source=see_link\">",
"       Patient information: Managing pain when you have cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/57/19346?source=see_link\">",
"       Patient information: Nausea and vomiting with cancer treatment (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/39/2676?source=see_link\">",
"       Patient information: Barrett's esophagus (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/0/21506?source=see_link\">",
"       Patient information: Upper endoscopy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/55/2934?source=see_link\">",
"       Patient information: Achalasia (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?9/17/9491?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16832 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-D7E3B57AC3-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9491=[""].join("\n");
var outline_f9_17_9491=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549577\">",
"      What is esophageal cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549591\">",
"      What are the symptoms of esophageal cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549606\">",
"      Is there a test for esophageal cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549620\">",
"      What is cancer staging?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549634\">",
"      How is esophageal cancer treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549649\">",
"      What happens after treatment?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549664\">",
"      What happens if the cancer comes back or spreads?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549679\">",
"      What else should I do?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549694\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16832\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/22/29024\">",
"      Upper digestive tract",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/39/37490\">",
"       Upper endoscopy",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/55/2934?source=related_link\">",
"      Patient information: Achalasia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/50/20258?source=related_link\">",
"      Patient information: Achalasia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/39/2676?source=related_link\">",
"      Patient information: Barrett's esophagus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/29/13778?source=related_link\">",
"      Patient information: Barrett's esophagus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/27/17842?source=related_link\">",
"      Patient information: Hair loss from cancer treatment (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/40/1667?source=related_link\">",
"      Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/36/579?source=related_link\">",
"      Patient information: Managing pain when you have cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/57/19346?source=related_link\">",
"      Patient information: Nausea and vomiting with cancer treatment (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/32/40450?source=related_link\">",
"      Patient information: Radiation therapy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/0/21506?source=related_link\">",
"      Patient information: Upper endoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/41/33426?source=related_link\">",
"      Patient information: Upper endoscopy (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_17_9492="Tinea pedis manuum";
var content_f9_17_9492=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F57816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F57816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea pedis and tinea manuum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 300px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEsAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDrJNRhSPYNQaSAgho7pVcMDyeRznFZlze2u7EIY5I+cN8px0I9/euVtLV22CZy/cqWyB+dOvUe3gMsJ24P3TyOeK8/me59a6WhznjXWribVViiBa6dgsYbABOOGP05P4V0/hWwgsbKQiYOzNulnkwDI38Tc84rE8KeH7LxJ42lW/QvaWloZPL5IDMwXn2AzXouoeH9Ks4lK6TZMiqwH7pSGBxkHPcdjVKMpLn6EYeCjd9WcfqV/Bd3JGn3YzAjMQhUjAHXJ7ngfnXLawXCSG+8sOPnMgP3l6kgZ4989MGut1u7WENEscLRIqMvmRAjy+gQkDpzkms7wloi+MPFM7Og/sTT2Bmzx58mMrF7gdW9cCo5ebQzr3ukup0/wg0efTdDfULm32XGpusy8crCAQmQfX5jj0IrsNSKshjbBlbIGemfp0q+QFVvKkJPUcYJJ/8Ar5rIvRHJJN5xZvM2ng8rjPT8a2mklZGShyHn3jvS21Lw/fNKCEjt3C5ypdgCR+Ax+tfMu5vU/nX1j4ma51PSmsIMM9xJ5DMh6R93PsRmvm3xzoX/AAjviS6sFDeSDvi3ddh6A+46fhTw7SbR52P1kpGBub1P50bm9T+dJRXUeeLub1P50bm9T+dJRQAu5vU/nRub1P50lFAC7m9T+dG5vU/nSUUALub1P50bm9T+dJRQAu5vU/nRub1P50lFAC7m9T+dG5vU/nSUUALub1P50bm9T+dJRQAu5vU/nRub1P50lFAC7m9T+dG5vU/nSUUALub1P50bm9T+dJRQAu5vU/nRub1P50lFAFmxhe6u4oV3HewBxzgdzXt3gqxj0q/WSKLZDKAB3w3IIz7ivPfhnpxuNZWWSMFWVkj3YwTxn9P517fpOm/ZrP7K2dp5G5cEe/8A9euKvJylZdPzPcymgn+8fU6nSxL5W8KfJBG9zxz0AA6k1qon2a7NweYSMyENjaSOG/Mc1kacpSPEjuE5XcOcZ6V0BjYWiqChRFPyleGz1z704q6PcmuV2FuSjNC5fGzH0ZSevP5/zrgRO1tdW6pEAFCsw/56AMfT16D2rsI5XgdY5DjByNw/Q561y2v2gN4WjcbXI24JG3IzgEntTqa2kgjTV2mVI5pZIpg7pP5WYI13YC4bjBHXjP5c1YlugDC6lgHjUsSeT+Iqj5z/AGVkJQtIMdcAkcbiOxOMg+5q1FE80UTMEVVQdB1A4/nXNK7dkCj30Llu4mSWHzPLD7MBWxkAsSM/XArodPYWyhpEM5DLs3kHB53ADqOPfrXP29ubdFkkO4HGXCkrzx1q9HdNhw4zhThu5z1H1rpotrcidFS22Nm2lkMk0dzIJA8mSM4wwU4x7ZOfSrD3NugV0jaR3JwUyrZ9z35x+NYaD5wySFhgbVUZx7e/1q0sgija4bBMeHxjILDJxW6aW5nLDl+G8S8ubm1SE272/wC8SJixLFcAh++QCcY9eeKmudPP7qYCQbuvtxnpnj8aNJtkgVZGZS5XEo5bBJyxP97qOc/jWxb3EV8GBCJGilsdWAHJ4/Ac+tDjc5ZWWsVocbrGnLdW4EpVz8xUMVGP9njpn1zmvHPG2k3mkx3J0kSMWJdrWSNhnP3mQ/xEZ+vTjNfRVzbhWjMQRExnYiklh0zx25PPeuF8W6OLkSbUBV1I2ncRkEENx0P9OK5qi5dUZVqMa0bI+S83F/MzsSzDrz+lXoEkjyY5Oq4CgdfWtXxZoy6RrEm9XMVyplQrxtY/eA+h/SqIBjiRiG2p8pY9K7Kck4po+UxPNCTgzLvnIIUMeuarx7mdQCc/Wpbw+ZcsyL8pOBxRAIy6BjnnnIpmsXaKPqqQxrkbeB0I5z7Vh69ciBCsZBVslueAPSq82qiVpmdhhV2jjv61w/izXPs8G1WJnk+SJfU+v0FeS6jlpE+4xEo04uTZ6L8E0M+pa9fBgsaSJAHBA3BQSV/M12euXkQEiwct1BK56H1+lcB8PdOvPCGkxPIwdLpf3qkbhuPcg/0rZ8V6rHDE91OVjgAZjg9Py756D8K39olDlQUKPLHnl/Xc5DxNeuJRawKhnuJNsQznkclm9lyST7AV638L9Li03whFFFlY5TvVmXkkfLn3zgsT/te1eSaRp8zak11fKsd1cKAqu3Fsh5CE+v8AE3vwOle2aTfZs44LKGaaGNFSMuduVAwKKbS3OTklVvO2hpTKyFhyB1BA5JH+f0rA1i4CSne/mSOu0Rp95m9fYHrnitYfbrnev7uG2xyV3NITnt6DHp9aZDYxq+VVWCgbm3bw7djn1I6/QdK0leS0LcF1OcFlKjNOB8zjBRQQoGec/jXiXx5skaSw1BIyjbmhcDkA43DB/OvojUkCg5RWEo6Zx0ryn4yaXHN4XvHZTuX96hHQMOf5Z5qYrkaOHGUb03JHzhRRRXaeCFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABU1rA91cxQQjMkjBFHuahrqfAWmPeamZjHmJB5YZgdu9hgc+uMmlJ8quOMeZpI9V8E6VFDZW8VvEoW2cFpMcyOAc89h1/Ou8SUtsURgcggjIOegx7Vj6Bp50+yWFuccYB4+vvW7Zw4/jdieC2OPyrztXufaYOlGEFZaF7TGRr5IAp8twfkc9D7fjXYWVszRH53EQAIJGencEcfnXHWkcsTxYPG7PA5U4/l7VrWrX488SOY42BAUcF+eMDvz29q3puysy8RFy2Zs3EVtdSM7YZRyBtPTPzH26AZrmNdsZbbTobksSfnV0yGES5yMe5Bbj0z6VuPdSi2kebcXRMAtycucAkjjPWsPULhG024txGrGRklWRnYN8jdgOmeh59ac5Jq3UzoKTatsmchcQPcQYVQxEZfKLyQDnr6DNQQyNHKHVnXDZ4Yjnj9M1r38Wb15beBIoSAdkbHapHcHsDT7GQIwEqqUA2sCOWUkEjPY+/tXM43Z1yfJrYjtL/ybVmQrKv3uGPHfHp1zWgrQOvIZjztw2R7c/nVF4IZQ7yRGOUllLf6tQB0yAOST371XQRhsB5AQN24tnBA44wK1jJpaiTi27HRwwSxSRqRlW5Uk9O+AetWWCXEsMMWWeWVVwepwcsPwAzWTYw3LW80nnx/uwJAjoz7854G0k8DnPQVrRTGaPZPGC6skySIAckKQSGHflevXB9K3upIwqN3vc2I2QvHNCFdfLO7aeofI4P4H6VnxPaWVrd3Ms+fMt/KCqSQXBGcZ/h4yR1APuK0JjsaISxrGwbgoBtIYEFfYH5j7ZrltUQQsolkJtYwNkjsGEhzzg+pIyc+3pV1JWRy0Y80rXL0WoyGX97Iz7kUtk9+eM/oKv3g+0RbPL388rtDAZz7isG1VpJx526LztzZYbQMAEDPt6da6C5iktZGkhV2ttzE5XbgA4xnPtXM7vc6akY3S6nmfjfwot9aSiNDKy4A+QFlPVcdc47/AM68S16KfTUlS5to45xjJ3ZSQdNy/l06ivrGSFLiEMytFvBIDgq/s38+mK47xJ4KttUguOFeNojkPEo7HDZGOc98VEJSpvTY8jHZfDEe9tJHyv5heILI52qflUVNHKxbciqoDAABea1vEOgS6LqTREGW3Jyj7SAw9iRWcUDzKUQBM5AHUfWu6M1NcyPnKsfZycJLU6LUvFzNujsImZiT8zjj8B3q54Q0O8vdRXU9Wimlx8yqRy2PbtX034P+EfhrwyiTw2a3t+vzfaLr5ivuF+6Kk1zw3EGmlih2vncCoGWbn9cVyvD8kLQVvzPpqXv1VOtK9vuPKdS8SXtvCYo9PV0K4UPL1rm7i7vr7UYpNUVGjtcNBbxkiMN2Ys3LkdjjArvJtNeOeSNsEBtqkDsf84rL1nTlEO8xhSo+YGuCTnHc9mdLnWj07Gp4HsLe+vrm/wBTcA25VIoy2RkqGZvck/kK9M0edLtWEJA29cnp7f8A1q8k8GQ3l3byIHCqHYEgA7gMKPrwK6vS2ks9W+zzsII7mJo96gkFxgqWH0BBrppy0tYxnFch3t7qFrbr5ImQORhm5Kp7nFc+2q2KOI47232q33TIFOT1bn35q1ZabCpAuCfMLZxKCFY89umBT9U0u0uIWEkcByMjhcCtLSepEFGDsilf3R8wiRTJwcMDgY9c964bx05vdJuoIhm6lheKME8DIPJrUudBmhPl2c01ozthGikym7srDoc9ARzXFeIp9Y02GeOdBIyoWG1drDg4Yf3h/wDX71lKUluTiHF03E8AIwcGkrb13R5LSGG9hil+ySqm9iOEkIyVz79R7fSsSvTPjk7hRRRQMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK9W+D9s72rkxu8RmLHB9ABwP/rV5dbwyXE8cMK7pJGCqB3Jr3j4T2Bg0aaFVLPBdbS23DZB+bH+z2qKmx04RJ1oo9D0y3SONFQEncWBBxjPX6VrxW+WUBSM8AAc/TPr/Om2EUZAAZgcdQcdq3LKFRt8wfKR0X1rGNO+59fzKnEpQWjDGNytwAVOMf8A16swQJJcKsjJIrEnDkhlOOD9OOcc9K34rJXjiKgemRxzjOPWq1xp1u8RFwVVhnG7kg/Qc5rTkOSVdS6lXV7doLO1tZowruQ7HI3DH3Q3oO4HvVGO0gcILmSNdwYIBypx03nsD0p0t7PprGOdWv7dOVJUiVQfQn7w9jyMGoJLpGiWRdjwEgAqcbR+Wcj0qeVOVy6UJqNvxMrWh9puVligjCugUxqfl4GAR69M5rAvImhvVinIJ3YdfvDkZGfzFdZJbq8UgTfHJFtzFJHtAUngjnntn61y+rQTyXCuJdgJCsX5AH97PtWc42OuEk1ymvZ2l1IjGASzSnap+bqB2IPGMcYPFMls2gnL30lvDLPKViQyA+byDtAUEjAHtVZJJb9Y9008iAgEBslj0yffvVxLe2tzGgeKeR8psxvVCf4i3QnjtUJ667GEYOLs/wCv69DTjtLS3ihlht5I1uW3GZ3MS4xjCqev8XU88cVLp+m3EVxHJHKkIYvEVAO0Mw6gc+i9PrzyCmm6lIk7eZLI0LAkxgggntxjH+Oa17KeCKJ8q8aH92sbbnQsTnuNwPsMgY6iuiNmY1FOCaev4mO0btbfZtRglRvt32SQswYBpgWDnGPlyBgjPX2xXM6g93PdR2wdIwkht3ibC5AJyGx2JGR6jB716Lqtnbata7bwPKQohWeKQK+M5X5gRko3I6HJ46mvMfFT/wDCOXaXr6hFeN5ZeaO4URzNERgMp+7IFxyOGxxzgVFRNE0Kri7ssW8jLA6CR3EbfJ5rEmA8/wAJzwemffn1rpbi8P2gxoV8xS0mWbO3Jzhc8bh0zziuWs7+0uLU3MTefBImRIvBUHnGQfmUj+tTWLSm3jUsVRSQIwv+o7/L2I6k+304z5mtDqm1P3un9f1/WvTTyWzqJl8uR/vbZSQG9z39+TVW/vIipimaBGY/cGWjIPP3qyWvN6yKX2EADbtHzAZ4BHbGOvrVkKlwdp3M5P8AH06Um1LRCjRW9zF8X6Fo+u2620t1bxLKpzIswVlzz0P3uR0yOmfr4T4s8LHw/dhTN5tvniZefpnb/OvpRtDLKMxx7H5EWAC3qcenFY+q+GLWZNr2ke3AICYOCexGaI+0hqkeXjMuhiNU9T2iwcD7/IYEEY9D/WsvxArxSySP9yQEnHI4/wAmrYl6kKxbrtUAk+/t+dVdSf7ZbFCjH5eA/wAueOldzWhMVadzgbuyBMMgTaNgJdBkjvxnt0+lZl/YlYnkcZT5sn2PT610s8gSNiMbCN23PTj17dxWTebTbloTwijjsR6H24/lXFVgj2qMnaxj/Di3P9nahCE3CK7dVbHABAbH15Jrb16xnFot1b7oZo1DqmeNw54P5j6Vm/D0tBqmqeSAI3u+Qx+XIjGOPXn8ciu2vVilsv3ahUKhvw6flSgr00RKXLPbQk0mZNQ0q3u4NptpYw2x+sfZlH0IP/6qfPpioF2RsMgE7x09ayPh9cCOPULHhVjlMsYYclW6gfQ/zrsY0ULtG3Y3pwB+dbpKUVI45VHSm4nG39olvI+GYwvnco/nj1HYj0rE8QC3vLOYXpRmXEm88cMBv/Ann8T61u+KLpbZZy8mI4gXU8Z968y8Z3Ttbxx7hGWHmSDdkqD0Q478dPasJT5bouvBygqhx1jCt3ZTxNatcWO+S2ZWBAZFJ2nI7r1FeWa/pM2jagbaYh1Kh45B0dTyDXs+iW8FzplncwLNF5puPNfkrK4bOwg4BJ5I74HtXOeI9IGrQtAP9HeNcrHIpJDgE/K2OQcHg/0rqg7JI+OleM2+h5RRU91bTWlw8FzG0cqHDK3UVBWhoFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUV2ngXwm+qSR3l3hbYMPLjKkmU5x+A/nQJuxN4J0qOAC8uHAu5FzAjLkBT3Pue1el/DiV7SHUIZllE32uXdnKiPBByxz9Meuas6RobzPAbiUbFUrGoTBDehJ78Gr2jWR0/xPqlvllg+SdLdsFC7qoJb3+THPQHjrWEp3Z14KlKNRT6s6yyvprmJSUdATgPjG8D/AGa0bHUbuzYuiZXaR+8P4/gada7Y1ZmG3aoyduM5xgKOuPQUszL5QjkV1VfvMOOOC3+FCbXU+ti1JcrWh0mm65Klgs16gQuMRrA5XcBnJJIOPT65p739r8szSzpK2C0jIJNx/wBvZweO/Ga5WVnnljcxrk4CxqMIgHAyO9SyxzZEU7PtHzBc4X/Cmpu5g8Er8ydjq7myMsZmmkhljKlVEbZyT/8AY/rXM6lpj2t5FNayyRKfnBkjO0r6EDPP4VNGZbuxEBWMw26Fv3hOWbcNoJHUnOPoKrrf3enQ+TcSB4ixVkYGTHqVyPl/MVTaerJpKrTur38iGW9X7WJ4kwJI+EbGATxjp09M9KpX8u9UXaq727/MR/nmtnWpYGiEsTXUUdu21XZVlR1c4UAqcg57MDxnms5mCxrJaxxXg6eSMpjnBJz9B7c0mm3Y0hVUknY52BTDPLbNIQpPyoT94f4fWrVveW9urLbsvy/eY/Mq57DHU96i1xI7jWPLh3mJ5JCqsN2ccYBH3uuB096ltbG4hkFvCmyVFE+5MfLGBklSfYnnrXO4Wd0dLqQdm3uXbEzzSAeVtDZSJHBLOf4nwOVAHQdzx0ya6AWttZwedq965BUNIFwS3YKeij6CotGsNOjR5DPcQKzFmm8xVIHqWA5B9fasTV7fTbm6EWn2N1dhhlJbre2856hSRwfU/ka1T5Ik8yqS5VdL0/VkEviqM3j2ug20UgRg0tzcy+XFGB3eTtnoAMnOABXNXekHxBeyyalLM9spPmNGhgSXuIxH/dHBy3J9B0rrY9HkRhbzS2896xyIkOEtQepVcbQ3+11PtVbXZmgtTpun7QyAtJIDnjucjnj8+3esJ81ryLlGEtv68/M8o17Ul8JX7yaVGJLIr/pNqxwiHONyDoG9R0PB6113h3xNZeILVfs8qISpYYfGGPVT3U/55BzXkfxRvY3uI7WE/u1O4DuT3Zvc1xmn31zp1ylxZTPDKpyCpx+frVUqbnC73PnquYOjXlFL3f62PqG7cG4s9iFj5aghDnjsTjsSK3NJlaR495VRnC+Y2FH414hoPxIFzFFBqKRxXAjMXmAAK5JGCfYYHBPqR6V6Hovi22mcZYxOB80btyH6YUjt7d/WsrOnLU76GLjVVonqkT7zlVlZ0BR+QVx0PuRxV+C3tZSAFUjj76Zxxkce/P5Vyun67E8Si3Icdh93Hr3OTV1r8gxHzsEDIwDluecntiuynNWNFBy8jorW6aa9fBwnGPX8Pw4pL8mWJo8FlYbjGGIzjvnrnNY9tdNFdyMEIDdu4Ga0byUy2r4wT6HByPTNaXuiZ0bSRwmsXLafqYMjyi0mkADsDhe3X07UtrMZLiWGTChVDMTxgY/rkH8K0tbtYdT0S4hmVc4dFLNjaSQeMexNcRa2k+p6lDY3Fz5NtPbD7YW+/I0RAZB3APGcfw1x1L81t7nbSkuWzOk+H6rPpkl10W6uJJQWGWCk4U+/C1213MgsCrkGXAYAH26/TI/WuAvLuO2sreOAgCJsZT5cbew9PalvPEMV1BbLBMGuHPkquNpLHHB/MnPpQpKMbFVMO5SU7l6xujpsltOAzrcxAdcddp69uR+pro9L11TeNDMzYMLMnHBIOQPrgn8qz/EFlYS2lpZpGkjxxiN32kAkD6/0rnm0OOdQpLJgbVYOQV9xzz2/D6GnzSh7qM5whUhz2LqXsXiDXZbgKJrGFvLiHLLJKDyxAHKL9eWHtUmp20V9qDtdRI/msWcmEdcYOOeMYz+Jqp4fW40y4i0W6Eca7f8ARpFXAkUZO3/eHb15711bWKvb/PtYADBUHj3oUbq4nKEo2OGu/DsOj27Wcq+bplw+YgyDKOx5jOf4GJwDnhvY1l32ktdSFtySt54iLMzRyRlV6EsOMt3Oe4rvHtRd2F5p1yvmRPEZFUZ4GMMPyBI9wPaqVjAusWbiRc3sMwtLkDAJcKGWQ+odCHGeMk+lax8j5vG4ZQn6nhnj3wvLqW6eAsL6EFUjkVd86jkr8vdR3PUdK8odWRirKQwOCCORX1hq2lRkSgptZVBEsYBBTDAMw6gDpxwe9eW/ELwjJqMJ1G1hj+3YRFS2x5ciKvJJJ5OACPritYz7nmyg4eh4/RT5Y3icpKrI68FWGCPwplWAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUtS2tvNdXCQW0bSSucKijJNep+D/AAELeeCTUIzNcvgqAPkQ8ce59+1JtITfQwfAvgqbVJ4rvU4mjsQ3yo4x5pHOPYdPzr3LTdCt4fIimQCUDMXICIAvA4HX3P4Vd0LSzbxsjrCZD8xOMZPrj3rp4rd0iRZE2KvLYOe3T61jKbZ00aVveluZiadG7opDhSQ6BFweO5/U1zWpPHZeOrreERZLa3jUseAeec+nAr0FIvKQyNuRnjIx3Uen1rivEUUUvj3TBbxmSeK0QspjznMhK5PXp2HPuBzWZ2U5ck00b9mX+zGR8bkGSSctjPUj/PBFXrdEmXaCcNx16dz/AErJ0m3vkTUZHuI1SNTF5IK/MGwOnJ44xknnNdDHp7rojQNNGl3BwqsoVw3UBifqR/WqPdhVVtdxsduryKsUZA4+Yt1pbiykdo1PmFVORzg/h7Vc0e7S+MEyBVLg79xGE4xjj0xWxLHEgYxcouApc43+mB+vNawStdCliHTdmZBxaPEjW8v7vE3mHplcdMe5B5/CuPCSzX0zo7qm44Bbh+a7LU7gwGSBXVt6qm1QFUhBxtA9yT+FcgEZ3XaGX5+4+8frWdRXasdGDV05PqXbV1iCW7TM9s75nhK5Vwcd+oIIyp7fQ1TuXjlglWYvDd+a0DsPlaNUbLA44wQQucd/arhtzsdyhaILyyAk/lTb64c2aXSlTsVYgzYUNIiAHPpu5PvzSV+ovZL2iceplrGIXjnVJUL/ALxeOnOa1HWC7thFdR7cbnj2Z2q5GGIXqM9OuPaqlmGunSeSZz5jYLkfnx1/AfpWxDaISgjjkckjHzbf5A4/SpTfTYutSinruizYwQPMqiSFokTdDGoyr+zL6gD8cZ71fs7Caytpr2SN3upVyrS/32zhmB54A6DpWRHayr5zrkRyNt8lOd/Q/P3x071oxTT28StBJkhszjJ2g9lHoPcdeRW0WuxxzjJaJ3KuoWsttay28LN9rfDXFw5+ULjnAHfpzxXn+s3EEsM0dtt+zxgGWbGfMYHse6/zrufEF2t84juEgj++Y/tCny5Mn7rEYKNjoSCv0rzzx3d/ZbZ4o42gkjH7yFgPkXHGwgYI/I8jrXPiGrXR00W1B8/9f19yPnzxndC61uUpjavoMYJ5IrAq9rDl9TuSVC4cjA9jzVGumlHlgkfGVZc83IKtW99c24xDM6j0zVWiraT0ZCk4u6O/0H4hXFqxW7MiAjh4j0P0Ndla/EyKUxJ5x8zG3cOM+x968OpV+8PrWDw0fsux208xrQ3dz7lhI+1F2DYOeByfrx1rXWFPseI8hQuDtwc1nwRM1y7nEeMfTJrXuIjLbnDiPqcjnFbQ2Po60tkci3yX8lvIyhZF5QdSfUZ7YLVy+pQzwjzd5DRXwVmHynEnyMPoeDmuiupma/Bby8D5C6g8A8cA+/OawtdIFnqaDHmApMnTOR1+vNclVnSoNSXyL8WmQ8xyExxkbfofXH9axtW0N7KVL2yBS6h5JxnHYnHoRwa6ywfz5gZRuyDkjmpZYj5ROBg/uznkfj9e9DpI6JSd7Mz/AAtcpqMBZowtypMcqk52MP6EHI9a6K6tIhEHideexPIPqAenOK5BIhpGtRXSny7aUiGbOfuH7rfVTkfQGvQFgW6s2hwpAY/N/EOetVD3lbqctaVmn0OG1K1N5btHMpV4zlCvLIf4gP8Ad+8Poa6rwlfi8t1trgql3Ads5x8mMcOP9lhz7cjtVGWE292mHUg4ILHAJBxj69M+uKqsyWHiO2G4LDc/6O6L3Rzujz/uvuH40R916mdVKSsi5rGpJb6jH9mt5WlikWRHKkLIo6geg5rndLuo7TxIfmaOx1aJbdiwx5Vwh/dAsOAGDFQfULmu1aKO9YIdhYHc59G7HP4Viazo8TK8ckIZnBVgV4Pofqf5/XjRuzOPFUFVgor4kWtSszMN0kPy53DcDgHIGMfieT0rl9UsF+Q5DtKSULjaI9xPAIAHAz2xW3omoXEhfTdRG7UUybeZh/x8xKBkH/pooPTuvPUHF+4hBXg7GDiRY2HPIKkc/dbPPv8ArQeJKNtJHgvj/wAFJqCzTwmOC5hdo98swPCjJ3HrjsDjqRXihBBOetfWmrWCNHI8d5OLeRHUSsnmGJgNodlOWxkHKjrXjPjbwtFM8r2sUov/ALxGwKmcDMeehIGWzwccGrg+hx1I+zfkeYUU91ZHZWGGBwR6GmVoIKKKKACiiigAooooAKKKKACnAFmAAJJ6AU2u8+HGjOb+G/dVdyD5CAB2BzjdtPf0/PtSbsJux1/w88KR6XZLPfwK17cqDncQ0SZ5Ht7+/wBK9SsbNi6RgkqgC7DjCr16+579ay/D+nSwzzmQl25VlznK9Ovb/wDXXY6ZBDbLt3M7HAY9l74FYSk2b0qdtS9bWgRABlt3zlsfdP1/CtAw7lRVJVVB4+vf60238wlXyEjyfkbkgdKnkuY0JGQAGyGbHpUNHTaxVuIN0m4sijPzZz0/wxxXn0Fy13ruq3sJYxvcGNH6EonygD2+U10mr6gzC6lZmW3toXuMYwDgEjPqcgADpzXOeG7cx2MMUmPPYDLgcZIHJ9+tFrtWO7ARUqjb6HXzTLa6YsflgyfLuwNuBt7/AIsfyNYwnnt8y2spWdGyQwyrjHQ1e8gxyOEOBIwDNISSceue3SnXcfl4Cou0jIIHJGOT9KuSvqz3KShBW3MPwZ4g8m81KzuABcRzs20cZjY7gwHpng46EV3x1tJHQOQU8vkA8jJ715PEguviJbLCSptbKaS5mJAVI+CNx6YB9e9dBbeOvDlnfsJdc0mEqxGDKHb/AL6VT3FKi9LNmGKdPmblud8lsJikhtneNz1MZI/PtWDLC0F39nSJhuJB2jORuOMZ/Ct7w/r+ja6m61u7W9IA+e3u/OKnOfm9M89QPasrUo1tvEaqJDsZCFfrgb2BBHqD/MVbi00Y4es22iO+DK6xxIxBUEAEZx0rN0+NpbC7tCR5mx2LsOhJPrzzz+dbkY89RMS2UY4BPAPA578DioLIRNdO5KKEkOGUZ/iPfv1pSV3odEKvutGPomCXi2fODtG1TuwBwa6DTAqLEs4Rfl+4Tg9epHftWXZQTAXMeH+0WxMb44Zs9O/IxjitGxtJUSNwWQOTnA5P0FOmrRLrTU7u5qFrcyQPbbiAcMEGNhznqfw57CpGCxxtMUVFwEY8k4543Hk5PfgVRitRFI8kkjRqAQQASSv0/wAeKvGdLeO1/dqEcYbzV+baR1BPHGQcYHQVSOGemkdTmtXgkk8yNHDIWA29+2M+4HbtXmXxKjS3sL5mmtykKHY6ZBYHqMHqARkY9TXqzLtk3zrp7Q5HklbQI0uCeSQQVPf5q8Y+P2qJDpyxQIYzcDg7QOM9OOO9ctaPM7dzavX9nRd+x8+MSzEsSSTkk96bRRXcfIBRRRQAUq/eH1pKVfvD60AfdUGTcRrvCjAxvbrk/qa2dWkhWJdsvlkHaQnWsjRCkipE45OGyAPnP+0f6Vq3turL8q7WQ/w9/aojax9fUac1c4jUruFJx5TqpBKMjHk49PXrXN6rKJYbhY8L53lxqOxOcA5PTrXS+I7UzLLj5lXlgw5X3HeuPcg6xp8GGVFlEp3cghFyCP04rjrHoU2nY9C0y0wy/L95sKD+f+fWrGoRJHKS8ZBcYftx2qDTZ/NI8uU4UZzjBNa3iV8LCJQiyMvChzkkdRiuiOsbmVSclUSfU5jVIEuLeaGWT5pEO8jpnB5/U/nW94QvozpMN1esu0xjIz8xYcHj3Irir7UJIZRiOQAcOHGCcn/61bXg6WO5tJ1YfIJ32jIGeR1/Ws4StIKsE48rZJ4iuoZLpzun8krlWZANrenBPesbxRq0Wr6UJbeQJfIoPl4O4SDkEH6gV1r2trcDGMsDtGOM+vFcrq+ji0nZfK+TB+X0HpU1L6jgk7Jbo6XTdWjuraG7jcbHUOSCMDI5/H+ua1L947mzWTYGlIA2L/dP97P+TXmNt5+j3YnhVpLNjsmgHBYH+IDs3t3wR1ru9KvI59LhuEmDxsmIm3cNzj6/1p0582jMp01dPqch4gurm2R9gCyqQ0DoMiJ1bch6A5B9M8ZHQmuqs7uHVtOh1a0SNI5owxjikIZJBw6H3DZ9+nFN1fT1v4sgKzYzgrkE9sjv16VylpOfC+pLco0jaNcMI7+I9Isnas3Q4Kngnuv0qtU7M87HYRSXtYb9TotShlSPEu+GPHkmckuoHVgTjIz6qeOtcD4x05TLKbP7NNG7b5LNmWPaqfdcMeJQQWBYc8YIr0ufcHe2juFEhfaY2A2gDj5MYBJ7jHvXN+IIxDP5V1bTWOUkEbo6mIBj8pQHocklygIPOcYrVao8OpFtHzn4m0ET3kZ0dDI7RNJJCI9pjwfu/wC0cYOR1rjiCOD1r31bNhfz3N1azPHDGwmltSELgENvVj0dSc4/iXpXmfifQ7cPDLbiSF5Vf52wUmkDkDac8ZHfpmtIvmRzNOG+xxtFWL20nsrh4LqJopl6q3UVXphuFFFFABRRRQAUtSQQSXEojhUs57V0+h+H3wbiaPzFjYBmzwpJ4AH8R/lUykogUtA0KS+mRpVO0kEJjqD6nsK9l0DTRa28aKyoI1wJGACxegz1rA8NWqwSKA6QmVWzKclnHJCjHPOMDtXeaLC727XE8f7oHckS4ULnjJx79qxcuY3p0JfEze0iXdErJEFyCwYnBPoRn1xx3rfslWBUdmAQZKgndzj9TmsTSkcQvNMsTM7bAv3mYAYAHbHPX1rorfzYlJLRGQALuU4CHOMDAwenOKGdMYMsiZ4IWaRAzAfMp4+g9+vSsm8llkwh3MXOApfB/wA98U9rZ9jGGUbeWLFT1z3P+e1SwRQwZZzLLIv3gDwv+JJ6nt0qNTTl7HMeLLoQeGbvP7v7VJHbqFJHVvmx+Cmo9AldryF3tIigJ/dSzMo6YGcdB04q14rha41jR7KNMH57g85yQAi/zNX7WRYzFHGmExycdOeppRTTud+Bp3TkasFx5Tqk01jLcK24o8zAEYOeQDjIxj3FM8QajFbLLcRtMYjiNBkAoSoJ6cHqMEHHBHBqTY08zykle6nvj3/SuY8eXUFhbSTPujjjRnkQjAJG48+3T86c6j5T0KcFKav8zz7RrabWPEmsX2yN4YpTbK0iiTcRjgIflzkkknPUYFdtZeG9N067aK2tYbe4tnf98iqrckjrjsN3bvzWf4IgkttFsLYMRIzi6cE8mRzuJPv2rfEBacykZEhB+Y5Jbd1P6/nWcKaUb9TpjQ9prU/q4mo7LiFJNVsIL2WMARXcWLa8gGMBUljABAHRXBHapNO1O7vdSsob/Ure+heO4jhu/L8m4SWNVcxzp0V2jXduGQdpwTkVq30SwQAjGGHIBHOfX8TXG6XYrcfEGN1UubazcuVwM7m2hW/Ddj8aq7jJJHI8JBRc6Xu/l/wP1PQrWeORJA9xHDGSWVftccefX1I9RUjwm1t4LtDDcsJdxUTq+9RyQDxlsAkDOcjFVy6q58pAQq+XHGnsBjJ78nH4UHZHIz25jWQsHDKq/MQO6ng//WrdzRlyTT0Zctr2NtZu5mceTLGspxwQoQcDPGenet2ERExvIApkJ2AHgAHsc4/H614z4Z1G/k8VahHLeSPapA2+JwMK7vnj8jj0Br0awQyxB2d2cjywWJwORgD0wPSpp1E0VXw7j+Rrxm2lmXyhFOi9WDswznrgKScDHXipdTuEikQz3ccMzEIApYsflzjAHy/dHNMhUruWJnDZZPM/H278d6WVVuVdZc+Wox8wGCf6/wBDWt7I5VbmuzmPEhZbXN2IJ45QQk8bAujZzhivDZ4yD6V83/HK9nk1S0tpNwQr5xzzk4wOevrXtviOMB5IZCypjnc23cuOCffFfN3xIeN9bjaJFUNHu46/eI5/L61zRlz1thZrLkoKKe7OSooorsPnAooooAKVfvD60lKv3h9aAPuXwvOGsoJHPUA9DyOnNb0crS28j8L6YUn868u+FXiOLVfDVrKnyPCSsgDYxyTj869GsJ2y/mtsBGPuk4x7etZR7M+qptVoKojM1ZY5ZmdgyOy7dxTGBXJX2nrtaSD/AI+LdxJCScqMA8Z9G5H412OpMvlMYS+BxlgQo9epzXMCQJfNGWDJcJswQAo7/wAwKxqWvZnYoy5broTaZcJKkckeQGYHIGQc9AOOO9aMtolzEdq7Y2HODjNYuiFRdXdk26OSFjIkb9ADyfryD+BFdHHg3DjH7snKAnjnnr/npU05XWp2Sn1RiXlksZTh5FXngc49BmqFoJ9HaS8sCs0LHFzAR+O4f3SR0PTqK6e4tcYkXcUPIJPash7TbPtLMN/AOMcdx/UfiO9Eo22IspI1NPvoZ0e5tWDpKWAJGCvHIx2I5q8scE0LgqzggA5OVGOMj0zXBymXTLzzrY+bCcNLHkrntuUeuPzFdPpl7DeQW9z5uYEKsiqmdzc/ePpz0+lKFS+jJnS0uirqNltRvLBBxggqcOCfu59f6gVkWF2dMlkglkVtPlZmLE8RyFDhvYEgBvfmu2uQjRi48xEVjgqCGLDudnpXGa9d2XkynyBHGg+fe2FUHPI/Hr9aqUOV3MuaW6Wx22mA3VlGcZfYCzKcAen49Kz9X02O8SdJCpimQxyBeVOV71D8Kr8alCIfPQvB+6YhskrglW/EcfUV2F5HDEHHllvlZjtXB3fT14rospRuYVKiU3FdTznTriW50KOG6jmnvLFmsbhMeYJAi/LIScYBQocgk+nSoWvGht3jSOe701zi4thcbzGuc5j352OOeejDIPWr0eYfEl9Ez7PtMEcxQqSjsjFMkDkcMOen5Vbv7G6eAIxfzwCwkkZXc8ggDjkc469+amD0ueJXpqFRw/r+kecarpoM6eZdRt5UpeKVbdZA6Zym6LI+7gA85HOM1gTNb3Rfch+0felt7jkNIW5ZDj3yNp6D1r0LUUkNxtliihk/1gEg+ZB35GBn8Mc1j6nYMDBf2i4lQlpU2KwIXggA5HK84+p7VLnyszeFclzI851bwhBc218yRXSSDLwBDuVX6nOedv0PFef65ot9ol49tfxBWUj50YOjZGeGHBr6ESNmW3gt3ma3VgtvGyCWSHcPlwT/AKxcnBPBxjNQX2jWWtfaLaS0Fve2fNzGATHNGCMsi5zj1A5+bIq/aWZy/Vn9k+b6K7Xxz4Lu9Jv7m4sLWZtOLM6qInBiTryG52jP3q4qtE09jBprRhWppWi3mosphjIjY4DHjP0q/wCCdBbXdUKfIY4huZW/i9BXt+n6JDFBDarEFLKN5xkqo5GP7pxWVWo46I3w9B1X5HA6R4WgtLR5XQlVYKXP3pH67VHp71oizEaqrJudRkIvIGf/AK9dnfW9uIAyHaoOE9AB2H06n3wKp6RaJJP9qlXYqtv57Y6D9c/WuJtt7nrU8FHsS6NoQjInn5kUALHnpj1/Ouy02zldQhxsySRwT74AHSkMYi0yWQxquXA8zb87ZGMA+ma3LC2VFtLJlJaRN8x3ciNcZyfet4o1rU1GNh0Fvtbjcf4eg+VPx71q29urnzGU+UpCAF8jIPAHsP61XtseWZpCsUGxp3JXlE7fiRgCrO+Q8nfvzlYSOU4HBHTcM89gT7VZw2uMuwYhsjjVWYbVGc4yeTj39T6UtlbLKhyV2AlT2zz+pJpYIDNcPIylxg5JXaM9OP73fA+pq7GWm2+WuVA3K/Uc9/z/AMgUtylscB4lli/4TGdJCoFpbRRlQRgbstg/WtC2O6VWJTAA2DI9Of5mufvbdNS8ZazeIJDbrcCNV3ffMahC34kH8BWrbQjIzkxgnaWOTg+hFJK57OChemb0s8ttpwHlsGlyA4wR+deQfEqS91/W7zTbdyLa0sPtd5L2WFecfVmwoHvXoV4qwh9jYJIIJPUdP0rj7Py2+HXibU5G/wBO1q5W0VlcZMSyCONcegKyN096mUU3r01Hir0qSUd5u337/wCXzN22u2SOJJRhRGqnaOAOuCe/euktII7khElACjfl3CgjPYtgHr71w2n/AGsyqkbtgDAJ5PHv2H0rexPtXzPszucndhpCfxc8dB6U6T01R3OMtlobWrLHGyxsV2kg7gQc56HIrN8H2f2q81i+ALme5WJG65WIDP8A48WrOle4guTK7Bon5JVQqjHXA6YFdF8PcL4VtpZVIWSF7jpjDNISc9zxim2pTIrL2VK97s0LeBZUbK5I3EEZG5cgD8+fzpNXtvJtVkIG4txkYGfT+dbV1DvtHeEHJwBg5KgDP1rJvJ8WUcD7mPTpnn3zTnFWZxwm5u6OO0O3V/EOtFQq77naMHIAVF/luNeiWkWxLU4UEyMcquCR16jp/hXCeBws97dvuGJNSmI9cbgPw6V6LZ/vYlRMMwgcAE5AJ4HI/pUUNY3NMbLltHsOs3TyZCZCmSFBMYYD1PB5pLhWV0WVSS2TlTwwBAxnseelXRabIeEfkbVKnnA9jxVe/D2rF9zAsmBjk4weq9+Tz9O1dPTU83mTloeZ+L7WOKScThCIojgnJGM5IPcenFfK/i6VZNfuhGCI0baoOOB17fU19MfEy4+wWGoXcnmbfKMcYB278YJBJ6DkjP8A9avlK5l864llC7Q7Fguc4yemaxowtNs5M0rqfLBEVFFFdR5AUUUUAFKv3h9aSlX7w+tAHp3wZ1wWN/c2kshCOd6rnqc4r6i02VljBGXLDg4/lXw1p97Lp9+lzAcOjdPUdwa+yPAOsx6v4Y06+RizSwqM9ORwfy6Vi1aVz28rrXi6TNXXW6q23fjjyzuI/GuKvXiHyyOqseQT616PcxCSzYlhuUdh0ri9ZsfMR3GQBjjP61hXi2tD6LDzTjynN6vqL2WpWV+JFMhHksQeCSCc+/SuqtL5Z7eN0cbcB17kjOCoPsCK4HVbGO/tZrIkQynmOXb91x91vpnrVfwX4hd2Fnd7YrqFjDPGx4Vx6E/jj1BrmpzCUvZTUJ9dv6/rqezWZS4jUlxtP3AOcf59Kp6jZkRHgh92QQeQ3rWdpmoKGkXeAysQexwa6EzQLYn5FeftkcLzwT/hXampxJnenK62Ocv9NN1bLKEI3DcwAyVPf8j0rF0ub+ztVezBK210GliXPKSDkr9DyfzrX1RnjBaSd4w2cBfl+uO+a4/U5L2RreaWKVJ7dlkj3beeuVbHXgkZ9a5alk7msOa990d9Z4VHQsW3Ng+4xkfpTb+wtJUYyIpZwVO0ZGD61haBqsep28xIZZEyWiPVG24xj6jOfeuljaNoFGDvdd3Ld/b1rog1OI5XTuefRaddeEL6O+8PufPgcuySHKzKSMo3qD69uvavTbPxHba3p0V/aEpEQdyP96Jx95GHqDx+VZF5arKCNinHO0rjOeozXLyaPdQavZrpl8unQalL5MzTReYEkx+7cDIGWxtJPGSuaI3padDkrRhH32a1jdG48X6rclU8m1tEgYycIZGcMU+oXBGeOeetdRbxJHbOi7kXZIYtjEFZCnyg5yApx0A4OaztJ0RdEgW0tjOrSSNK05lBJlY8tKeBhsYHAwMDtV8OHiklmMww/lS7WyyqfmWRTj1GfpmrhseFVl7So5dzF1bz30+O7t4is0ByBLzuwdxVz0IPTNULeSEwD7IJB5TecqFdpxz5i474z+OK6OG3luJ7mBpFL5ZlZW+YOvOOmOVY4/WsHTliXU0WcbBcymJhnAD4weByMjafzoOqjFbHPX2mi23S2zL5aS7HEhONr/cJx/BkYb0/KrNkq/bbe7jWVvJI+Xf84bunqRu9OoqzcQXNs0sMuH8jK7gP9ZDjG33IIU/UGrWl2rbrYxYE7w4ifkkSlwCe3IBbGeOBWafQVeny+8P17SWfUXnyZY3iaDa8nDxnhlPXbuy3PavlvxroT+HPEl7p7JKsSOTF5o+YoemffsfcV9mS26mzCTwvNbwtIYz/ABYOFzjjgMTkfU14l+0Tpsb6BpV+Jv3lrMbcRZDAo43Zz1GCuMHNbRdmeXiIpx5luS/CHw8NO0uR545457hEk3SKF2ZHbuc8AV37aVPDaD/Wb7hirF8AoowSM+tct8IXg/4RWzSS7VUPllsv827oB9Bk8V6baqt4lm0LINpZZCORn6/T+dTUipF4GbitDib7Tnummhgj/dpH8p28Bc/e+taVlo4SSFVXAIBBI7f0PFdLfaWkkZMTbGdQHUgg9Tjp+WemaeoTz8AICqY+XPynHP8AhWfs0j2aVZPVGRrMYTT41JLKXiUIP42LcD69a0I/Ia4vp2/eTQrHARjgk/MRx6AdB61VeBru+0aJTlFupZm7BgkeFz+J4rUhhgjstPaXakEl9JdSy5+7DEvX3yV4HfNaRSMK0lJ/1/XQtXELQQJBLJsd4/td0Qu4oob93GPXkYA9qrW0YMQV9qceZJhiGDHkIWyRnJOff6VIkkl7dedPCEd5vtEiluEYf6tW9Nij861LJRITtlLkZmB3YOM43n0BOcDrgfWhrU4nJ2EETJCISMNxvOOPzx/+s0rFbO3mu3ZkjgiaYtjdwgLdPw/CpIFeScMxkKjsTgnOTzj+Igkk9s4pnixvL8JawUZcGymCgPgkBCT+f6496npcP7p5n4aty9hE8rN5sg82Q7sks/zH9TXTC1UYOzIGckdPpWd4Ss/+JfaMQfniTIJx29PpXbSWoazjZxj5cqvQAe/9a1pxVrnuufs0kebeMbz7Hpks5+VYgX6dQOc+w7Vj6tatZeF/AmkNFyIjqD5A+8sY545+9MevpVj4hxSXoj02AZlv5ks0Xd3cgH9Mn8Ku+LkSbx5JDGxKWNlBArFs8Nuk/lsrmm/it6GtWClXox7Jy/yILKAKQCQNoABPGf8APNbtlbLNM4Jfg7Sq9+f1ptjpzNbqQGjZvXn+XWrkduLVAQWDD5W3d+f/ANVaQg0jarU5tE9TB8TSiz02WUoUAifIxxwDWh4Mnil8L6Yd7PKYYo1jXJIyA3TB9D6VzHxNMt1YJp9vJmXUJI7QMOwY/Nx7LurQt5tR8gadbM32OFVXy3faoC4CDHQ4wPxrKE+WTbIlGTjyr1PVY1injBF1EpdS4R8q6r0ztIBxmsDxZJHFEWjcMEwCU9SAQD7455qu0kqaUEMt0wLF2VrltmcDjjtnnHasDxFqk1xFMztLIXQKfOYsFzxxznHuc9q6Kklys4sLRnz83Qg+GaPLBf7YvMjS/liLYAG8sHUZ/wA9cV6pp8QklYRzIwdAyHcNu3dnAGc9+4GAa8j8AtPbaa8yyFTNcSyqhXuxAOfbCA5r0OxtA0fnsscfnDOxNxB/M89O/WooNciKxsZuTbdkdp9nKoC6ZJONocZz2A5rmtcm+z+YZUuFdXyAY23HjkhsYxzirqRQlCLiBW2gKrNFuXOONwPIrD1QxJHLHbRrFgo6R7iIg3TJAIYAZxlSCPfpW8rbnmQUou+582fHrxcby7XQrdSqQHdI+R8w7DA9eDzXjdbvjXUk1XxPf3UUXlRmQqqltzYBwCx7n371hU4KyPGqz55uQUUUVRmFFFFABSr94fWkpV+8PrQAN94/Wva/2ePFBt57jQrmQCNz5sOT0/vAfkD+deKN94/Wrmj6hPpOqWt/Zttnt3Ein6dj7HpUzV1Y2oVXRqKaPvCzcNHsy24EMu0E7vUH2Oe9UtZsmBKAR/MeOeo7j8RWP8OPElt4m8NQ3lgw37Arxk4MbDqK6TUn863jcKu09WDDK468GpSuj6ijU5pKUNmeca1ppEjSKvRtuAOAPr61wuteEL/Ur/UNW8OBZNWs1ieazwB9qgbIDDP8QK4x9Px9cnCTF/MU5wQ643DpgEf57VzmnTfZPF1hIqsI7iOW1Zc+gEifU70AHfniuPkUZ+p05jGVXDt9Y6/d/wAA5/wn4i/tCwikMflXUDfZ54mBDxuD0cetehW9yFeJySQ53Z/r71yvxG8H3dvdHxV4ZtVe5hjAvrSJSTcRKAC44wXXnpyQM1N4L8QQa7pqJA6l5FKICPuuDkfTkYwfU07OnKxhg8X7aHLPdf1c7S5g81FljKtIBtUhcsO/HtWNc6f5jfvUBLH5X6Akdq2tJk8+FF3MqyJ8pGFYfl3qVbb7X5isC7HAOR1IPBrfkUjpjUcLo811jTrrSLpdSsfmaPCyQqfvpnOPr6e9dToeowX8VpcQvmF2bnPQYGB9AePwrV1OzIikjmC+zAcY+v1rhNAV9H8YvYg7bW9Vp4FbkK6n94o+oIb86y5fZSstmbwqKa1PRrO2RpyXUNERjjsT71meLNPiurK4tlfymZc/L1Rv4WHvuwa6tFjgtY2yd5XGVPBGP88VyuuMZ9zM7Ak8n+9z/jW1VJROWLdWXkXtFvZNV8PWGozSjy7u3DSRhSGhmPDlW5JQsDle2MiiV3sp4rweYZI1zMgfcCnHJPPQ8g+hbrVT4c2ynwBYGUSiOVp2YKSpVDNIQ6nqCOD+PcVp6pC2D5yMWjGxZF/ukHchBPJ6njqOme8w2TPAmkpOPZsy7Znt9St1WNPOSRYppJGIV41UhX+X+IIQPQgE8YqHVrHy7i5QQFLhNk+Djkk7c+/Ix2qG2ZrtrZ3JiuIStvJiHAVB8qZyTjKtkHndgit7xQY5ba0v44Dm6gkt2VuNrjBKk++3ih7M6KdXVJlCaNbiMNtDSEmPnCDaQHG7PvmktLaO3NszkuYCpYodwchjtOO6ksPy7CrlrGSNTNwjBwsdxgfeU8qCO/QfgRmoWs4RHNFOPPjW0eOdSwUbhKSDjqw9TkYKe9Ul1FiKikrGvdK5vvLefdGlvJA7qnIlIG88HAIPOPSvHP2kTb2vgazi3E3E1+EChQQgRDn5uvOQQK9knnWSC3leaR5GhLRnGzcMcbhnjqa+Wvj5q0dzrNpp0Ls7WwaSVt5YMzYxj6YIqranl1Z+7Yg+GfiNrSGKKSQbIpF3hlz8oIxj/PavpHwleG8eGKRkBZiFdiBuIDHcMdvavirTL17C7SeMnjqAcZr2rwR4ojlu47iNmj2DKLLJyoI+YKe2T+NZ1G4Sv0DDP7J79Kxltg582TyFLLtfIIY9Sev/AOoVWKqkkcLElsqS4BB9+O/X+dcvoWqx/ZsyPJAq74iZCG5c5AQ+mcHFb8d5HdahIjtHCyqDskJ27wOcHHHH4dKafMro9GMnF2FiUW1je6jIQzWN18mBhQm7YSfYEnPuK0LxA+laPaRsPm8sOxPRcru7HryPxrP0t/Lj8TW0bscpL8hOQ2E4OD345H/1qm1HUJIrEy2jYkTSysCgj5pCG24P+9t6+lEdh1ZbsdpkE9zPZW7o26UPfXSSNlkLt8kZHYBVVuccH3rcAMdukcDsBI298cFmxxwccAAADtkmsjSvLWC5kZyYfMIdm5aSOPbGF4HVyuCfetJz5EDTXaASv98YzjJ+6AByx9AOncUOxz36GjGGIAGI0Vec8lR/Pnr+Pbmo5kE8Mtuqu0csDRlx1YMuMHnjOe3Yde1U4zLOgDxoI15aHI2R59fVie1aFnvmGFZxnA2kHgZ/mTk+v5Utws7HnHgiaSG2ihuMBoCYHQjkMnykH05Fel3kkSaRvz8xUbevBxnjNcr4h8PXUOqyajo4idpQPtFuz7fMYDG9W6BsYyDw2M5BqOQ6vcWS2qaVcwuuB5k5VY1zxuJViT9APyojU5VZ7ntydPEKE1JLuYegWbar48e7jXNvo8bS8AcTy5VeOhwu8/iKr300Efj7W/tT+VvvFjDoRIERI0UFgO5HSu98OaXBotitvbyM80shd5tvM0hwCSOnsB0AA+teYXsv2/xPrWo20hWCW8aONkG3KxgID/46ay7LzKjL6ziJShtay/D89ztLPVoEmZfsrbM7WDOqkdeO5/lU+q6xo3kuqLKjEYXemOnJyRnnvXJ2+WTbuYueh6j/AD1p2oAxRv5xGcck8Dp29625+VGiwqU1dmFqWLvxfpsbyYit4ZLt+O5ARf5mum0u1YzxITgNxERtO8euOtcz4TglvfEOoziMyeT5dsRkc4BY/wDoQ/Ku+a1iaUKIQqjCqxGDt68nH61hSV/eZ0YiWvKmWL2fyLaGII7hI13F87gck89iADXG+KDBBod5PbsjYgd9ozlcA8H9K7aW1khujJGkiBj/AAsew7n071wnxBwdOu0QuROFj65yWIHXuDzV1n7rZz4VJzUU9ze8J6YE0nTolATyLZY8kdX2DP513ZQIqKRGw2qCSeB61jeGUiltEKAk79pXueB+uAa6eWHzJpGKHglPkGcDOP8A69bQSUdDkxVX37PoUp3KMfNPPUAtgnH9a8/8X6l9js7m4LbkjWSXb0JwpNd/qT/Zj5ZGT2DZLY9celeD/HzU1svDEixgq924hUnkkEZb9AfzonfZGPMoUpTfY+a3Yu7MxySck02iitj5sKKKKACiiigApV+8PrSUq/eH1oAG+8frSUrfeP1pKAPQvg141fwj4kCTyEabekRzDsjfwv8AhnB9ia+u9Gnhu7RkdQAmd3ORz3r4Dr6R+AHjN7vSW068cNc2g8sSO/3kONmR6jlc/wC7nrWcnyu/Q9bLq61oy+R6fqkAjlcxsUPZ1HUfQ8GuFnk2+LdCy6KF1GIk8YXG7P0A4rs9RvWuGZtzNwcZYZJ96811q93+NtEtIWLTRu11JtCkoFU7OcYGWHX0BNcVRc1WPL3Po8TVVLCTc30t957bZu5Fn5TOHyqEqSnPr6g4zwOBwM85riPFvw7lk1B9e8JtFp2tk+ZNbPxbXbdSCB9x+fvDg9+pNdXpF5Fd3K7AyRgeahZQGVZgZQRwN2BtBPoK3T5bGNQVYlQmWyMg8rnHYkkk9e3auyUbqzPmKcmndHkvg/xTJd319p1/C9jqsD4mtJRh4mzgjHcehHBr0SxWOS3cuGMr/PlSMDGP84rO8beE7fxJFDd2bpa69aIGs7wKM7s/6mQdXRunt17VmeEddMyA3kX2e5gYw3Vs78wyqSGBx2yOD3BHrWcXy+6z2qNZ1o26r8Te1BBHCWmJDswJU9/pXAaxo51XWtPtoJTb3LzE2844MMwRmR/pkbSO4Y12Wp3nnHALMg5xjj8axtGj+1eNNIBYlEnM7Y7KqNz+oH41FV3kkdyptUZSfZjP+EjazBsPEJ+w6in34pWwpPqjdGU9QR/Oqt3evryyWHh+T7ZcyZV5kBMduD1Zm6Z54HUmvVNQsoLu0Mc6xSIMYDruA9unFUIITbqYYljRR0RAMexx0FTZvRvQ5P7QTh7sbS/D7g0uKCHRrOxtkkhht4fs6xyR5K4XAyB1/Dis53EMgtrqN1gkxHGzKcrhc7R2JHYdxwDxWg17Gs4t2IEzfMjEna4HbI9CQP5Uy5ImilhuJEHy53cuAD69ORnGc/rW61PJlG26OD1m2mstQeSNGE0sb2zkHAaUAyREj+LOMDuN3eun8VzpJ4PsLmHHltNFcR/KAf3gJZic9yT7DOKytdikudNkidIzeQFRmNc4OQUkGeD05x/WntMmpeAbC6bfPsklwEGCwjdmAI7AADqP8aqK3RHNZ6mxHNLDqjXMMSmaKJDHETtUNuwgz1wATnPXJxWILq2XWvssMfmgWjJJE3zbCXHl72PVvvMfbjqTVrxLdxafpDyQEmVreC2tt+HDmVVAkOeeASTk8kjoFrg7fXnRZbmVnKtGEMisAmyI7EfjJHGef9oD3obUdzGc7mn448QHToy6EQpEWfzQA2dvUjPB+v5V8qavfSalqVxdzEl5XLc9h2H5V2/xC14z2xhjK/6SxY4GCFBweO2SP0NeeUU1f3jjqSuwrV0TU3sJlOTtDBhzWVS1coqSsyIuzuj3Lw/qbyxebZlDLngEBvTP6V1d1qM94sWtW8LTQ2CeVeQKfm8rOC23r/8AWrwPwlrEmn30ahsBjgZ9emK9R8L+IX0yf7VC7m3YqLiMDLLg9f05FcLi6b5WenSrqa13PUfC2pwTa09pLcIkN/E4t5HO5JCVwrenIwO2COeKht7+SO3sZZIy7WulIrpkYV1Z1Jb2yCDXIeJNLeBIdZ0CT/QbuTzUl3gLbTk5GOyoxwMHofrSG/8Atltr80sDxyyRw3DRHIaF2lCyJj+H5mb8CK1Uu4TbSsz0zw/chmhTCOIolk388ckDk+5dvxFdNGiyzefKJhIo2/e5iX0HoT3J6c+1cb4OXzs3Jdd0srwo2dx2qVGB6kY/HIrtUmieba6gwRsE3O5X5w3OB/EAfXqfxqlsNq+pbgVVXlDtXKovrz/X3qcTFCQWITAADHjknIzxnryaz5Lh5Bu+cbjyHOeOwI7nrwPwq7Eiyf6/HA4Lcd8DgHr/ACoURvQAm4FQshYHJAzwe3pxSAIEYROfkBHqAD3J/wAntV6RD5e9SuB8wOcY6nr6e/eqRUxP+9cqBnpwOT2x0NJqwRlcyNcvrjSdNurpWkmjhhdj5KjKMF9O4569q8z0eEx6ZEpBWNMZbrk9D+tejeNAp8L6woklb/RnKxg7QCBwSB1Hfn0rA0m0X7NGixRjA3Fc/ebA5I/I1EFedmezl0lFOT8ivDbRg+eu7OeF9vXFR6yqywFy2SFyuRyPpXUDSkis2lZXBxkbMbR+PpXIeMZDYWFxPgZihZ/Xkfd/MkfnW1ZJQZ305Rqy0ZD8N57eXTrzzd8cct9OxnCkpwQASRz0UD869StYraeISWjrMMj7sikse4xnPHoce1ea+GdKew0i1Jk8to4FVkYlG9+PqTzzXSo9vJulkhw7IQW67DxyD3HXg/hWdNNJJo8/FU3ObcGaeveXp8JeWA5wMn5l28+3Tp1rx/4iao8n2KGGItLPdxRiMdT8248+2Dz6fjXa6zq6gvBMDLCo+RBIySKOPuP+Z2tkHkV53Ci6l8RII4ZWuLext/OVyuzc8nCZXJw20Hjtms6suZqKKw0JU7c27/r8EeueD5LpPKF1C0qqoeTy2B3sSfu8dBkZJx0rt7W4gESrKZkVUB3LHnj8O+c1zGgoLeHLuojXGEIGM9efbGfStp5EeKQxgKM5AGRkc9MmuuN0jkxceeo7FXV7s/ZfNLoY1UgMWG4HqcjOcdPpkV8sftD6oJ7zSrBJNyxq0xGT3wB/Jh/+uvonxJl7Nx5YMyqxVmTJJPAGfTFfHfxJ1Iap4xv5UZmjjYQruxnCjHb3zUrWZx4393R5e5y9FFFbHjBRRRQAUUUUAFKv3h9aSlX7w+tAA33j9aSlb7x+tJQAVPaXM1pcJPbSNHKhDKynBBFQUUNX3Gm07o7sfFDX/s+xmhaXGPNIOTx3GcZrrPg/ZTX2oTazqvnXVxdsIVy+WbPIwB8w5XbnGMEj2ryPSxC2p2guhI1uZk8wR43FdwztzxnHrX0hoUELy2xt1t1FrCVRPL2qGUucOw+U8sGIGTkYA4rH2cYfCjWeJq1mo1JN2PRPCk8kga3kxHMC3yK237q4U8jGc5C4IBGTiumRvOiEswMbyclWY56ZO7PQ8c8H261yttbASJZo8geGSNQrEMVCDauFPGRuGFyecE9hXSae3mwRbVUTzAySOTkxMeAWOMAkAn8MVdmdFKWpp3JAUCVPlXAxwOPTHb6/h3rk9c8Jf2lqraxpV9DY6gyqkyzJm3nx0DBfmDAfx854BHAropJfNiXOCrMCFlX5Tg/Ln1659/SnWjmBGlaVtzdjg4+mBkcGsZpPRnbSm4WlB6nET6X4nWQQrYWR+6A/21dhz3xjd1HpXQ+GtD/sQzXN3MlxfTR4MyDCooOdiD0zySeSa2xIZI3YLGDkncOA3Xt39zURmLE4ARe3HIx/n9ayUEtTsqY2pUjyO1vIfJdzOpjQ75ODgEjaP8aSXax2uN2Qchjjp1ANR2+12IR3xn7wB+Y459hVgqvG7GVGARjAPuPSrSucjaWxEHK5ZgXAGNzHHH9fSq04iMRLbgVG5GycAdxjuOeR0xVlisZYpyAAT0GOw/8A1+1VmVGUMGyVG4NuxyB1wP6dcVa0E1cxPEMGYluF2EIreasTl1KMMMnHIyMMPQgVz7XkifCa6bNwZ4biazjWN+AGkAMmSOpVsDPUsO2a6qZ8EmRgZ0QI0WMeYp6sG/Xn0rzbxfqCeHvCHiawRwVlv7K5s5G/1e2T+97Dyz09PerOSsuXVmZ8QPELahrMtraxy28Fv5cCLjOwiPAz6FVZufV89sVwuva7HY2UiwFBHEggDx8GQYGF+bkqOvv+FVbnVDaWBvC5e8upZHDSEB2J53kfwjGMZ+lef6zqBvbhQrMYYwFXJPzerH61nZzkcbnfUr311JeXDTTHLHgewHQVWoorpSsZhRRRQAo4PHWui0PxBPayKPNKv3Ytw49PrXOUtTOCmrMcZOLuj3bwl4ng0eNxcql/4eu42juYQNxiVjgn047jtUXi6wfwxfG9s5Td6FqVs0EV0SWBY4ZVc9pBtGCeCOeteX+FPE0+iXASVTPYO26SAnv03D3/AJ13Wp6vHb+HZ7C1ffo166vasp3bTuDbD/dKnlT2yVNczp8mj+R1Krzxsz6E8GW0dto1iBLNE3li3VwQcbcvLKp6H723Prt9K2opDdEXMIEdshIgTnGMdT/TP171i2kEclzBpxmhSMRqJGGQUtkJ4GO8km/PsPStxd19ePNJmO2jIAiVSSQOgP6H8h2q3orHTHVlq1k82U8KUX+7y7+w9P6/StSPYCRECuPvKSSPx9vp+tZscrGVeNrqMHH8K56ZrSVlGCzHPADMMfh9KIsqcbDVvIZ3MUQLhOGyeP8Avr19aJdpckMNmdwYdc+pHrVC/mRbaV1AjIVmUr0U46jsR9eakaRyfMUZQglcn1Oc59eRT3Jsr6EWpWz32lajaCQqZYHC71DbmIOAPTn865fS7jzNKgmCbnUKWPXAPXA/P6V1QSQFSWw2Adynv2rlNYhutDvXuo4Tc6fIdzJApLwMc5OzqUPXjoc9qyvytNnrYGUXeF9XsdvFPZixlMsqBpByW9McEevTFee+J4E1HVdNtE2+VJJ9okDnA2R4IB+rlfyqvL4s01IwIbwM7fdjRGdmPoFAyfpiodGvru7vL+4vrWWzlV1gSCcYlVAA2WAPyk7s46jvzVzqKekTto4f2Mnrq1t+B0AheVvLTDP1YAcH3x+dMA8uAxnexXGNp4681r6LbM6MZIvNeRvlAG7jGT75qlcxxySIFURyKWG5ejYPGRW3JpqSpK7j2OM8QBUk+ZRnOPlwP16ZrhfhTN9t1HW9TKgrPeFU9dqgBVz9DXQfErUo9N0y8ut2BArALnBLH5VH5nNc/wDAuAN4biJ+9JcuxJ9sf1rkjD32yZTTxMKfk3+n+Z7vo1uWiMTZVHKklcjjrjPpgVr3pNt5ayqd4UFPmwCuev4ZBxUHh+N2nLllG3anXpjnH0p+vrvfOcDZsiXHYEkn6dq73ZI5pvmq8rOK8daimm6XfXMpfy1B3HHDAD169Bn3r4vuJWnuJZn+9Ixc/UnNfR37RXiBI9AjtICQ9yREQT0xyxH6DPvXzZWNPVtnkZnUvNQ7BRRRWp5gUUUUAFFFFABSr94fWkpV+8PrQAN94/WkpzffP1pDwaAEopcHGccUlAC19T+AmF9ZrOZHIndiGKrISu0ucKuNu3d67cr3r5Yr6x+G1pIdDsGijZsWEQRJQUbLBQw7fIACDnvk+lJgviR0Utw5lSW4hlkmVBIsMQKvJEzAjaMH5gFxvPbI6810cciSzMs0UMjcsyBuQMcdzg5wMHpgisCe6UX7Rysywo7TYj+dpWAAC4xkIcbAecc/Wt6xQNI3lK3llmX5UEZ3EANnvz8xzx0zSlsjalLVk1qZXjWUnczKSZc+UCSeQO6jgY4/pWjboNmN/mv91iyEgn/D3pgO6NziMKmEK/eYgfdAPvirTbshWwzKM7fvDHYYHbtg+9YSZ6EXoVSPkALDpyF4J9PwqrIibiobaD335+uRWtDC7n0JOSQR39Khn09HdSyqRu4x/EfQ+1QtSnPXQrQy7PnIO0ZUYbjb3AHep5JkITag3eijk8dPSofkTmN938O7HAx29jUTsFOJBlG+U7jjjrj/ADzTuNLUkmMUib9uWVdybx/L2qszqgcEyYQgHjDRj6dqcrxTuymVgj4J+U5z246fjSkkZMe6VWU/IcbxyM7T3Hf1+tO5XkZ1y0czHLgMXx5g5XJ7kfXrXlnxgszc6KGul/d2F3HNOVwA8HzA5HU7XYfg1esSpHKzmFQM4SVcYyP9r3965TxfpIvLGeEhMtG8cqnJ8yNgVYZxwcHggZ+UfWqu7E1qfNBo+TPEGrtql482GAICjd1VRwFHtWRUtzEYLiSJ/vRsUPGOQcVH2zW6SS0PGEooopgFFFFABRRRQAVt+Eopr/xBpemJIyx3V5ChAPAJcDd7H3rErovh3A91478P20SB3nvoYgp6fM4H9aTA+zvD8JudM/tCNGVr+Y3EYIIyhJSBCDnAEahz65rQHlRxQqhkYAsqMCcSHHzSHt26dvrUt15drAbS1by47eFYI5GP3FRQHc9shcKPU1Vgg+0bC0LJbY8zYDjCjoOD3PJ+lZOJ7FKOxYjmit4/nwWxkKQMj3P/ANfnmohNKzoUWRmP95jjH+fWrUdpvHnSjBkO1SeC3sB2HWr6Wm5NrfKsY+6eBnHoOePes2jWfLEpwRuyHcr715Pyj8+tJahIoWRU2oFDIcdFxyh59vyq0Y2jGURAPu5GSD9faq299xijzwMYJA2/T/PenF3Oe2obpMhuVVTt6ZHc5AqedXKdQ3YZBB+lJaowVjnAIzsYjI+vP6+mKt3WSy7zhlYLk87R9f1p8pXOroq2cJWN/LLbGPzAcHJ7+pyK4C0gKapqodsO97JuCj/b4P0xivSLNscMnzkHIxgE57flXGeNM6RqcmprDNLZT8TmMGRo3CjD7QMlSoAOMkYzjvS2aZ6GArqNSXN1R1eixWcliwnPy84Jzx7/AFziuT1e8jh1A3GzgHdt3cY6c/lmsuPxPYS2bTQalZSQj7xFyoC49RnrXlHxD+J2nQutlYSvqBd1+0Pby7AI85ZVfBwx6ZGcfWtZVL6R3Or93hlKrUno+l/yOV+OHiMX2rLpFrJmG3YyT4OcyHoP+Aj9Sa6j9nu6EumTQE4MFw3OegZQRx9Qa8R1W7F/qd1drBFbrNIziGLO1AT0GefzrpPhp4vbwjrbzSI0lncKI5lU8jByGHuP6ml7O0bHhYfHf7X7aps9PRH27oThI1++pwMnH+HvVfXbyPDTDG4NtJznjsP1rznRPiXo9/aCS31CMqigsOQIx0G7P3c9Oa5zxV8UdBkm+xnUzFan5rh7QGSTZnJSL+He3IDEgLnPYAy63Ras9Wo6VNutKSt6nj3xk1oar4zuYIZN9rYkwRkdyD8x/Pj8K4SrWqXEd3qV3c28PkQzTPIkW4t5aliQuTycA4zVWtYR5YpHzVWo6s3N9QoooqjMKKKKACiiigApV+8PrSUq/eH1oAcwG5snFNpX+8frTaAFpKKKAFr7K8EQsnhtpPJea4a0hU5bnIjABzjBJwpB6ZGfevjiJPMlSMsqbiBuY4Az3PtX2Jo11b22jSG5mk2tDEWL/OSAzKXYgAHcAAM9iMgZzSauTezI49suslrQtG6zGFd7ZMg2qCE2jC/NtABJ43HIzz3GnukaKI/mG5kRAwIHPK4zgEgEYHYE1xHh5PO3TNKnzs7SbQY9uTuRfc4IJzye/AFdxaD92N2CThyoIDtk4JYDgEgcY/8ArUpG9BaXL0bGOB3eRR8gZiPlAAycjj8voakjZcqVGN2SCozgDgAY61AwjfEbLnPVCudwx39sUiTkwko+1eCcenY+wrmkejFXRtRSKMl2VWXqoYYHsOOtZ91es6NvJKIPmXHB7dfpmo4Z1jUeUhZxzg524xxwO1Y13dTTK+JwqjnpgEevHGKTZcKauX51YyvLh9uOinYceyjjjimtgxgiEuSdxbdk/j2qppYGR5iNIGUZkYnGf6cVrRqWU/dVQOMcZ/DPFLcqWjM6SyK5aMyxjt6ZqrNePEjswDBepAwc+47cdxW780bbRv2sfQMAP6fnVQ2UJRngDiVWJQ7t27jptboPoaqKNINdTNDxSL5quFlIOCf+WnsT0Psf/wBVVb5meJfLXDxDfG/AAwepz2GdpH+0KnmtPLdiiIID8zRFcqo7lR2qtPAWdoVJLnLRgqc5B7+oOCDnjHNaNaGs423PlD4t6Imj+LppbaMx2WoL9qhUnO3JIdf+AuGFcVjnrXvH7QmmB9D0vVIIiYPOOZQ4OC45Q9sjYvTOST6V4VheMnjPBFaU3oeBWiozaQzGelFSKhwXGMDnpSBdwx/ETwc1VzIjop7ptOM8/wAqaaYCUUtJQAV2PwfdYvij4Wkc4CajC34hgR+tceeDxVzR7yTT9WsryA4kgmSVST3BBoA+4rAm90RyZUEzEKdzcuSN2zGOCOTzjNbWnosi2cqF3NwjyAMPu4IByPbJ/I1geEr+2Xw6uoOD5MU0iyYwpBU/MT7bQOemCMda6nTY2RLQSIEaS2csq4IVnbcRn3G38KiJ60Z2WhOmctI8jOWbbAu0L5SYB28dSB3/ANo1ZhWJQCp+VewH6nPqabcQ/wCnrEwDbBuKgY56AfTj/OahhuULOUdAobA2jgn69z/Kokhv3loXfIDAttAfOc9ePTPH6VTkRFMiiPCkZ4GD15FWlfev3yyg46jrVSYblB3Op5+5wev/ANapVjHUjEZQtyAo7kfKMf41JJIYuG6IT5ieo2kdP8Krl5om3IWY8YboSD1G3vmrM+Joy9urJKMFPmwc9wfT68VpuZSk4jLQlI40YEhM7eSd3Ugj2GcUmq8x/f8ALKMCrLzg+34E89afpe37RPGFIKgYJzkA5IyfQE/qKdqCEBmLMCoDDIxx6kD0z2/KpkrMqE7nl/i3wrpGrhxqmjWP27CB5ngQSM43A/PwTkY6nqRmvB/E/gjTbW3u7mOC7s7hbeSZLZiCh2KxyCCT2BPUZJHGK+kdYQXttGhzJuyFZVGFIPzZ9cAhgDzwRXmXiuzkktorjyYzHck258onexAIILNhSjAkLjjpnpiqizmxcbLmR8zUVJMhimdGUqVYqQTnGDUdaGQ4E4PPWm0UUAFFFFABS0lKaAEooooAKKKWgBKVfvD60lKv3h9aABvvH60Hg0N94/Wg4zxQAlL2oHWlPHcH6UAbHg2D7T4t0WHCkPewhtwyNu8Zz7YzX0jE93/a8Ycg2YhW6gyiFMFTEn3fu4PznHUnkDt4B8Lokk8eaO0kMs8cU3nNFEu5n2gnbj3IA9gc19J+GLKbYJXhtwEZVhWJcxTurYmkzjJ3OdgJ52pgU07IykrzsbujWkcBjhheP7OxxuMfyM3UeWO2eSQem3nsK6COXMhiVz83y5IPUHkgDnt+tZkfmpKLfDSuYxC0UahXIDYzg/dGc9cHA69K3rCzPlsWLnGN204U4xy2OoGBxWUtTup2RHIyq0nlqSxGw557fMWPQduKSOMfNNOMRROCokby9x28yMT0Ht/WtI2iwq0nlFQrA7CM4JB6579PesPUGuZ9QayhfK2hXzpHQEtLw+1f90EcnoTWSXc6ZVLLQsyaosVgZp5FhtCh+YxhEBx0XPzNkE5NYsF8sr/6LEskY5V448DHoN3P1NWpNISad2aNrgs2WkmkLZ552jt+FbcUSBDgx5HIVedo6VMn0RpHYrW3mspeaNmbGcbsY/KtWFptmcAhV3Y38n86gEi5IwM5x0HX3qdIxKGKYJA5J6ihajatuJcSJ8u5ArZG0sgwD9V/wqtMrM0U5AO84DnruHXBHT8asxyENscYBXJDDORnqDUYBBeMgFhIDjoCc9PbitUjWDsVmXN3EA2x2yCyjnHQEjvnpVSCzaW9u2iMEV0sSPFumVmVejbFPPA7ngFunArZu18jyJEc7YLoJNwCYwcY49QpP5msi+guori1ltIomwrEsVCtu4GCffgkdSBTCdTmiePfHaOJPh7eWwgKcxXaKZGlEbCXy3AcjI+8OvB7dDXzGrEFRxwcjNfVH7Tbm18HRusheC8YKuQDgsY5Pr/AxB9BXyuAMgEHOecelVHax49Z3mx2flC4I+bqOPwpmQGyACPellZicE54xSDqe/FUjMccMwzk/wAzSEHuCAOoPrSxlNw3lguedvWnOCWUltzPzkn+dLYCIjHTB4oI55/SpSVBG0Hj19RTWC88krnr0z+FO4EYoPWnHHTmkIIGexpgfUXwD1s+JdI1rQyxF3c2qzJIT8zNs8lhz2BVDn/ar13wxqr6roGgXgUrPdxukkYYMwliX5o854Pyt/3zXxr8H/EreGfH2j3UsuyyafyrgHONj/KScenB/wCAivqOS+Ph/VtasVceT5o1vT1LYzv+S4RPXazFsej+1Z35XqdtCV427HfuZb2a7kgcotxcNFvHLOFO3ap7DgnPvTprc208cLOHaPqV7egA9BTrmRbJ9KnBLxISQBx85j5BHvyfrVS2ZriaWWdhvLEHJ+6AegqZ9jpg3t0LQfaw8zIwCFB4ye3PbNOUAxndvBxgMwwOPTNKkZlkDFQsZH8XXPb8PpU7BTgxlXAGPvZHp+NQiZFaWGSYFUWMgDjaOPrg9fwquWdQzxlBG3PGRheQPpzxV9I227MOFPzYznH9aYWQylXODkYbOT659a0RlPsReG2lnvkV4ijeXsb58jjlW47HBFamqOIYUWLY0eNw3McnHHbn6VzkMkun6pM1shL3KmJGf7qsx+8ccY4J49a6v7MlwgKneT1ZxyeOv061Td9TntZ67Hnuo2zXN1dbVCXEnEbSHqVOdoI68Z6jnpXI6nYzyC+s7rLW5Kx+UCG38fK2w5JDJyF/2G+lesalYRPCVdNwxxxgj8q4rXbRZPJtJ5SswYi0upXHUtu8mXPBBP3WPfg9aSauOpBuN1qfFPie0ay1++gYKAJWK7ehUnII9sYrKr2H9oPw5LbX1h4ggiCWl0v2WaMLg286Z/dt26dPULXj1WtjmWwUUUUxhRRRQAUUUtACUUtJQAUUUUAFKv3h9aSlX7w+tADpPvsMY5pCMNjH505+C2OmcZoQHkqQCvPX+VIBv50YI60Y9Tz1pccnJ/OmB6p8AbW4j1fU9Ys4Hku7GBVtzj5RLIdqg+39M19Ftaf2No9tYaZxJLKFQ4YFgo5Yc/L8+5s8kkA15z+zZ4WRdITUHR2knH2mUMFOxVcqm3upI3k5yCMGvSb+e+1PXzHoSKi28ItmuyvyqQSXKjuxJIz6DPcUpOyFTi5SbResLaHT4IY5CXn2jcrL5km7B+bHv2zW/pl080wjnsmh8wYDysDuH4HgmjRfDqWUQGS8jHLuB8zH3PeulsbZFTdx8vQEY/WoTuzq5VFbmdr6nTdFkukYSuijylcY3yscDcB161zNnHFp1nsnkEtxKfm/vSE8kk/WtfxvqASGxtmk+Td9ok7njhQMe/P4VzllMbq4MpJWQnjcozx/KpnZF0lJ6mvaq8yO2UTOAF5Zs/yPHvT1t/KmMcMjyLjB3gKKktkyFBbJP3c1N9nZfnYZz71jv0OyEbdSEptx8qqc/MKlCYBKjr1HTNIYyHJzuZRxnng09y72kjRKSq4z7VSiW0TWoEspQqu4H5W7qvrVeWEPJOvKgui4YEkk8jkd8CljmaS4gn4aMEhmHQ/40152RdTv2yYrRTDApU/NPgg9D2BA+pNbRMW3HYvzNHcaJLdBkcSMWWJ5MBlHGM9SeDXK3tzB5lrHMGkW3Mm0q2d0WFxu6ZIU5H0rS1y7g0XT7KwQRFUhECbsHzV29z1xnOe+TXlfjbxGNG02aaeUr50jySkfe2rjge33V9aUpWIbtC7Z5v8AtM+Izealp+hhgrWe55Yt+8pn/V5YfLypztA43da8XheBbe4WWAySuo8qTeR5Z3Ak475GR+NP1O8bUNRnupesrlunQdqiYoQhX5T91lGfz/H0q1ojzW7iuAqIrJt5zkHnBAqLAJA596e6nDAZOOcH0pxJ2bSBjaAMAZPf/Gi4DAuJdoALA4xmnr8iMpU7wc+uBjn+lLv+UHB3kZ3Ht9KeSWJYjKhCAcY65P8Aj+VJsCFoiBuwduM59RnGaDgAYyfUH9MVIQRtwEOMAgDOcUj4ZizcIDtwOuPSncCLGCwK9uhNPICuVKg/j/KhsibKsuc8EDinjaqjOdy4YEcZB6ii4it05HWvpXw74gHjH4YRX0cgk8SaFFtMR587YpwMdSJI9wPbI9q+dxCrKGYFYyOq4JHUgn8v51r+BfE1x4S8Qx3ceHgbEdxEeQ6Zz+YIyPpUyXMtNzWlU5JeR9ri/XUfCei6pG5ntw0EhZMbVjkXaTgcfxD6c1Lpcd1K8kkihnR2hQbiPM2nn6jjt1rkfgv4h065jvvDMkqz2OGubIt92azlY/LnsUYuuO3y4ru/C1wbPSrBZY5ZbI25RSZfM83dJ8mAP4sEZJxzikrbs6vattWLtsjOWZwWZxkZGR9cVsWsAZlJXAVemTg++KhuYBbQuqhyVOQwywK/3v8AGrFtOCjKOcNyegI9aHE1m+eN0R3aqnzLyyjpWdKFYFxszyNpGAcev61c1BSIwUHzbSR/+v8AGs93JVVBKuBzzzUbBGF1cztSQTeX5ZcMkqkgYJwCcD+eTXVWE2YvL2SD05x/KuP1CdYgszkhEIO5OCRnnmuttHjtxEicbwePUeuatSuiZ07KxYdDIpLgL29q5DxRp8MyGG4iEkUi7JY+mRnqCPzz2rsy5K5OMn1Gc/5FZGopHKwLAHA79h6//XpNXCjPklqeeeJvD1l4p8M3+iauQbwRKjXQjJYqcmKY47hkwcZ6N03V8Wa/pF3oWs3emagmy5tpCjAcg+hB7gjkH0NfdkKef4ruoTuWIacquG6Nul4Oc+1fPH7S3hdrW/t9aiQ4KrFKQOB94Dn6gj8RTTs/U5a0FduJ4TRSkUGtTAKSlOMDGc0o70AIBk4ozzzSk5o7GgBDjmjpRRjjOfwoASindqbQAuDSp94fWgc9TSL94fWgCSQkMRkYPp0pme3H1p0nEj8Y5PHpTeO9ACqpbO0dOavaFpk2s6xZafb/AOtuZRGD12jPLH2AyfoKzx1r6K/Z88ILaxQaje2xF5fxmZJGGdltkqAB2LsDyey46E0m7B5Hpen2P9k+FLGyt1MFpIVt7aInDMACA7nqSFBx29a7vwxp0aWyhE8u3T5RtfA+mepPr9axtfgaTW9MtwpYwRNO8eAT8x2rz24BNdlp0JghVpiqRxqQONuB1/Cs/NnRTjyrQ27e3RUwYwox2JP86r39xFAh3MoOQP8Ad96abnYBtwOMkmsPVfMGnTzoYzwQpkI4Y8Bj9Kpa7FwhZ3kzhNbum1HWp7jaSdwiQZ4Cj/JrUslKKmMrnge1SaXoemukX2kXF5dMpUhXZUyOpGMAn610Q0rRLbR5ZzaT2SpwcSFmLdAM5OSah0m9WdFPE0laKRVtMBs549TV1ZVkDDdlsdBWFbzzMuEAI9uw9/etRYWAWSRgGHPpmkopHZKFtWSSNiAoxwV5HFSWYCHzGeMRFcck8n0NOMEgmG/IUjPJ7VzvihrZTZXF55oNjO1zGEYBGcoVDOO+3cSB64qtjGbutCze3KWWlXU0shEUU7nIYHy1zwox6+/rUmsqll4asLS/MkQknjech1K72fzGB54we9cXod5H4gkgjkNx/ZsVxJqGoS5xvYt+4i28nbgbyO4x61ifEXxPBLdvBp/7tHwS2M7zuG8MpztIHA+tOUrI5W7kmv8AiKW987U7pYjZxkxRPnapxncyZPzZJHOBjFfNnj/xVNr2ovHHI/2VCV5Y/Nznp6Z5rS+Ifi03rHTLMnyIcpkSblUZ5Ueue5rgkjZhuxhM7Sx6A1MI3fNIwrVeb3VsEYyTkqBg9aVjkZwp4x09O9PjBxj5VXGGJGcZPb3qW1jT97IQzpGpLAZGQeAR6dRWjZzCOQXDINq5wv5c8/5601AdrbN3ygE+wz1/OrMsaLJJGHyvIUscHBAYN+P9agZ1GJIYto4OMnB4Ab68+9SgIxEwJG0ELnnOehxn8KuRNDHFPHcW0jXfAhcSAIOSW3KVO7I4GCMe9VwqhyF8wAgHOO3Q8d6sQpGSsxkdZRukG0DDAAYAPY/eH4ChsGQGJ41IKYYcdD16jH4c1EdwO7apyf7p9jirTEyeYUJkVQqru6hcgL36444oWVkcK+0ruXDKSMkcfhx+WKVwKsqMvyjCjPIz396DHlTk4K8c/wCFXITuYsYldnOWVgBnjJA9Mjpx9KjxtLhEVmz1XJz15B9CM/pTuFyFQysrhs45DdcfUUrQNIjMithOSNvPOP0yR+YqxOsjWYCRnYpyzY55P/1wDjjkVEshDsxQqw4ZBkYHAwfr09qE+oGt4S8UX/hrVLSeF2Atpt4U9Vzww+hwMj2HfmvtH4Ha8+u/DrT7xUha4MLxPKcsuY5CMOex27TXwnON0jlmDMc85/Wvev2TfEy22t3Xh+d2/fE3VumeGIXbIvXGSuD/AMBrSCTHF2aZ9YIi2sYiVESKMFI0TKgAE457ZyKz3DRfvGfzDJksEGGH5datxyEkMZN5ZdnJxtxgZIqzdWweSJiFDLwCvGOOvFS9D0oS5d+pQtTJcxRKhZ3Hy4x05yM9vaor7TbpEZ44CzLklU549quaKssd5cIREsrRfwnkMD6dweDVy7tY2bzQuGY/fViN3196mSW5NSs4Tsjhbr97ZzNECZIhkIeoYc4Pp2roLRzdT/aHZVjADEkYwPQUXRimuf7PuiVu50Jtrgrt84jqjdtwAHPcVLotsqaZAq78H5WVl5Yg4wc++aVkloaxrKcb9TUyzWyMR8rdMcZ96xZbhjF5joVwSCD2+h9OK6C8Cw2yrtwNvCj0rjNdv/7Mt2ubhv3RB3shyAMcfjSvZmUPei2iPRtlxNrN2nKmZLdf7p8tcsf++nP5V5/8Wrb+1LVdNlOIdQH2cZGcNyV7HHzYP4V6PbW0mleGbfdlrkRmaTniR2+Yn2OTiuB8QTR3+v8Ahq3AVke884gN91I4mdifbOOPWlP4rClD9y5HxrdW0tnczW91GY5o2KOjDBUioeO9ekfFjQ9tlpniOEfLetLbT8YO+ORlUn3KKPyz3rzuHyi7edvC7Wxt67scde2cVrF3Vzgem5F2zRSjngnApBgYzyKoBcZyR0FKVwcYx9aQcHI5FOKkN8+QRweKQCHoB+GaRuuMAEccU7BI46U3OAcfyoAbS0UHrTAUD16Ui/eH1pxct949BgcUicOuPWgAf7x+tP25VQEIPTPqabJxIwx3PFK4UH5GLD1IxSA2PBehP4k8U6bpCPsF1MEZ8/dXufyzX2Z4Ct4Pt2pTWypHbC5+yWynnbDCBEij06M3pljXz3+zVpaT+KrjUpSym2VYoyBnDMeT+Qx/wKvdPg3NJJpiOx/dRSznDD7zCRuf0xWc5apGlKN3c6TR7xbzxbrE4AeOO4WAyO33AgAwPxzXYRXXmxhxEVCZH3s7ueDzXmPw2klu9Ge7uNgF1M0+M8gszED6Yr1nSLdHgQHpgEHGQaUW5LQ7pU40opsw9U1i20yxa5u1wWYIsY6yMeir6mudNrr/AInjE72vloGzDbZAjjAP3yf4mro7bSbbU/FOoanqYWS004C3tVk+4rYzJJ9eQM+1a8+tRk/Z9NZcj5TKy/Ko9h3/AJU7M55OVWXLBaEOi+HrewtlW+eS7nUHLSv0z6AcYp+q2Zv5ERk2wIPkQcY96v2Eayxo7sXbHJY5J96vGNMEnk+/Wq1e5MWqMr9TmINNZEciNNoxhe9I0LRwFCgKqD1PJ59a25yqorsQHH3Sf1ya57XtVhtoJNuWmLfK6dHHr/8AXqjthUnUYl/eImHkIRAuBk9Ca8O+LPiybJsdPwtzIwgjZmBJduF+uOTWz8RfGSWsRW2dTcADceox3NfNGteMLm48Sf2hCUcw7hESvyhiMFsfyrCT55cqJrVFTjZbn0BrXifSfBvhxNF0kiA2yL5kzvl3lZQW3sDkk8/N7ACvAfFPjGfUbi4Fs3yv8vnYKkr7AcA9ie9c1qOoXOoS+Zdyl2x3/n9feqg681ry3d2ec5NqwVMrbEzt+YkFW7ce1RKCc4BPfinxvsDgqp3Dblh057e/FUySdgvkJuGcNtGCAQOSQfz4P1pY52jVsKVDEB9vykjoVz6EGmCUusYEZbYCWA/iAJ5P0zTouZJB5+FJwW45B9j9BUiJHXZEs0bgSqd23dkqAcD8ePywajnG3Aj3MFORuHJ4zyKnuLaRVCzoUlCKwUoclCu4Pz2II+uc1CzlUI3Op5MZHHB659RikgJ7ld0a7HGEUuu/5T1G5cexzx6UsaxNI8SNHGW+dS+flIViFz7n+lVuUi5OWOHQggnHIOcdO3WpctGrrCpWPcWAY7jGQR+vrjtSAV3ZFCbzJAANrYwDySAfx3UgMaSLKDhMqwP8SkHlR+Z69sUQuxmYYK78hNr42t1/z9aWRlDIJMMMKGkC/ME4xj3HSgBLp2WRvJ++rffQYBweo79s9sUSuzR7hIMYIwFIABPT9Mj+lRvGBuRlLS7gMMcEckHNMVV6n7g5G7jOO39KYFiKSERiISTDKENg8FuQCOOmMZHf8qZGhLRjlPMGGKk45PGfxH6UwCLexR3GFymOpORx+WfxokUK3ILDOFIbpkZx/n3oAnlI+zqGQFVYqzZydxGc8cY6kfU03SdRu9C1q21DT5Ql3ayiSNxyMj+hpiuCoSRcOoIyWwSMAAY9RUc6hkDKx+XgA+lOLswsfdXw68ZweOPD8GqWrRwykItykjgBJMYYfnj8CDXo0Lb1Z4zGXCAHbnqO9fnr8NfG9/4G8Qw3tsTJaMwW5tz0kTv9Djoa+7/C+tWeqadZarYzB7O/t1eIg8ZHX6Ed/wAqt66nbSlzw5eqNCa2M8JlibbNH88T5yf09ea2cwXcR5V4398jP4dKzY5Y0CtyEYhlB6D2/r9KabuOEO0DGME5K46EH+RqLFTpyqbGXrmkyGBYzEskLOCqs3KPngqeqn0PvWj4euV1DTVljuA80ZKyO4AYnqGIHAyO496qTeJBCo+025nAY7HQgAjHcVj+EfsUet317odzL9lYmG5sHAbymPzI6Y528tx05ohGysZVaVWl7zR02uTTwQh5Y2WJR87ryv8A9Ye9eWfEm8jk8OfZN2GubmG2Hq2+RQcfgSa9W1DVreGa2hcLvmcRhcj94SOUGep6cemfSvI7ZZ7vxtfa3EY5rPw95yW0WTie5KEOwB4IiXIOOdxPpRKF7G9GulBprVHe6reWzJKqvG0YBVVyDhQMD8eK8XivY11fxN4gZ9ttptvJY2zdAZcB52z7AIv4mur+I19c29tp0WjReVrfiCKMwxDlIP3YaWZv9lAc8dTiuG1O20xtSsfCVrIzaNo0H23U52yd6qdxVsfxyvjOe2axmmpalOScFFHA/EmY2/w60rSp9v2wTpIyk42u6+a4/BnxXkC5IwuPQ5rpPiB4hfxB4guZ1b9yJGZcdCSeT/ID6VzHXPrWtNPluzhq25mkB9T1pcDZkHnPSkA7UoGOxxnBNaGYpX5RyOmaRcZAcMVz2pRkEg5HPX3p4G1gfnXHU+hpAMHyrnI6dOtTSLAtvG0UjNMQfMVkwFOeMH6fSoWXaBnHPX1FAxlc52+1ADD9KMcZxUzxARI6OrZBLKOqc96hpgAGelPjUtIoAyT0puR6U9fmk+UYBPTrgUAMb7zfWlO3YDk789McY+tSyRLvbk9aDEuAcmgD2L9m+T/icrbDJM10p2juFXNe0/CkbNIS0ZRkPPHJnnnzHXArwv8AZwUr44DK7DYu4DtnB5r6c+GmmWs+veKklTdHbahNGiE8EEh+fxY1zqF6judcHyU7mV8GrZZPD8Xnh9lmHjnjz1KuQR7dK9g0m4FzahxsBzjavRccYryvwxDHpXjL4gabZrstEuIpFTJ+UyojuB7ZJxXpunAQRR+UMCRQxHUA+1bxSjFJEV6jqO7OP8eazPpdhJALOc/bZvKkuGAEcOTnjnLFgOMDjvVXRZUkChcsqjJJ61F8frh4fAouUC+al7FtJGcc4/rWL4VupH0gS5AdehFRu2j0cDFeydt2z02zldjvd0RiOcfwj0NW/tYAUEls/dPT8a5uOVtiNwcjpjiqHiDVrq1ilMLKNnTir2IlQ5pWNDxDrcKBo5JdkYUgtn+VeI+NPG2+dfszu6gMsSg5DdjWL4x8RahfaobWaRRDjogxXmPi++eLTJ4UjjDyzKvnc+YiBT8inOACeTxnjrWEpOb5UOrUjh4WSKPjPxTLd+dawylpJT/pEint/wA8x7etcRU3lD1NHlL6mtoxUVZHlSk5O7IqUH/69SeWPU0+KBWcAk4NUSQKSDwcUZJ47VL5S+ppyRKx6kcE8UARphXJ3FeDgj6U5S+wNj5U4ztzgH/JqQxIGwB0qWaJY2ZR0I/mAahsCFSOQGyCM49x9fzpQymPG0HacgZ/h7ipI8Dym2rleOnXr1q7awIN0wGGRQVHYHIGcfTP51LYigylX4ZM9QVz3wev6U4NubPILEgPk/MeufxHH41YvbZIVfYWASZ4R0+6CCM+9MWFHMJbJyDnPsTR0AbudpInXZggqVcqAG24J9uMc0RgSxhdwJ6ZbjqRyfy5/wD10qRg+YnOGAf6EHtTXgQCNgWG+MuQDxnJH9KAEdmLNM03myEZkUnAIBAwfXnH1pxjDNtYrt28Ofm3cHBH9fSpYgUtyUO0qWjyAOVI5B/z3qS0tEe3Vyzg+ZtGDjHyg8UmBVXEcRiljInTpzjKnt9c4INKuUQxuFyyZVi/GDyPx9PfNXILaOW1tGfJJSZc5/ujcv5GqaKPOU5IPJyODn1piEkBkjklALM4B5O48k8889R/nNVhneWB5HPA4zW3qNnHaohjLbpLaK6LHGQzdQOOn+FUblBbSqU+b7sh3AHJIyQfUe1NDRQliZERzjDjIwa9O+DPxZvfA1wNOvi1z4emcl4TyYCerp/Ud/rXBWtpHNcywPnaBkNxkdKoywKrAAnkA1aZUZOLuj7+0nxBDqNlFqWmXCXWnSLueSD94CgGcj0ZT1FW2uDNAJIyHD/MNpyMds+n0r4U8J+Ldd8KTmTQtRntg2d0YOUbPXKnj8a9F/4XJ4maFspp258EsIWBHHs1Jux6tDFxa1Wp9C65fw2gllnmEccQy0ZH3R9a8s8L/GPw5o2u+Imv7iYPK8PkTwwZWWNFIaHcvzAbjuB6ZH5+LeK/Hev+I4/I1C9KwHlo4RsDH37muQ8pfU0R1dzLGYx1V7OKskfSfjv496PfyadB4ajvfPt5GdNT1FAzQO4Kl1wSWAVmGMA1Gvxc8OxaCuj2jyNDFAbcvMWVJVb/AFjtt+Ylsk7RySeo6184eUvqaeFztBJIBzg0SV9jjhVcVZHvWo/Eq88SeItS1Pw3a7YIbdLGxa5+RLG2XqzkEje5GdoycKK5zxb4t0/RfAo8PaM32jVdUVZ9Wvi+8u5JOD79ML/COpyTjz2fXtQk09bBJhBZgbfKgUIG9c46k+9ZQjG4A5I9KyUXJ80thOo2kkRL044zweeKTbg4zz7VIYxnvTgoJznpyK2MyDPTpmlbIyM5+lStGPm9zQYxigCMfN268dKlUF4d5l3OWwEOSTx1pdg3LjI6dKkiiBKkFlZRkEHnrSYiq2SoPb0oJwBwBx371curZEEZXdlhzz1oS3Q+eCSdi7h09R/jRfQCpvIJC8AjHHTFNddrEZB9xUzxLnjI4zU8UCPZTyNncjKB9Dn/AAp3AoU9eqcjHWn+WD60oQEqCTgHimM//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This image shows concomitant tinea pedis and tinea manuum, also known as the \"two feet, one hand\" presentation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9492=[""].join("\n");
var outline_f9_17_9492=null;
var title_f9_17_9493="Acute ISN Light I";
var content_f9_17_9493=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F64378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F64378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    High power light micrograph of kidney biopsy of a patient with acute interstitial nephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power light micrograph of acute interstitial nephritis showing diffuse interstitial infiltrate of inflammatory cells on the right and an uninvolved glomerulus on the left.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9493=[""].join("\n");
var outline_f9_17_9493=null;
var title_f9_17_9494="Torsemide: Pediatric drug information";
var content_f9_17_9494=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Torsemide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"    see \"Torsemide: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?36/44/37573?source=see_link\">",
"    see \"Torsemide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F229463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Demadex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1062630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihypertensive Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Diuretic, Loop",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1062623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"      see \"Torsemide: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults (",
"     <b>",
"      Note:",
"     </b>",
"     I.V. and oral dosing are equivalent):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Edema:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Chronic renal failure: Oral, I.V.: Initial: 20 mg once daily; may increase gradually by doubling dose until the desired diuretic response is obtained (maximum recommended daily dose: 200 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Heart failure:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: Initial: 10-20 mg once daily; may increase gradually by doubling dose until the desired diuretic response is obtained.",
"     <b>",
"      Note:",
"     </b>",
"     ACC/AHA 2009 guidelines for heart failure maximum daily dose: 200 mg (Hunt, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.: Initial: 10-20 mg; may repeat every 2 hours with double the dose as needed.",
"     <b>",
"      Note:",
"     </b>",
"     ACC/AHA 2009 guidelines for heart failure recommend maximum single dose:100-200 mg (Hunt, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic cirrhosis: Oral: Initial: 5-10 mg once daily; may increase gradually by doubling dose until the desired diuretic response is obtained (maximum recommended single dose: 40 mg).",
"     <b>",
"      Note:",
"     </b>",
"     Administer with an aldosterone antagonist or a potassium-sparing diuretic.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hypertension: Oral: Initial: 5 mg once daily; may increase to 10 mg once daily after 4-6 weeks if adequate antihypertensive response is not apparent; if still not effective, an additional antihypertensive agent may be added. Usual dosage range (JNC 7): 2.5-10 mg once daily.",
"     <b>",
"      Note:",
"     </b>",
"     Thiazide-type diuretics are preferred in the treatment of hypertension (Chobanian, 2003)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F229439\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 10 mg/mL (2 mL, 5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 5 mg, 10 mg, 20 mg, 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Demadex&reg;: 5 mg, 10 mg, 20 mg, 100 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F229424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1062634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Administer over &ge;2 minutes; reserve I.V. administration for situations which require rapid onset of action",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer without regard to meals; patients may be switched from the I.V. form to the oral (and vice-versa) with no change in dose",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F229490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Milrinone, nesiritide.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1062626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Store at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). For continuous infusion, a 10 mg/mL dilution in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS, or 0.45% sodium chloride is stable for 24 hours at room temperature.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablets: Store at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1062633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of edema associated with CHF and hepatic or renal disease (including chronic renal failure); used alone or in combination with antihypertensives in treatment of hypertension (FDA approved in adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F229492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Torsemide may be confused with furosemide",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Demadex&reg; may be confused with Denorex&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F229489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Chest pain, ECG abnormality",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Nervousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Constipation, diarrhea, dyspepsia, nausea, sore throat",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Excessive urination",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, myalgia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough, rhinitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Angioedema, arthritis, atrial fibrillation, esophageal hemorrhage, GI hemorrhage, hyperglycemia, hypernatremia, hyperuricemia, hypokalemia, hypotension, hypovolemia, impotence, leukopenia, pancreatitis, rash, rectal bleeding, shunt thrombosis, Stevens-Johnson syndrome, syncope, thirst, thrombocytopenia, toxic epidermal necrolysis, ventricular tachycardia, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1062638\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to torsemide, any component, or other sulfonylureas; anuria",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F11470058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with cirrhosis; avoid sudden changes in fluid and electrolyte balance and acid/base status which may lead to hepatic encephalopathy. Administration with an aldosterone antagonist or potassium-sparing diuretic may provide additional diuretic efficacy and maintain normokalemia. Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics (except ethacrynic acid). Use in patients with sulfonylurea allergy is specifically contraindicated in product labeling; a risk of cross-reaction exists in patients with allergy to any of these compounds; avoid use when previous reaction has been severe. Discontinue if signs of hypersensitivity are noted.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1062622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Loop diuretics are potent diuretics, excess amounts can lead to profound diuresis with fluid and electrolyte loss; close medical supervision and dose evaluation is required. Potassium supplementation and/or use of potassium-sparing diuretics may be necessary to prevent hypokalemia. Monitor fluid status and renal function in an attempt to prevent oliguria, azotemia, and reversible increases in BUN and creatinine; close medical supervision of aggressive diuresis required. Coadministration of antihypertensives may increase the risk of hypotension.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Ototoxicity has been demonstrated following oral administration of torsemide and following rapid I.V. administration of other loop diuretics. Other possible risk factors may include use in renal impairment, excessive doses, and concurrent use of other ototoxins (eg, aminoglycosides).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F229477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C8 (minor), CYP2C9 (major), SLCO1B1;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2C19 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F229433\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Loop Diuretics may enhance the hypotensive effect of ACE Inhibitors. Specifically, postural hypotension which can accompany ACE Inhibitor initiation. Loop Diuretics may enhance the nephrotoxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfuzosin: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: Loop Diuretics may enhance the adverse/toxic effect of Allopurinol. Loop Diuretics may increase the serum concentration of Allopurinol. Specifically, Loop Diuretics may increase the concentration of Oxypurinol, an active metabolite of Allopurinol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Loop Diuretics may enhance the adverse/toxic effect of Aminoglycosides. Specifically, nephrotoxicity and ototoxicity.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: May enhance the hypokalemic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the absorption of Loop Diuretics.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Loop Diuretics may enhance the adverse/toxic effect of Cardiac Glycosides. This by increasing the risk of hypokalemia.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CISplatin: Loop Diuretics may enhance the nephrotoxic effect of CISplatin. Loop Diuretics may enhance the ototoxic effect of CISplatin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Orally Inhaled): May enhance the hypokalemic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the hypokalemic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): May enhance the adverse/toxic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inducers (Strong): May increase the metabolism of CYP2C9 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Moderate): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Strong): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diazoxide: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dofetilide: Loop Diuretics may enhance the QTc-prolonging effect of Dofetilide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: May increase the serum concentration of OATP1B1/SLCO1B1 Substrates. Management: According to eltrombopag prescribing information, consideration of a preventative dose reduction may be warranted.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May diminish the diuretic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: Loop Diuretics may diminish the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Licorice: May enhance the hypokalemic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Loop Diuretics may decrease the serum concentration of Lithium. Loop Diuretics may increase the serum concentration of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: May diminish the therapeutic effect of Loop Diuretics. Methotrexate may increase the serum concentration of Loop Diuretics. Loop Diuretics may increase the serum concentration of Methotrexate. Management: Monitor for increased methotrexate and/or loop diuretic levels/toxicity with concomitant use of these agents and monitor for decreased therapeutic effects of loop diuretics. Methotrexate and/or loop diuretic dose reductions may be necessary.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP2C9 Substrates. Management: Use CYP2C9 substrates at the lowest recommended dose, and monitor closely for adverse effects, during and in the 2 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents: Loop Diuretics may diminish the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. Loop Diuretics may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May diminish the diuretic effect of Loop Diuretics. Management: Monitor for decreased therapeutic effects of loop diuretics with concurrent use of an NSAID. Consider avoiding concomitant use of these agents in CHF or cirrhosis with ascites. Concomitant use of bumetanide with indomethacin is  not recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May diminish the diuretic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May enhance the adverse/toxic effect of Loop Diuretics. Probenecid may diminish the diuretic effect of Loop Diuretics. Probenecid may increase the serum concentration of Loop Diuretics. Management: Monitor for decreased diuretic effects or increased adverse effects of loop diuretics with concomitant use of probenecid. Bumetanide prescribing information recommends against concomitant use of probenecid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RisperiDONE: Loop Diuretics may enhance the adverse/toxic effect of RisperiDONE.  Management: Consider alternative diuretic therapy (e.g., thiazides) to more potent diuretics (e.g., furosemide) in elderly patients receiving risperidone. Patients who require use of more potent diuretic therapy should be closely monitored and adequately hydrated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May diminish the diuretic effect of Loop Diuretics. Loop Diuretics may increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: Diuretics may enhance the nephrotoxic effect of Sodium Phosphates. Specifically, the risk of acute phosphate nephropathy may be enhanced.  Management: Consider avoiding this combination by temporarily suspending treatment with diuretics, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, hydrate adequately and monitor fluid and renal status.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Loop Diuretics may enhance the hypokalemic effect of Topiramate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Warfarin: Torsemide may increase the serum concentration of Warfarin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F229435\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F229449\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A decrease in fetal weight, an increase in fetal resorption, and delayed fetal ossification has occurred in animal studies.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1062629\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Renal function, serum electrolytes, fluid balance, blood pressure, body weight",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1062621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits reabsorption of sodium and chloride in the ascending loop of Henle and distal renal tubule, interfering with the chloride-binding cotransport system, thus causing increased excretion of water, sodium, chloride, magnesium, and calcium",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1062636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 60 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 60-120 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Within 60 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Oral, I.V.: 6-8 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1062637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 12-15 L; cirrhosis: approximately doubled",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Plasma: &ge;99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic by cytochrome P450, 80%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~80%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 3.5 hours; 7-8 hours in cirrhosis (dose modification appears unnecessary)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Oral: 1 hour; delayed ~30 minutes when administered with food",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 20% eliminated unchanged in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1062628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?36/44/37573?source=see_link\">",
"      see \"Torsemide: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rise slowly from a lying or sitting position to minimize dizziness, lightheadedness or fainting; also use extra care when exercising, standing for long periods of time. Take last dose of day early in the evening to prevent nocturia. May cause photosensitivity reactions (eg, exposure to sunlight may cause severe sunburn, skin rash, redness, or itching); avoid exposure to sunlight and artificial light sources (sunlamps, tanning booth/bed); wear protective clothing, wide-brimmed hats, sunglasses, and lip sunscreen (SPF &ge;15); use a sunscreen [broad-spectrum sunscreen or physical sunscreen (preferred) or sunblock with SPF &ge;15]; contact physician if reaction occurs.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1062639\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     10-20 mg torsemide is approximately equivalent to:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Furosemide 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bumetanide 1 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bard RL, Bleske BE, and Nicklas JM, \"Food: An Unrecognized Source of Loop Diuretic Resistance,\"",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2004, 24(5):630-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/17/9494/abstract-text/15162897/pubmed\" id=\"15162897\" target=\"_blank\">",
"        15162897",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chobanian AV, Bakris GL, Black HR, et al, \"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,\"",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(19):2560-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/17/9494/abstract-text/12748199 /pubmed\" id=\"12748199 \" target=\"_blank\">",
"        12748199",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12852 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-210.101.131.232-F3B3B15694-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9494=[""].join("\n");
var outline_f9_17_9494=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229463\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062630\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062623\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229439\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229424\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062634\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229490\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062626\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062633\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229492\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229489\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062638\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11470058\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062622\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229477\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229433\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229435\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229449\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062629\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062621\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062636\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062637\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062628\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062639\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12852\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12852|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=related_link\">",
"      Torsemide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?36/44/37573?source=related_link\">",
"      Torsemide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_17_9495="Breast abscess";
var content_f9_17_9495=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Breast abscess",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9495/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9495/contributors\">",
"     J Michael Dixon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9495/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9495/contributors\">",
"     Anees B Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C)",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9495/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9495/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9495/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9495/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/17/9495/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A breast abscess is a localized collection of pus in the breast tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast abscesses develop as a complication of mastitis (",
"    <a class=\"graphic graphic_figure graphicRef68275 \" href=\"UTD.htm?6/27/6579\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/1\">",
"     1",
"    </a>",
"    ]. In a review of 89 patients with breast abscesses requiring surgical intervention, 14 percent were lactational and 86 percent were nonlactational [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/2\">",
"     2",
"    </a>",
"    ]. Breast abscesses were more common in African Americans, obese patients and smokers than in the general population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Lactational abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for lactational breast abscess formation include maternal age over 30 years of age, first pregnancies, gestational age &ge;41 weeks gestation, and mastitis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. It is relatively uncommon for lactating women to develop a breast abscess as a complication of mastitis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/28/454?source=see_link\">",
"     \"Lactational mastitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Nonlactational abscesses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonlactational abscesses can be classified as central, peripheral or skin associated. Patients with nonlactational abscesses, diabetics and smokers are likely to develop recurrent infections [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Central (periareolar) nonlactational abscesses are usually due to periductal mastitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/53/857?source=see_link\">",
"       \"Erythematous disorders of the breast\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Peripheral nonlactational breast abscesses are less common than central abscesses and are sometimes associated with underlying disease states, such as diabetes, rheumatoid arthritis, steroid treatment and trauma.",
"     </li>",
"     <li>",
"      Skin associated infections are discussed separately (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/53/857?source=see_link\">",
"       \"Erythematous disorders of the breast\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presentation of a breast abscess is similar to mastitis, with localized, painful inflammation of the breast associated with fever and malaise, along with a fluctuant, tender, palpable mass. Although this is primarily a clinical diagnosis, ultrasound imaging is helpful for confirmation of the diagnosis and for directed aspiration of the purulent drainage. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The time course is variable. In a combined review of data from two studies of lactating women 0.4 percent",
"    <span class=\"nowrap\">",
"     (5/1183)",
"    </span>",
"    developed a breast abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/7\">",
"     7",
"    </a>",
"    ]. In these women, two presented with mastitis and an abscess concurrently, the others developed an abscess 5 days to 4 weeks after their first or second treatment for mastitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Poorly draining segments of the breast &ndash; Patients sometimes present with localized areas of milk stasis with distention of mammary tissue. Symptoms include a palpable lump with tenderness. They are distinguished from mastitis and breast abscess by the absence of systemic findings. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"       \"Common problems of breastfeeding and weaning\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Galactoceles &ndash; Galactoceles (milk retention cysts) are cystic collections of fluid, usually caused by an obstructed milk duct. These present as soft cystic masses on physical exam, but are not tender and are not associated with systemic findings. Ultrasound may show a complex mass. Diagnosis can be made on the basis of the clinical history and aspiration, which yields a milky substance. Once diagnosis is established, excision is not necessary. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"       \"Common problems of breastfeeding and weaning\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inflammatory breast cancer &ndash; If a patient with a breast infection does not respond to treatment, inflammatory breast cancer should be suspected. In inflammatory breast cancer the skin examination will demonstrate thickening, erythema, peau d'orange and there is often associated axillary lymphadenopathy. Magnetic resonance imaging (MRI) may also be of value if inflammatory breast cancer is suspected [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=see_link\">",
"       \"Inflammatory breast cancer: Clinical features and treatment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound is the cornerstone of the assessment and management of breast infections (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62711 \" href=\"UTD.htm?31/34/32288\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/9\">",
"     9",
"    </a>",
"    ]. It is the most effective method of differentiating breast abscesses from mastitis and also allows pus to be drained with ultrasound guidance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most breast abscesses are caused by Staphylococcus aureus. Methicillin-resistant Staphylococcus aureus (MRSA) is becoming an increasingly important pathogen in cases of lactational and nonlactational mastitis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/2\">",
"     2",
"    </a>",
"    ]. Risk factors for S. aureus breast abscess include in-hospital identification of a mother having difficulty breastfeeding (odds ratio, 5.00) and being a mother employed outside the home (odds ratio, 2.74) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/28/454?source=see_link\">",
"     \"Lactational mastitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=see_link\">",
"     \"Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Less frequent pathogens include S. pyogenes (Group A or B), E. coli, bacteroides species, Corynebacterium species, coagulase negative staphylococci (eg, S. lugdunensis), Pseudomonas aeruginosa, Proteus mirabilis and anaerobes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients with recurrent breast abscesses have an increased incidence of mixed flora and anaerobic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary management of breast abscess is drainage, along with antibiotic therapy appropriate for the underlying cause of the abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/1,9,12-15\">",
"     1,9,12-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While standard treatment for breast abscesses was traditionally incision and drainage, two case series (33 and 45 lactational breast abscesses respectively) and a randomized controlled trial (45 patients) have shown that needle aspiration can be used for effective drainage of the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Needle aspiration can be performed with [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/19\">",
"     19",
"    </a>",
"    ] or without [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/16,20\">",
"     16,20",
"    </a>",
"    ] ultrasound guidance. However, while needle aspiration can be done without ultrasound guidance for confirmation of the diagnosis and to harvest some of the purulent drainage for culture, it is best to utilize ultrasound if at all possible. The use of ultrasound ensures complete drainage of the collection and allows drainage of any loculated areas as well as collections that may not be appreciated on physical exam.",
"   </p>",
"   <p>",
"    Needle aspiration should be chosen as the initial approach to abscess drainage when the overlying skin is normal. Surgical drainage is indicated for patients who present with compromise of the overlying skin. Both approaches are described in detail here. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Ultrasound guided aspiration'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H11\">",
"     'Surgical drainage'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For a successful outcome of the nonoperative approach, needle aspiration must be repeated every 2 or 3 days until there is no remaining purulent collection. Few abscesses require more than two or three aspirations although larger collections may require 5 or 6 aspirations to resolve. The majority of breast abscesses can be managed in this manner.",
"   </p>",
"   <p>",
"    In treatment resistant cases, where the abscess is unresponsive to the combination of repeated drainage and antibiotics, surgical intervention is indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. In a randomized controlled trial of 45 patients with lactational abscesses, 40 percent of the patients",
"    <span class=\"nowrap\">",
"     (9/22)",
"    </span>",
"    treated with needle aspiration required subsequent incision and drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/18\">",
"     18",
"    </a>",
"    ]. In this series, risk factors for failure of needle aspiration for breast abscesses were abscesses larger than 5 cm in diameter, unusually large volume of aspirated pus, and delay in treatment. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Surgical drainage'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Our approach to the drainage procedures is based on clinical experience. Please note that some technical details presented here reflect the author's preferences and are not meant to imply that these are requirements for successful outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Ultrasound guided aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;If an abscess is suspected, an ultrasound should be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/9,12,23\">",
"     9,12,23",
"    </a>",
"    ]. Management of ultrasound confirmed abscesses is then based on the state of the overlying skin (",
"    <a class=\"graphic graphic_picture graphicRef50110 \" href=\"UTD.htm?0/9/144\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    If the overlying skin is normal, then aspiration of the abscess under ultrasound guidance using generous local anesthesia is the preferred method of management (",
"    <a class=\"graphic graphic_picture graphicRef74709 \" href=\"UTD.htm?3/43/3762\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/9,12,15,23\">",
"     9,12,15,23",
"    </a>",
"    ]. Infiltration and irrigation with local anesthetic reduces pain and the use of epinephrine reduces subsequent bruising. If the overlying skin is compromised, surgical drainage will be required. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Surgical drainage'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Local anesthetic is infiltrated through a small area of normal skin some distance away from the abscess. One percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    with 1:200,000 epinephrine at a maximum dose of 7",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    is injected into the skin and through the breast tissue to the edge of the abscess cavity using a 21 gauge needle. If the visible pus is not particularly thick, it can be aspirated with the same needle. Once the pus is aspirated, the syringe is changed and the abscess cavity is lavaged with the same local anesthetic. Irrigation with local anesthetic to dilute the pus is continued until all the pus is aspirated and the aspirate from the cavity comes back clear.",
"   </p>",
"   <p>",
"    If the pus is thick, local anesthetic is injected gently into the abscess cavity and aspiration attempted. If the pus cannot be aspirated, remove the syringe and needle. After waiting for the local anesthetic and epinephrine to take effect (at least seven or eight minutes), a 19 or 17 gauge needle is advanced along the anesthetized track into the cavity to wash the abscess with local anesthetic and dilute out the pus. Up to 50 mL of local anesthetic can be used safely in an adult and larger volumes are safe providing that the local anesthetic that is irrigated into the cavity is later aspirated. However, too much local anesthetic injected into the abscess cavity increases the pressure in the abscess and can be painful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33689?source=see_link\">",
"     \"Infiltration of local anesthetics\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The patient should then be reexamined every two to three days and the cavity imaged with ultrasound and aspiration repeated in a similar manner until there is no further fluid visible in the abscess cavity or the fluid aspirated is serous [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/9,12,15\">",
"     9,12,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The usual sequence is that at the second aspiration the pus is thinner and it subsequently turns to serous fluid. Few abscesses require more than two or three aspirations. The majority of lactating breast abscesses can be managed in this manner. In treatment resistant cases, where the abscess is unresponsive to the combination of repeated drainage and antibiotics, surgical intervention is indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Surgical drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who do not respond to ultrasound guided aspiration or if initial presentation is very advanced, surgical drainage should be undertaken.",
"   </p>",
"   <p>",
"    If the skin overlying the abscess is very thin and shiny (",
"    <a class=\"graphic graphic_picture graphicRef68502 graphicRef60139 graphicRef79340 graphicRef59342 \" href=\"UTD.htm?9/8/9354\">",
"     picture 3A-D",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef63472 \" href=\"UTD.htm?27/59/28592\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef76304 \" href=\"UTD.htm?13/55/14192\">",
"     picture 4",
"    </a>",
"    ) or it is clear that the abscess is about to burst through the skin or the overlying skin is necrotic (",
"    <a class=\"graphic graphic_picture graphicRef60139 \" href=\"UTD.htm?3/45/3792\">",
"     picture 3B",
"    </a>",
"    ), the best procedure is incision and drainage. If the skin is very thin then it is infiltrated with 1 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    with 1:200,000 epinephrine. Care should be taken not to inject too much local anesthetic into the abscess cavity as this increases the pressure in the abscess and causes pain for the patient. Seven to eight minutes later, a small stab incision is made through the thinned skin and pus drained. The abscess cavity is then irrigated with local anesthetic and epinephrine solution until all the pus is evacuated. The patient is re-examined every two or three days until the wound closes and no further pus is visible either on direct inspection or on ultrasound.",
"   </p>",
"   <p>",
"    Large incisions are not necessary to drain breast abscesses (",
"    <a class=\"graphic graphic_figure graphicRef63472 \" href=\"UTD.htm?27/59/28592\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef76304 \" href=\"UTD.htm?13/55/14192\">",
"     picture 4",
"    </a>",
"    ). An incision over an abscess does not need to be dependent. In our experience, drains or packing are not necessary for the management of breast abscesses [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/9,12\">",
"     9,12",
"    </a>",
"    ]. Incision and drainage can be performed with local anesthesia in most cases, although some patients will require sedation or general anesthesia.",
"   </p>",
"   <p>",
"    If the skin overlying the abscess is obviously necrotic, then the necrotic skin is excised and the cavity irrigated with local anesthetic and epinephrine solution to drain the pus. The abscess cavity is then inspected every two or three days and irrigated as appropriate.",
"   </p>",
"   <p>",
"    Male breast abscesses are treated in a similar manner by aspiration or incision and drainage under local anesthetic (",
"    <a class=\"graphic graphic_picture graphicRef63826 \" href=\"UTD.htm?17/15/17648\">",
"     picture 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics are adjunctive to definitive percutaneous or surgical drainage. Empiric antibiotic therapy for breast abscess should include activity against Staphylococcus aureus; therapy should be tailored to results of gram stain and cultures results when available.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the setting of non severe infection in the absence of risk factors for methicillin resistant S. aureus (MRSA), outpatient therapy may be initiated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=see_link\">",
"       dicloxacillin",
"      </a>",
"      (500 mg orally four times daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/37/37462?source=see_link\">",
"       cephalexin",
"      </a>",
"      (500 mg orally four times daily), pending culture results [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/2\">",
"       2",
"      </a>",
"      ]. In the setting of beta lactam hypersensitivity,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (300 mg orally four times daily) may be used.",
"     </li>",
"     <li>",
"      In the setting of non severe infection with risk for MRSA (",
"      <a class=\"graphic graphic_table graphicRef53504 \" href=\"UTD.htm?5/9/5275\">",
"       table 1",
"      </a>",
"      ), outpatient therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      (1 to 2 tabs orally twice daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (300 mg orally four times daily) may be initiated.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"       Linezolid",
"      </a>",
"      (600 mg orally twice daily) is also acceptable.",
"     </li>",
"     <li>",
"      In the setting of severe infection (eg, hemodynamic instability, progressive erythema), empiric inpatient therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      intravenously in two divided doses every 24h) should be initiated; therapy should be tailored to culture and sensitivity results. Gram stain results demonstrating gram negative rods should prompt empiric antibiotic therapy against these organisms with a third generation cephalosporin or a combination",
"      <span class=\"nowrap\">",
"       beta-lactam/beta-lactamase",
"      </span>",
"      agent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of a subareolar breast abscess with a retracted nipple should raise the possibility of anaerobic infection, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    should be included in the antibiotic regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The optimal length of antibiotic therapy is not certain; 10 to 14 days following drainage is likely appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ROLE OF BREASTFEEDING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Milk drainage, either by breastfeeding or pumping, is important in the setting of lactational infection, and along with pain control, will help relieve the patient's discomfort from a breast infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/9,24,25\">",
"     9,24,25",
"    </a>",
"    ]. A small randomized trial showed that emptying of the breast resulted in a significant decrease in the duration of symptoms and a significantly improved outcome in cases of lactational mastitis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women should be encouraged to continue breastfeeding following the development of significant breast infection, even following mini incision and drainage. If the incision does not interfere with latch-on, breastfeeding may continue on both breasts. If there is difficulty with breastfeeding because the incision interferes with nursing on the affected breast, the infant cannot relieve breast fullness during nursing, or there is concern about spreading infection to the baby, hand expression or breast pumps can be effective for maintaining the milk supply until the woman can start breastfeeding again. Nursing should continue on the unaffected breast. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"     \"Common problems of breastfeeding and weaning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rarely, women present with widespread nipple excoriation and whole breast involvement who are in obvious pain and significantly disabled by their infection (",
"    <a class=\"graphic graphic_picture graphicRef76043 \" href=\"UTD.htm?9/21/9555\">",
"     picture 6",
"    </a>",
"    ). Such women should be advised to consider stopping breastfeeding so their breast infection can be controlled. It may be advantageous in these women to suppress milk production using the agent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/2/7206?source=see_link\">",
"     cabergoline",
"    </a>",
"    , 250 micrograms given twice a day for two days [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/9,23\">",
"     9,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Poor cosmetic outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;If treatment of breast infection is delayed, significant amounts of breast tissue can be damaged and the cosmetic outcome can be poor (",
"    <a class=\"graphic graphic_picture graphicRef62468 \" href=\"UTD.htm?41/53/42835\">",
"     picture 7",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Mammary duct fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mammary duct fistula is a communication between a major subareolar duct and the skin, usually in the periareolar region (",
"    <a class=\"graphic graphic_picture graphicRef78199 graphicRef58118 graphicRef65757 graphicRef75481 \" href=\"UTD.htm?28/58/29610\">",
"     picture 8A-D",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/28\">",
"     28",
"    </a>",
"    ]. It can occur after incision and drainage of a central breast abscess caused by periductal mastitis or it can occur after spontaneous drainage of a periareolar inflammatory mass. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/53/857?source=see_link\">",
"     \"Erythematous disorders of the breast\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who develop a mammary duct fistula usually have a history of preceding episodes of recurrent periareolar inflammation including recurrent abscess formation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/9,12,29\">",
"     9,12,29",
"    </a>",
"    ]. Occasionally there is more than one external opening at the areolar margin and this can be from a single or multiple duct.",
"   </p>",
"   <p>",
"    Treatment is primarily surgical along with appropriate antibiotic treatment. The surgical intervention consists either of opening up the fistula tract (",
"    <a class=\"graphic graphic_picture graphicRef78199 graphicRef58118 graphicRef65757 graphicRef75481 \" href=\"UTD.htm?28/58/29610\">",
"     picture 8A-D",
"    </a>",
"    ) and leaving it to granulate or excising the fistula and affected duct(s) and closing the wound primarily (",
"    <a class=\"graphic graphic_picture graphicRef78199 graphicRef58118 graphicRef65757 graphicRef75481 \" href=\"UTD.htm?28/58/29610\">",
"     picture 8A-D",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/30\">",
"     30",
"    </a>",
"    ]. Excision can either be a fistulectomy with a transverse incision over the duct (",
"    <a class=\"graphic graphic_picture graphicRef78199 graphicRef58118 graphicRef65757 graphicRef75481 \" href=\"UTD.htm?28/58/29610\">",
"     picture 8A-D",
"    </a>",
"    ) or excision of the fistula and diseased duct up to the back of the nipple combined with a total duct excision through a circumareolar incision. The latter is preferred as it produces a much more satisfactory cosmetic outcome (",
"    <a class=\"graphic graphic_picture graphicRef78199 graphicRef58118 graphicRef65757 graphicRef75481 \" href=\"UTD.htm?28/58/29610\">",
"     picture 8A-D",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The nipple areola complex rarely needs to be removed and when necessary, is best combined with an oncoplastic procedure such as a Grisotti flap.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Milk fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;A milk fistula is a tract between the skin and a lactiferous duct associated with surgical intervention for a breast abscess while a woman is lactating, resulting in milk draining through the skin of the breast [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9495/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Milk fistulas are very rare if aspiration or mini-incision and drainage are employed but can develop if extensive dissection is performed with placement of large drains. Large incisions and the use of drains or packing of abscess cavities are unnecessary.",
"   </p>",
"   <p>",
"    A milk leak will usually resolve with cessation of lactation. Generally the baby can be weaned from the involved breast while the mother continues to nurse from the other breast. This requires assistance from a lactation specialist in most cases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"     \"Common problems of breastfeeding and weaning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A breast abscess is a localized collection of pus in the breast tissue. Breast abscesses develop when mastitis or cellulitis does not respond to antibiotic treatment. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Staphylococcus aureus (S. aureus) is the predominant microbe isolated from breast abscesses. Methicillin resistant S. aureus (MRSA) infections are increasingly common. Patients with recurrent breast abscesses have a higher incidence of mixed flora, anaerobes, and Proteus infections.",
"     </li>",
"     <li>",
"      Breast abscesses require treatment with appropriate antibiotic therapy and drainage. We suggest initial drainage be performed by needle aspiration with ultrasound guidance (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Surgical drainage is indicated for patients who present with compromise of the overlying skin and for patients who do not respond to aspiration. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Surgical drainage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that breastfeeding continue during treatment for lactation associated breast infections (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If there is difficulty with breastfeeding, hand expression or breast pumps can be effective for maintaining the milk supply until nursing can resume. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Role of breastfeeding'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/1\">",
"      Dixon JM, Khan LR. Treatment of breast infection. BMJ 2011; 342:d396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/2\">",
"      Bharat A, Gao F, Aft RL, et al. Predictors of primary breast abscesses and recurrence. World J Surg 2009; 33:2582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/3\">",
"      Berens PD. Prenatal, intrapartum, and postpartum support of the lactating mother. Pediatr Clin North Am 2001; 48:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/4\">",
"      Kvist LJ, Rydhstroem H. Factors related to breast abscess after delivery: a population-based study. BJOG 2005; 112:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/5\">",
"      Dener C, Inan A. Breast abscesses in lactating women. World J Surg 2003; 27:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/6\">",
"      Rizzo M, Peng L, Frisch A, et al. Breast abscesses in nonlactating women with diabetes: clinical features and outcome. Am J Med Sci 2009; 338:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/7\">",
"      Amir LH, Forster D, McLachlan H, Lumley J. Incidence of breast abscess in lactating women: report from an Australian cohort. BJOG 2004; 111:1378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/8\">",
"      Renz DM, Baltzer PA, B&ouml;ttcher J, et al. Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol 2008; 18:2370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/9\">",
"      Dixon JM. Breast abscess. Br J Hosp Med (Lond) 2007; 68:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/10\">",
"      Branch-Elliman W, Golen TH, Gold HS, et al. Risk factors for Staphylococcus aureus postpartum breast abscess. Clin Infect Dis 2012; 54:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/11\">",
"      Leach RD, Eykyn SJ, Phillips I, Corrin B. Anaerobic subareolar breast abscess. Lancet 1979; 1:35.",
"     </a>",
"    </li>",
"    <li>",
"     Dixon JM. Breast infection. In: ABC of Breast Diseases, Dixon JM (Ed), Blackwell Publishing, Oxford 2006. p.19.",
"    </li>",
"    <li>",
"     Dixon JM, Bundred NJ. Management of disorders of the ductal system and infections. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. p.47.",
"    </li>",
"    <li>",
"     Hughes LE, Mansel RE, Webster DJT. Miscellaneous conditions. In: Benign Disorders and Diseases of the Breast: Current Concepts and Clinical Management, Hughes LE, Mansel RE, Webster DJT (Eds), Edward Arnold, London 2000. p.231.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/15\">",
"      Dixon JM. Repeated aspiration of breast abscesses in lactating women. BMJ 1988; 297:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/16\">",
"      Schwarz RJ, Shrestha R. Needle aspiration of breast abscesses. Am J Surg 2001; 182:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/17\">",
"      Hansen PB, Axelsson CK. [Treatment of breast abscess. An analysis of patient material and implementation of recommendations]. Ugeskr Laeger 2003; 165:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/18\">",
"      Eryilmaz R, Sahin M, Hakan Tekelioglu M, Daldal E. Management of lactational breast abscesses. Breast 2005; 14:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/19\">",
"      Karstrup S, Solvig J, Nols&oslash;e CP, et al. Acute puerperal breast abscesses: US-guided drainage. Radiology 1993; 188:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/20\">",
"      O'Hara RJ, Dexter SP, Fox JN. Conservative management of infective mastitis and breast abscesses after ultrasonographic assessment. Br J Surg 1996; 83:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/21\">",
"      Christensen AF, Al-Suliman N, Nielsen KR, et al. Ultrasound-guided drainage of breast abscesses: results in 151 patients. Br J Radiol 2005; 78:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/22\">",
"      Berna-Serna JD, Madrigal M, Berna-Serna JD. Percutaneous management of breast abscesses. An experience of 39 cases. Ultrasound Med Biol 2004; 30:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/23\">",
"      Ozseker B, Ozcan UA, Rasa K, Cizmeli OM. Treatment of breast abscesses with ultrasound-guided aspiration and irrigation in the emergency setting. Emerg Radiol 2008; 15:105.",
"     </a>",
"    </li>",
"    <li>",
"     Department of child and adolescent healtlh and development. Mastitis: Causes and management. World Health Organization 2000; file://whqlibdoc.who.int/hq/2000/WHO_FCH_CAH_00.13.pdf (Accessed August 17, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/25\">",
"      Spencer JP. Management of mastitis in breastfeeding women. Am Fam Physician 2008; 78:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/26\">",
"      Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev 2009; :CD005458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/27\">",
"      Thomsen AC, Espersen T, Maigaard S. Course and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women. Am J Obstet Gynecol 1984; 149:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/28\">",
"      ATKINS HJ. Mammillary fistula. Br Med J 1955; 2:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/29\">",
"      Dixon JM, Ravisekar O, Chetty U, Anderson TJ. Periductal mastitis and duct ectasia: different conditions with different aetiologies. Br J Surg 1996; 83:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/30\">",
"      Dixon JM, Thompson AM. Effective surgical treatment for mammary duct fistula. Br J Surg 1991; 78:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/31\">",
"      Barker P. Milk fistula: an unusual complication of breast biopsy. J R Coll Surg Edinb 1988; 33:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9495/abstract/32\">",
"      Schackmuth EM, Harlow CL, Norton LW. Milk fistula: a complication after core breast biopsy. AJR Am J Roentgenol 1993; 161:961.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 795 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-197.136.42.3-071942397F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9495=[""].join("\n");
var outline_f9_17_9495=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Lactational abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Nonlactational abscesses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Ultrasound guided aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Surgical drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ROLE OF BREASTFEEDING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Poor cosmetic outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Mammary duct fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Milk fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/795\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/795|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/34/32288\" title=\"diagnostic image 1\">",
"      Ultrasound appearance of a breast abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/795|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/27/6579\" title=\"figure 1\">",
"      Common sites and types of breast infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/59/28592\" title=\"figure 2\">",
"      Surgical drainage of a breast abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/795|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/9/144\" title=\"picture 1\">",
"      Breast cellulitis after breast conservation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/43/3762\" title=\"picture 2\">",
"      Lactating breast abscess treated with needle aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/17/35089\" title=\"picture 3A\">",
"      Lactating breast abscess with skin compromise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/45/3792\" title=\"picture 3B\">",
"      Breast abscess with skin necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/22/17761\" title=\"picture 3C\">",
"      Incision and drainage for breast abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/43/8881\" title=\"picture 3D\">",
"      Results after incision and drainage of breast abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/55/14192\" title=\"picture 4\">",
"      Periaerolar abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/15/17648\" title=\"picture 5\">",
"      Periareolar abscess male",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/21/9555\" title=\"picture 6\">",
"      Extensive lactating infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/53/42835\" title=\"picture 7\">",
"      Consequences of treatment delay for breast abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/5/8272\" title=\"picture 8A\">",
"      Mammary duct fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/3/39984\" title=\"picture 8B\">",
"      Fistulotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/17/36115\" title=\"picture 8C\">",
"      Post fistula excision with transverse incision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/25/18836\" title=\"picture 8D\">",
"      Post fistula excision with a circumareolar incision",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/795|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/9/5275\" title=\"table 1\">",
"      Risk factors for MRSA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=related_link\">",
"      Common problems of breastfeeding and weaning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=related_link\">",
"      Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/53/857?source=related_link\">",
"      Erythematous disorders of the breast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33689?source=related_link\">",
"      Infiltration of local anesthetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=related_link\">",
"      Inflammatory breast cancer: Clinical features and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/28/454?source=related_link\">",
"      Lactational mastitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_17_9496="Hepatitis C and alcohol";
var content_f9_17_9496=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hepatitis C and alcohol",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9496/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9496/contributors\">",
"     Gyongyi Szabo, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9496/contributors\">",
"     Christopher A Marshall, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9496/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9496/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9496/contributors\">",
"     Keith D Lindor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9496/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9496/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/17/9496/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic hepatitis C virus (HCV) and alcohol are common causes of chronic liver diseases in the United States, and both are recognized as major causes of liver disease worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/1\">",
"     1",
"    </a>",
"    ]. Each poses a major public and economic burden to society, and when the two coexist they appear to have a synergistic effect in the progression of chronic liver disease.",
"   </p>",
"   <p>",
"    This topic will review the effect of alcohol on the natural history and treatment of hepatitis C. Other issues related to hepatitis C and alcoholic liver disease are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=see_link\">",
"       \"Epidemiology and transmission of hepatitis C virus infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=see_link\">",
"       \"Screening for and diagnosis of chronic hepatitis C virus infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/50/31530?source=see_link\">",
"       \"Clinical manifestations and natural history of chronic hepatitis C virus infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/45/43735?source=see_link\">",
"       \"Overview of the management of chronic hepatitis C virus infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18554?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/5/30807?source=see_link\">",
"       \"Pathogenesis of alcoholic liver disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/42/21162?source=see_link\">",
"       \"Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/37/22104?source=see_link\">",
"       \"Prognosis and management of alcoholic fatty liver disease and alcoholic cirrhosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY OF HEPATITIS C IN ALCOHOLIC PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of HCV infection in patients with a history of alcohol abuse is significantly higher than that seen in the general population. Initial reports that were based upon first-generation enzyme-linked immunosorbent assays documented a prevalence of HCV antibodies as high as 45 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Subsequent studies that used more accurate tests like recombinant immunoblot assays (RIBA-I, RIBA-II) and polymerase chain reaction (PCR) found a lower prevalence (14 to 36 percent), but still substantially increased compared to the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/4-8\">",
"     4-8",
"    </a>",
"    ]. The prevalence of HCV among patients hospitalized with alcohol-related disorders is also increased (15 percent in one report) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/9\">",
"     9",
"    </a>",
"    ]. In a study of US veterans with hepatitis C, 44 percent had a history of alcohol abuse or dependence [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reason for the higher incidence of HCV infection among alcoholics is incompletely understood. An increased prevalence of high-risk behaviors (such as intravenous drug abuse) among alcoholic patients has been observed in some reports [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/11-13\">",
"     11-13",
"    </a>",
"    ], although others have not detected this association [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Most of the studies did not address other potential risk factors, such as cocaine snorting, tattoos, body piercing, and a history of sexually transmitted diseases. Understanding of hepatitis C epidemiology remains elusive and there is a need to improve the tools used to measure practices that can be associated with HCV transmission and are not usually volunteered [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EFFECT OF ALCOHOL ON THE NATURAL HISTORY OF HEPATITIS C",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have focused on identifying how alcohol affects the natural history of HCV and liver disease. Three observations have emerged from an increasing body of data on alcohol consumption in patients with chronic HCV. Heavy alcohol use:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Accelerates fibrosis progression and increases the risk of cirrhosis",
"     </li>",
"     <li>",
"      Predicts increased mortality",
"     </li>",
"     <li>",
"      Increases the risk of hepatocellular carcinoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Acceleration of fibrosis and cirrhosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A consistent observation has been that patients who are infected with hepatitis C and consume alcohol are at increased risk for progression to cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/18-28\">",
"     18-28",
"    </a>",
"    ]. An illustrative study included 2235 patients with chronic hepatitis C in whom three independent factors were associated with increased rate of fibrosis progression [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age at infection (older than 40 years)",
"     </li>",
"     <li>",
"      Male gender",
"     </li>",
"     <li>",
"      Daily alcohol consumption of 50 g or more",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Daily alcohol consumption of 50 g or greater was associated with a 34 percent increase in the rate of fibrosis progression, which was defined as the ratio between the histological fibrosis stage (five-point scale: 0 = no fibrosis to 4 = cirrhosis) and the estimated duration of infection in years. Other potential risk factors, such as the genotype, quantity of HCV RNA, and mode of acquisition of hepatitis C infection, were not associated with higher fibrosis progression. A standard drink contains 12 g of alcohol and is equivalent to 360 mL (12 oz) of beer, 150 mL (5 oz) of wine, or 45 mL (1.5 oz) of whiskey or other 80 proof distilled spirits.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Similar conclusions were reached in another report that focused on 1667 HCV-positive injection drug users who were followed for a median of nine years [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/27\">",
"       27",
"      </a>",
"      ]. The relative risk of end-stage liver disease was increased almost fourfold for those who drank more than 260 g of alcohol per week (RR 3.6, 95% CI 1.73 to 7.52).",
"     </li>",
"     <li>",
"      A meta-analysis pooled data from 16 studies involving more than 15,000 patients looking at the impact of alcohol on those with HCV. With regard to the combined outcome (cirrhosis or decompensated cirrhosis), heavy alcohol use (&gt;240 to 560",
"      <span class=\"nowrap\">",
"       g/week)",
"      </span>",
"      was associated with an increased risk when compared to those with less than heavy use (RR 2.33, 95% CI 1.67-3.26) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A prospective study of United States veterans compared with non-veterans with hepatitis C infection found that veterans were older and had higher lifetime alcohol consumption than non-veterans, but their median fibrosis scores did not differ from non-veterans [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/30\">",
"       30",
"      </a>",
"      ]. However, fibrosis in non-veterans was significantly associated with increased alcohol consumption (men &gt;150 kg lifetime: four to five drinks per day for &gt;10 years; women &gt;100 kg lifetime: &gt;3 drinks per day for &gt;10 years) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The exact amount of alcohol that increases the risk of HCC in patients with HCV is unknown but it appears that even modest alcohol use can accelerate fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/31\">",
"     31",
"    </a>",
"    ]. This was illustrated in a study of 800 patients with HCV who underwent liver biopsies and in whom a detailed alcohol history was assessed. A spectrum of fibrosis was observed for each category of alcohol intake (none, light, moderate, and heavy).",
"   </p>",
"   <p>",
"    Another study of 3404 newly referred patients with hepatitis C identified factors associated with severe liver disease (ie, cirrhosis or liver cancer) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/32\">",
"     32",
"    </a>",
"    ]. Patients with severe liver disease were more likely to have past excessive alcohol consumption defined as &gt;21 glasses per week for women, &gt;28 glasses per week for men (adjusted OR 2.6, 95% CI 1.9-3.5). While this observation was significant in those with &gt;5 years of excessive alcohol use, it was not seen in those with &lt;5 years of excessive alcohol use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Increase in mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concomitant alcohol abuse has been associated with increased mortality in patients with HCV [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/28,33-35\">",
"     28,33-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study in a referral center found significantly increased five-year mortality in patients with HCV and alcohol abuse compared with HCV alone (28 versus 10 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study evaluated more than 7 million death records in the United States from 2000 to 2002 [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/34\">",
"       34",
"      </a>",
"      ]. Patients were categorized as having HCV without heavy alcohol use (HAU), HAU without HCV, HCV plus HAU, and all others. Among men, those with HAU and HCV had a significantly lower mean age of death when compared with those with HCV alone (50 versus 55 years). A similar observation was seen in women (49 versus 61 years).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Risk of hepatocellular carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;A growing number of studies have demonstrated that patients with alcoholic liver disease who are infected with HCV are at increased risk for the development of hepatocellular carcinoma (HCC) compared with those with HCV alone [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/36-42\">",
"     36-42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25194?source=see_link\">",
"     \"Epidemiology and etiologic associations of hepatocellular carcinoma\"",
"    </a>",
"    .) The mechanisms underlying this interaction are poorly understood. The following examples illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A case control study included 305 patients with newly diagnosed HCC (of whom 122 were HCV RNA positive) who were compared to 610 controls without liver disease [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/38\">",
"       38",
"      </a>",
"      ]. The risk of HCC was increased 26-fold in patients who were HCV RNA positive (Odds ratio 26.3, 95% CI 15.8 to 44). The risk was increased 126-fold among patients who were HCV RNA positive who consumed more than 80",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      of alcohol (Odds ratio 126, 95% CI 42.8 to 373). An additional finding from this study was an increased risk of HCC in patients with concomitant infection with hepatitis B (Odds ratio 132, 95% CI 15.3 to 54.0), a finding that has been confirmed in several other studies [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/39-41\">",
"       39-41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A prospective cohort study included 290 consecutive patients with cirrhosis (69 percent of whom were positive for HCV antibodies) who were followed with periodic ultrasound examinations [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/40\">",
"       40",
"      </a>",
"      ]. During an average follow-up of 46 months, HCC developed in 32 patients (11 percent), including 20 percent of those who were HBsAg positive, 12 percent of those who were HCV antibody positive, and 14 percent of those with a history of alcohol abuse. On multivariate analysis, independent predictors of the development of HCC included positivity for HBsAg and HCV antibodies, male gender, and alcohol abuse. These results were comparable to an earlier prospective study with a similar design [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A case-control study included 115 cases who were compared with 230 controls with non-liver cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/42\">",
"       42",
"      </a>",
"      ]. On multivariate analysis, independent predictors of HCC included antibodies against HCV or HBV, heavy alcohol consumption, and diabetes mellitus. The risk appeared to be synergistic.",
"     </li>",
"     <li>",
"      In one small study, bile duct dysplasia was found to be associated with chronic HCV and alcohol cirrhosis. Of 19 cases of dysplasia, 19 were in the setting of HCV and 4 out of 19 were in the setting of combined HCV and alcohol use [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF ACCELERATED INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanisms underlying the interaction between alcohol, hepatitis C, and liver disease are incompletely understood and are likely beyond that of just additive injury. There are several theories regarding the interaction of alcohol and hepatitis C (",
"    <a class=\"graphic graphic_algorithm graphicRef65942 \" href=\"UTD.htm?27/7/27773\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Alcohol increases HCV replication",
"     </li>",
"     <li>",
"      Alcohol and HCV affect host cellular immunity",
"     </li>",
"     <li>",
"      Alcohol and HCV increase oxidative stress",
"     </li>",
"     <li>",
"      Alcohol increases HCV quasispecies",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Effect of alcohol on HCV replication",
"    </span>",
"    &nbsp;&mdash;&nbsp;One possible explanation for worsened outcome in alcohol consuming patients is that alcohol may increase HCV replication. Several in vitro studies have demonstrated upregulation of HCV replication (about a threefold increase at 96 hours) and protein expression in cells treated in an alcohol rich environment [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. Disparate data have also been published, although differences in experimental techniques may have accounted for the varying results [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several studies have also suggested that HCV RNA is increased in drinkers compared with nondrinkers [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/10,18,30,48\">",
"     10,18,30,48",
"    </a>",
"    ]. However, the strength of this association is unclear. A meta-analysis of 14 studies found no significant association between HCV RNA levels and the amount of alcohol consumption [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other authors have looked at the acute effect of alcohol on HCV levels in patients. One such report included 21 patients with chronic hepatitis C who were randomly assigned to receive a single dose of alcohol (50 g) versus placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/50\">",
"     50",
"    </a>",
"    ]. No significant effects on HCV RNA were detected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Alcohol affects host cellular immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have evaluated the interaction of HCV and alcohol on host cellular immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/47,51-55\">",
"     47,51-55",
"    </a>",
"    ]. The following general observations have been made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alcohol influences hepatocyte transduction pathways possibly acting with HCV to induce alterations in cellular responses to HCV.",
"     </li>",
"     <li>",
"      Host dendritic cells are modulated by HCV infection and by alcohol. The presence of HCV proteins (core and NS3) reduced dendritic cell differentiation in vitro while alcohol further reduced dendritic cell function by decreasing T cell stimulation and interferon production [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/53,55\">",
"       53,55",
"      </a>",
"      ]. These effects inhibited the antiviral response. Animal models of long-term alcohol consumption have also demonstrated an impaired cellular immune response to HCV infection attributable to altered dendritic cell function [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The presence of alcohol inhibits the antiviral actions of exogenous interferon [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Alcohol consumption did not influence T cell immune responses (interferon gamma and IL-10 production) in HCV or",
"      <span class=\"nowrap\">",
"       HCV/HIV",
"      </span>",
"      coinfected patients [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Alcohol and HCV increase oxidative stress",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alcohol intake increases oxidative stress in patients with HCV. An illustrative study compared measures of oxidative stress in 145 patients with chronic hepatitis C virus, 20 heavy drinkers without HCV, and 50 controls [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/56\">",
"     56",
"    </a>",
"    ]. The risk of developing oxidative stress during chronic hepatitis C infection was increased threefold by moderate alcohol intake (&lt;50gm",
"    <span class=\"nowrap\">",
"     ethanol/day)",
"    </span>",
"    and 13- to 24-fold in chronic hepatitis C patients with heavy alcohol intake (&gt;50 gm",
"    <span class=\"nowrap\">",
"     ethanol/day).",
"    </span>",
"    The authors conclude that HCV and alcohol act synergistically in stimulating free radical generation as well affecting antioxidant defenses.",
"   </p>",
"   <p>",
"    In vivo observations are further confirmed with in vitro studies. In studies of hepatoma cells, HCV protein, enhanced CYP2E1 expression, and alcohol acted synergistically to enhance reactive oxygen species and sensitize cells to mitochondrial depolarization and cell death by TNF or oxidative stress [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HCV alters the redox state of hepatocytes leading to changes in mitochondrial structure and function. As an example, the HCV NS5a protein appears to contribute to development of reactive oxygen species in mitochondria and endoplasmic reticulum (ER). HCV core protein induces ER stress, an effect exacerbated by alcohol, thereby further oxidizing the mitochondrial antioxidant (glutathione) pool [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/58\">",
"     58",
"    </a>",
"    ]. Oxidative stress may contribute to liver injury and impair liver regeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/56,59\">",
"     56,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Alcohol increases HCV quasispecies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis C exists as closely related \"quasispecies\". Alcohol increases the diversity of HCV quasispecies by mechanisms that are poorly understood. One theory is that the generation of reactive oxygen species (see above) increases the mutation rate of the HCV genome, thereby driving viral evolution [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the clinical implications of alcohol and HCV quasispecies diversification are unclear. On the one hand, increased quasispecies complexity has been associated with poor responsiveness to interferon alfa, possibly contributing to the decreased responsiveness of alcoholic patients with HCV to interferon treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Effect of alcohol on treatment of hepatitis C'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    On the other hand, low quasispecies diversification has been associated with more severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/62\">",
"     62",
"    </a>",
"    ]. This may reflect immune failure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    selective outgrowth of aggressive viral variants. In one such report, alcohol had no significant association between the degree of quasispecies diversification and the severity of liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     HISTOPATHOLOGIC CORRELATES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver histology in patients with alcoholic liver disease and HCV may demonstrate the typical histologic features of alcoholic liver disease, such as macrovesicular steatosis, polymorphonuclear infiltrate, hepatocyte ballooning, and Mallory bodies. Superimposed features of chronic hepatitis, such as periportal necrosis, portal inflammation, lymphoid aggregates in the portal tracts, and lymphocytosis in the sinusoids, are also commonly present [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/14,63,64\">",
"     14,63,64",
"    </a>",
"    ]. As expected, there is a higher risk of fibrosis seen in consumers of alcohol (&gt;50",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    versus those with lower intakes of alcohol on liver biopsy (",
"    <a class=\"graphic graphic_figure graphicRef61200 \" href=\"UTD.htm?4/31/4607\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Acceleration of fibrosis and cirrhosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     EFFECT OF ALCOHOL ON TREATMENT OF HEPATITIS C",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ongoing alcohol use decreases the efficacy of interferon-based treatment of HCV [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/44,48,65,66\">",
"     44,48,65,66",
"    </a>",
"    ]. The reason for the decreased responsiveness is incompletely understood. It may in part be due to decreased compliance, although several biological mechanisms have also been hypothesized, such as potentiation of HCV replication [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/44,45,67,68\">",
"     44,45,67,68",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Pathogenesis of accelerated injury'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    By contrast, data regarding the impact of past alcohol use (more than six months prior to therapy) are conflicting. Considered together, the studies suggest that past alcohol use has no impact on treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/67,69-71\">",
"     67,69-71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One of the largest studies included a total of 4061 patients, of whom 726 (18 percent) received interferon-based treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/67\">",
"     67",
"    </a>",
"    ]. Alcohol use (past and within 12 months) was associated with reduced treatment candidacy (20 percent of drinkers versus 27 percent of nondrinkers). Past alcohol use (more than 12 months) did not affect the sustained virologic response or end of treatment response rates while more recent alcohol use was associated with a higher rate of treatment discontinuation and tended to reduce the sustained virologic response rate. The authors concluded that patients who use alcohol and complete treatment have a response rate comparable to that of nondrinkers and thus they should not be excluded from HCV therapy. However, the authors suggest that additional support should be obtained to ensure their ability to complete treatment.",
"   </p>",
"   <p>",
"    Regardless of what has been learned of alcohol and HCV treatment, a history of alcohol abuse impacts the decision to treat HCV with interferon-based regimens. This was illustrated in a study of 113,927 United States veterans with chronic HCV of whom only 12 percent received interferon-based treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/10\">",
"     10",
"    </a>",
"    ]. Nearly one-half of untreated patients had a history of alcohol abuse or dependence (compared with 30 percent of treated patients).",
"   </p>",
"   <p>",
"    Several questions related to alcohol intake and interferon-based therapies for HCV remain unanswered since major clinical trials have excluded patients with history of excessive alcohol intake and who admit to continued alcohol intake at the onset of therapy. Precisely how alcohol influences the action of interferon, the optimal length of abstinence and effect of low levels of alcohol intake during the therapy remains unclear. Furthermore, the degree to which alcohol use impairs the response during combination therapy with peginterferon alfa plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    has not been well studied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     HOW MUCH ALCOHOL IS TOO MUCH?",
"    </span>",
"    &nbsp;&mdash;&nbsp;The amount of alcohol required to increase the risk of disease progression in patients with HCV has not been well defined. Although most of the studies discussed above included patients with alcohol intake of &gt;50",
"    <span class=\"nowrap\">",
"     g/day,",
"    </span>",
"    more modest alcohol intake (&lt;140",
"    <span class=\"nowrap\">",
"     g/week)",
"    </span>",
"    has been associated with increased HCV viremia and hepatic fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/21\">",
"     21",
"    </a>",
"    ]. Even modest alcohol intake is associated with increased oxidative stress [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9496/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A standard drink contains 12 g of alcohol and is equivalent to 360 mL (12 oz) of beer, 150 mL (5 oz) of wine, and 45 mL (1.5 oz) of whiskey or other 80 proof distilled spirits. Thus, modest alcohol intake translates into approximately two standard size beers per day, an amount that can easily be considered social drinking. Thus, a conservative recommendation that can be unambiguously interpreted when counseling patients is that alcohol should be avoided altogether, particularly prior to treatment with interferon alfa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic hepatitis C and alcoholism are common causes of liver diseases in the United States and in many other countries. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology of hepatitis C in alcoholic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Alcohol and HCV appear to act synergistically in promoting progression to cirrhosis and increasing the risk of hepatocellular carcinoma. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Effect of alcohol on the natural history of hepatitis C'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of the available data (in vivo and in vitro) suggest that ongoing but not remote alcohol consumption significantly impairs the efficacy of interferon-based therapy for HCV elimination. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Effect of alcohol on treatment of hepatitis C'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A safe threshold of alcohol consumption has not been established to date. As a result, we suggest total abstinence of alcohol in patients with chronic HCV, particularly before initiation and during antiviral therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'How much alcohol is too much?'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114791762\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Marshall M. Kaplan, MD, who passed away in September 2012. UpToDate wishes to acknowledge Dr. Kaplan's many contributions to our program, in particular, his work on this topic as our Section Editor for Alcoholic and Metabolic Liver Disease.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/1\">",
"      Regev A, Jeffers LJ. Hepatitis C and alcohol. Alcohol Clin Exp Res 1999; 23:1543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/2\">",
"      Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/3\">",
"      Bode JC, Biermann J, Kohse KP, et al. High incidence of antibodies to hepatitis C virus in alcoholic cirrhosis: fact or fiction? Alcohol Alcohol 1991; 26:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/4\">",
"      Caldwell SH, Li X, Rourk RM, et al. Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastroenterol 1993; 88:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/5\">",
"      Coelho-Little ME, Jeffers LJ, Bernstein DE, et al. Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease. Alcohol Clin Exp Res 1995; 19:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/6\">",
"      Par&eacute;s A, Barrera JM, Caballer&iacute;a J, et al. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990; 12:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/7\">",
"      Nalpas B, Thiers V, Pol S, et al. Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 1992; 14:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/8\">",
"      Befrits R, Hedman M, Blomquist L, et al. Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease. Scand J Gastroenterol 1995; 30:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/9\">",
"      Tsui JI, Pletcher MJ, Vittinghoff E, et al. Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol 2006; 44:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/10\">",
"      Butt AA, Justice AC, Skanderson M, et al. Rate and predictors of treatment prescription for hepatitis C. Gut 2007; 56:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/11\">",
"      Jiang JJ, Dubois F, Driss F, et al. Clinical impact of drug addiction in alcoholics. Alcohol Alcohol 1995; 30:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/12\">",
"      Nalpas B, Pol S, Th&eacute;pot V, et al. ESBRA 1997 Award lecture: relationship between excessive alcohol drinking and viral infections. Alcohol Alcohol 1998; 33:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/13\">",
"      Verbaan H, Andersson K, Eriksson S. Intravenous drug abuse--the major route of hepatitis C virus transmission among alcohol-dependent individuals? Scand J Gastroenterol 1993; 28:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/14\">",
"      Brillanti S, Masci C, Siringo S, et al. Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol 1991; 13:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/15\">",
"      Caldwell SH, Jeffers LJ, Ditomaso A, et al. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Am J Gastroenterol 1991; 86:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/16\">",
"      Thomas DL. Hepatitis C epidemiology: injecting new tools in the field. Hepatology 2000; 31:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/17\">",
"      Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 2000; 31:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/18\">",
"      Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/19\">",
"      Roudot-Thoraval F, Bastie A, Pawlotsky JM, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 1997; 26:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/20\">",
"      Ostapowicz G, Watson KJ, Locarnini SA, Desmond PV. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998; 27:1730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/21\">",
"      Pessione F, Degos F, Marcellin P, et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998; 27:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/22\">",
"      Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995; 15:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/23\">",
"      Wiley TE, McCarthy M, Breidi L, et al. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998; 28:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/24\">",
"      Khan MH, Thomas L, Byth K, et al. How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C? J Gastroenterol Hepatol 1998; 13:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/25\">",
"      Corrao G, Aric&ograve; S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998; 27:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/26\">",
"      Harris DR, Gonin R, Alter HJ, et al. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med 2001; 134:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/27\">",
"      Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/28\">",
"      Bedogni G, Miglioli L, Masutti F, et al. Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. Am J Gastroenterol 2008; 103:2248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/29\">",
"      Hutchinson SJ, Bird SM, Goldberg DJ. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005; 3:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/30\">",
"      Kayali Z, Tan S, Shinkunas L, et al. Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans. J Viral Hepat 2007; 14:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/31\">",
"      Monto A, Patel K, Bostrom A, et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004; 39:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/32\">",
"      Delarocque-Astagneau E, Roudot-Thoraval F, Camp&egrave;se C, et al. Past excessive alcohol consumption: a major determinant of severe liver disease among newly referred hepatitis C virus infected patients in hepatology reference centers, France, 2001. Ann Epidemiol 2005; 15:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/33\">",
"      Said A, Williams J, Holden J, et al. The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting. Clin Gastroenterol Hepatol 2004; 2:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/34\">",
"      Chen CM, Yoon YH, Yi HY, Lucas DL. Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis. Alcohol Clin Exp Res 2007; 31:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/35\">",
"      Younossi ZM, Zheng L, Stepanova M, et al. Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C. Aliment Pharmacol Ther 2013; 37:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/36\">",
"      Yamauchi M, Nakahara M, Maezawa Y, et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993; 88:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/37\">",
"      Donato F, Tagger A, Chiesa R, et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology 1997; 26:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/38\">",
"      Tagger A, Donato F, Ribero ML, et al. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int J Cancer 1999; 81:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/39\">",
"      Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998; 28:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/40\">",
"      Benvegn&ugrave; L, Fattovich G, Noventa F, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994; 74:2442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/41\">",
"      Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/42\">",
"      Hassan MM, Hwang LY, Hatten CJ, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/43\">",
"      Torbenson M, Yeh MM, Abraham SC. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Am J Surg Pathol 2007; 31:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/44\">",
"      McCartney EM, Semendric L, Helbig KJ, et al. Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon. J Infect Dis 2008; 198:1766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/45\">",
"      Zhang T, Li Y, Lai JP, et al. Alcohol potentiates hepatitis C virus replicon expression. Hepatology 2003; 38:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/46\">",
"      Trujillo-Murillo K, Alvarez-Mart&iacute;nez O, Garza-Rodr&iacute;guez L, et al. Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity. J Viral Hepat 2007; 14:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/47\">",
"      Plumlee CR, Lazaro CA, Fausto N, Polyak SJ. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Virol J 2005; 2:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/48\">",
"      Oshita M, Hayashi N, Kasahara A, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994; 20:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/49\">",
"      Anand BS, Thornby J. Alcohol has no effect on hepatitis C virus replication: a meta-analysis. Gut 2005; 54:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/50\">",
"      Manolakopoulos S, Economou M, Bethanis S, et al. A single alcohol ingestion does not affect serum hepatitis C virus RNA in patients with chronic hepatitis C. Liver Int 2006; 26:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/51\">",
"      Szabo G, Aloman C, Polyak SJ, et al. Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity. Alcohol Clin Exp Res 2006; 30:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/52\">",
"      Szabo G. Pathogenic interactions between alcohol and hepatitis C. Curr Gastroenterol Rep 2003; 5:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/53\">",
"      Aloman C, Gehring S, Wintermeyer P, et al. Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunction. Gastroenterology 2007; 132:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/54\">",
"      Graham CS, Wells A, Edwards EM, et al. Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection. J Infect Dis 2007; 195:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/55\">",
"      Dolganiuc A, Kodys K, Kopasz A, et al. Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction. Alcohol Clin Exp Res 2003; 27:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/56\">",
"      Rigamonti C, Mottaran E, Reale E, et al. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 2003; 38:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/57\">",
"      Otani K, Korenaga M, Beard MR, et al. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005; 128:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/58\">",
"      Wang T, Weinman SA. Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J Gastroenterol Hepatol 2006; 21 Suppl 3:S34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/59\">",
"      Duguay L, Coutu D, Hetu C, Joly JG. Inhibition of liver regeneration by chronic alcohol administration. Gut 1982; 23:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/60\">",
"      Seronello S, Sheikh MY, Choi J. Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic Biol Med 2007; 43:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/61\">",
"      Sherman KE, Rouster SD, Mendenhall C, Thee D. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Hepatology 1999; 30:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/62\">",
"      Sullivan DG, Bruden D, Deubner H, et al. Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease. J Infect Dis 2007; 196:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/63\">",
"      Fong TL, Kanel GC, Conrad A, et al. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 1994; 19:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/64\">",
"      Uchimura Y, Sata M, Kage M, et al. A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 1995; 15:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/65\">",
"      Ohnishi K, Matsuo S, Matsutani K, et al. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol 1996; 91:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/66\">",
"      Okazaki T, Yoshihara H, Suzuki K, et al. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers. Scand J Gastroenterol 1994; 29:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/67\">",
"      Anand BS, Currie S, Dieperink E, et al. Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. Gastroenterology 2006; 130:1607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/68\">",
"      Jamal MM, Saadi Z, Morgan TR. Alcohol and hepatitis C. Dig Dis 2005; 23:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/69\">",
"      Tabone M, Sidoli L, Laudi C, et al. Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy. J Viral Hepat 2002; 9:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/70\">",
"      Chang A, Skole K, Gautam M, et al. The impact of past alcohol use on treatment response rates in patients with chronic hepatitis C. Aliment Pharmacol Ther 2005; 22:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9496/abstract/71\">",
"      Russell M, Pauly MP, Moore CD, et al. The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan. Hepatology 2012; 56:1223.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3585 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-C801F8800B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9496=[""].join("\n");
var outline_f9_17_9496=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY OF HEPATITIS C IN ALCOHOLIC PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EFFECT OF ALCOHOL ON THE NATURAL HISTORY OF HEPATITIS C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Acceleration of fibrosis and cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Increase in mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Risk of hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATHOGENESIS OF ACCELERATED INJURY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Effect of alcohol on HCV replication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Alcohol affects host cellular immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Alcohol and HCV increase oxidative stress",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Alcohol increases HCV quasispecies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      HISTOPATHOLOGIC CORRELATES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      EFFECT OF ALCOHOL ON TREATMENT OF HEPATITIS C",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      HOW MUCH ALCOHOL IS TOO MUCH?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H114791762\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/3585\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3585|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?27/7/27773\" title=\"algorithm 1\">",
"      Mechanisms alcohol HCV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3585|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/31/4607\" title=\"figure 1\">",
"      Fibrosis duration infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/42/21162?source=related_link\">",
"      Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/50/31530?source=related_link\">",
"      Clinical manifestations and natural history of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18554?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25194?source=related_link\">",
"      Epidemiology and etiologic associations of hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=related_link\">",
"      Epidemiology and transmission of hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/45/43735?source=related_link\">",
"      Overview of the management of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/5/30807?source=related_link\">",
"      Pathogenesis of alcoholic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/37/22104?source=related_link\">",
"      Prognosis and management of alcoholic fatty liver disease and alcoholic cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=related_link\">",
"      Screening for and diagnosis of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_17_9497="Management of hepatic trauma in adults";
var content_f9_17_9497=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of hepatic trauma in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9497/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9497/contributors\">",
"     Ashley Britton Christmas, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9497/contributors\">",
"     David G Jacobs, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9497/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9497/contributors\">",
"     Heidi L Frankel, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9497/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9497/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/17/9497/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H462306208\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The liver is the most frequently injured abdominal organ. Most hepatic injuries are relatively minor and heal spontaneously with nonoperative management which consists of observation, and possibly arteriography and embolization [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Operative intervention to manage the liver injury is needed in about 14 percent of patients including those who initially present with hemodynamic instability or those who fail nonoperative management [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis and management of hepatic injury in adults is reviewed here. Surgical techniques to manage liver injury are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29880?source=see_link\">",
"     \"Surgical techniques for managing hepatic injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631340690\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The liver is the most commonly injured organ in blunt abdominal trauma and the second most commonly injured organ in penetrating abdominal trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. The liver is a highly vascular organ located in the right upper quadrant (",
"    <a class=\"graphic graphic_figure graphicRef62682 \" href=\"UTD.htm?7/51/7999\">",
"     figure 1",
"    </a>",
"    ) of the abdomen and is susceptible to injury from traumatic mechanisms. Among patients with blunt injury, motor vehicle collision is the most common injury mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/3\">",
"     3",
"    </a>",
"    ]. In patients with penetrating liver injury, the severity of injury depends upon the trajectory of the missile or implement and injuries can range from simple parenchymal to major vascular laceration.",
"   </p>",
"   <p>",
"    The liver margin, which can usually be palpated 2 to 3 cm below the right rib margin, rises and falls with the diaphragm during respiration. The dome of the liver rises as high as the level of T4 (nipple) with expiration. Thus, injuries to the chest wall are often associated with significant injury to the liver. Similarly, the inferior margin of the liver descends to as low as T12 with deep inspiration, and injuries, particularly penetrating injuries, have the potential to injure the liver lower in the abdomen than might be expected. The posterior portion of the right lobe (",
"    <a class=\"graphic graphic_figure graphicRef81897 \" href=\"UTD.htm?13/35/13878\">",
"     figure 2",
"    </a>",
"    ) is the most common site of hepatic injury in blunt trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631340668\">",
"    <span class=\"h1\">",
"     TRAUMA EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform the initial resuscitation, diagnostic evaluation and management of the trauma patient with blunt or penetrating trauma based upon protocols from the Advanced Trauma Life Support (ATLS) program, established by the American College of Surgeons Committee on Trauma. The initial resuscitation and evaluation of the patient with blunt or penetrating abdominal or thoracic trauma is discussed in detail elsewhere.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link\">",
"       \"Initial evaluation and management of blunt abdominal trauma in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=see_link\">",
"       \"Initial evaluation and management of abdominal gunshot wounds in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=see_link\">",
"       \"Initial evaluation and management of abdominal stab wounds in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=see_link\">",
"       \"Initial evaluation and management of blunt thoracic trauma in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/21/23898?source=see_link\">",
"       \"Initial evaluation and management of penetrating thoracic trauma in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hemodynamically unstable trauma patients should be transferred immediately to the operating room for evaluation and management. If the clinical setting allows, a Focused Assessment with Sonography for Trauma (FAST) exam, diagnostic peritoneal lavage (DPL), or computerized tomography (CT) may be performed. The choice of test and their value in the diagnostic evaluation of the trauma patient is discussed in detail elsewhere.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link&amp;anchor=H11#H11\">",
"       \"Initial evaluation and management of blunt abdominal trauma in adults\", section on 'Ultrasound'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=see_link&amp;anchor=H11#H11\">",
"       \"Initial evaluation and management of abdominal gunshot wounds in adults\", section on 'Ultrasound'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=see_link&amp;anchor=H11#H11\">",
"       \"Initial evaluation and management of abdominal stab wounds in adults\", section on 'Ultrasound'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link&amp;anchor=H13#H13\">",
"       \"Initial evaluation and management of blunt abdominal trauma in adults\", section on 'Diagnostic peritoneal lavage'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=see_link&amp;anchor=H12#H12\">",
"       \"Initial evaluation and management of abdominal stab wounds in adults\", section on 'Diagnostic peritoneal tap and lavage'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=see_link&amp;anchor=H12#H12\">",
"       \"Initial evaluation and management of abdominal gunshot wounds in adults\", section on 'Diagnostic peritoneal lavage'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Plain films obtained during the trauma evaluation are generally nonspecific but may demonstrate right-sided rib fractures, which increase the suspicion for liver injury.",
"   </p>",
"   <p>",
"    Specific elements of the history, physical examination, and imaging evaluation that pertain to liver injury are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631340912\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history of trauma to the right upper quadrant, right rib cage, or right flank should increase the suspicion for liver injury. The patient may complain of pain in the right upper abdomen, right chest wall, or the right shoulder due to diaphragmatic irritation. &nbsp;",
"   </p>",
"   <p>",
"    Abdominal tenderness and peritoneal signs are the most common findings indicative of intraabdominal injury; however, these are not sensitive or specific for liver injury. Physical findings associated with liver injury include right upper quadrant or generalized abdominal tenderness, abdominal wall contusion or hematoma (eg, seat belt sign), right lower chest wall tenderness, contusion, or instability due to rib fractures. Specific attention should be paid to any wounds that penetrate the right chest, abdomen, flank, or back, remembering that significant liver damage can occur without a wound in close proximity to it. A negative history and exam does not reliably exclude liver injury.",
"   </p>",
"   <p>",
"    In the setting of injury, many patients have altered mental status (eg, neurologic injury, intoxication) or are intubated and sedated and cannot relate their symptoms or medical history. Any preexisting medical conditions should be identified, particularly those requiring antiplatelet or anticoagulant therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31066?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of inpatient management in the adult trauma patient\", section on 'Patient assessment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631340933\">",
"    <span class=\"h2\">",
"     Associated injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other injuries are present in about 80 percent of patients with hepatic injury. In one series of 146 cases of hepatic injury, chest injury was the most commonly associated injury overall and the spleen was the most commonly injured intraabdominal organ [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/8\">",
"     8",
"    </a>",
"    ]. Other injuries associated with a blunt mechanism include lower rib fractures, pelvic fracture, and spinal cord injury.",
"   </p>",
"   <p>",
"    Injuries associated with penetrating mechanisms depend upon the implement and missile trajectory. Injuries to adjacent organs can occur in conjunction with liver laceration and include injuries to the vena cava, extrahepatic portal structures, colon, diaphragm, right lung, duodenum, and right kidney.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H933016203\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific laboratory tests diagnostic for hepatic injury. An initially elevated white blood cell count in the trauma patient is common and frequently related only to the physical stress of trauma. A finding of anemia is similarly nonspecific. The degree of anemia is related to the volume of blood lost, which can be from sites other than the liver, and the nature (crystalloid versus colloid) and volume of fluid resuscitation. The time course for developing anemia following posttraumatic hemorrhage is variable and related to the rapidity of exogenous fluid administration, and endogenous fluid shifts. Thus, the absence of anemia at the time of initial patient presentation does not rule out significant liver trauma-related bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H933016067\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diagnosis of liver injury may be suspected in the hemodynamically stable patient based upon mechanism of injury, physical examination or laboratory findings. However, imaging, usually using computed tomography (CT) of the abdomen definitively confirms the injury and defines the injury grade. Pooling of intravenous contrast in or around the liver implies ongoing bleeding and the need for intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. CT scanning also identifies associated intraabdominal and chest injuries.",
"   </p>",
"   <p>",
"    The Focused Assessment with Sonography in Trauma (FAST) exam is more commonly used in hemodynamically unstable patients. However, a negative FAST examination is",
"    <strong>",
"     not",
"    </strong>",
"    adequate to exclude liver injury, particularly intraparenchymal injury. On FAST examination, signs of liver injury include findings of a hypoechoic (ie, black) rim of subcapsular fluid, intraperitoneal fluid around the liver, or fluid in Morrison&rsquo;s pouch (hepatorenal space). Although diagnostic peritoneal",
"    <span class=\"nowrap\">",
"     aspiration/lavage",
"    </span>",
"    <span class=\"nowrap\">",
"     (DPA/DPL)",
"    </span>",
"    has largely been replaced by the FAST examination in most major trauma centers, it may still be useful in selected patients, if the FAST is equivocal.",
"   </p>",
"   <p>",
"    Organ-based ultrasound imaging, and magnetic resonance imaging (MRI) are of limited value in the initial diagnosis of liver injury. Organ-based ultrasound imaging and MRI are time-consuming to perform, and may put the patient in a location remote from ready access and intervention. However, MRI may be useful in a subset of hemodynamically stable patients who cannot undergo CT scan (eg, allergic to IV contrast), and patients with suspected extrahepatic ductal injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22266?source=see_link&amp;anchor=H2054878#H2054878\">",
"     \"Management of duodenal and pancreatic trauma in adults\", section on 'Magnetic resonance cholangiopancreatography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=see_link&amp;anchor=H2843337#H2843337\">",
"     \"Magnetic resonance cholangiopancreatography\", section on 'Pancreatic duct disruption'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Arteriography is generally reserved for patients who have indications for hepatic embolization to manage intrahepatic arterial hemorrhage. (See",
"    <a class=\"local\" href=\"#H631342355\">",
"     'Hepatic embolization'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631340675\">",
"    <span class=\"h1\">",
"     HEPATIC INJURY GRADING",
"    </span>",
"    &nbsp;&mdash;&nbsp;We use the American Association for the Surgery of Trauma (AAST) classification system, the most widely accepted injury grading scale, to grade hepatic injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/3,11\">",
"     3,11",
"    </a>",
"    ]. In a study of the solid organ injuries in the National Trauma Data Bank (NTDB) in 2008, 67 percent of hepatic injuries were grade I, II, or III [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The AAST grading system is most useful for predicting the likelihood of success with nonoperative management, which is higher for low-grade injuries (Grade I, II, III) compared with high-grade injuries (Grade IV, V). Patients with Grade VI injuries are universally hemodynamically unstable, mandating surgical intervention. The grades of hepatic injury are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Grade I &ndash; Hematoma: subcapsular &lt;10 percent surface area. Laceration: capsular tear &lt;1 cm parenchymal depth (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86850 \" href=\"UTD.htm?36/53/37717\">",
"       image 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Grade II &ndash; Hematoma: subcapsular 10 to 50 percent surface area (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86845 \" href=\"UTD.htm?36/37/37459\">",
"       image 2",
"      </a>",
"      ); intraparenchymal &lt;10 cm in diameter (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86844 \" href=\"UTD.htm?5/7/5234\">",
"       image 3",
"      </a>",
"      ). Laceration: capsular tear 1 to 3 cm parenchymal depth, &lt;10 cm in length (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef52550 \" href=\"UTD.htm?40/59/41904\">",
"       image 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Grade III &ndash; Hematoma: subcapsular &gt;50 percent of surface area or ruptured subcapsular or parenchymal hematoma; intraparenchymal hematoma &gt;10 cm or expanding. Laceration &gt;3 cm in depth (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86846 \" href=\"UTD.htm?12/42/12964\">",
"       image 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Grade IV &ndash; Laceration: parenchymal disruption involving 25 to 75 percent of a hepatic lobe (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86847 \" href=\"UTD.htm?17/48/18181\">",
"       image 6",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86848 \" href=\"UTD.htm?22/57/23441\">",
"       image 7",
"      </a>",
"      ), or 1 to 3 Couinaud segments (",
"      <a class=\"graphic graphic_figure graphicRef81897 \" href=\"UTD.htm?13/35/13878\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Grade V &ndash; Laceration: parenchymal disruption of &gt;75 percent of a hepatic lobe, &gt;3 Couinaud segments (",
"      <a class=\"graphic graphic_figure graphicRef81897 \" href=\"UTD.htm?13/35/13878\">",
"       figure 2",
"      </a>",
"      ) within a single lobe. Vascular: juxtahepatic venous injuries (retrohepatic vena cava, central major hepatic veins) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86849 \" href=\"UTD.htm?0/25/403\">",
"       image 8",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Grade VI &ndash; Hepatic avulsion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631340682\">",
"    <span class=\"h1\">",
"     APPROACH TO MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Improved speed and sensitivity of diagnostic imaging, most notably CT scanning, accompanied by advances in critical care monitoring have promoted a shift from operative to nonoperative management for most hemodynamically stable patients with hepatic injury. This practice has been associated with a decline in morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/1,2,4,8,12-17\">",
"     1,2,4,8,12-17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7088099\">",
"     'Morbidity and mortality'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The management strategy (operative or nonoperative) depends upon the hemodynamic status of the patient, grade of liver injury, and presence of other injuries and medical comorbidities.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The hemodynamically unstable trauma patient with a positive Focused Assessment with Sonography for Trauma (FAST) scan or positive diagnostic peritoneal lavage or aspirate",
"      <span class=\"nowrap\">",
"       (DPA/DPL)",
"      </span>",
"      requires emergent abdominal exploration to determine the source of intraperitoneal hemorrhage. When the source of bleeding is the liver, exploratory laparotomy is performed and control of bleeding may be through a damage-control approach or by using specific techniques for liver hemostasis depending upon the presence and extent of associated injuries and the extent of the liver injury. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29880?source=see_link&amp;anchor=H909580604#H909580604\">",
"       \"Surgical techniques for managing hepatic injury\", section on 'Techniques for liver hemostasis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with blunt liver injury who are hemodynamically stable and who do",
"      <strong>",
"       not",
"      </strong>",
"      have other indications for abdominal exploration can be observed [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/1,2,4,5,8,12,17-23\">",
"       1,2,4,5,8,12,17-23",
"      </a>",
"      ]. Hemodynamically stable patients with right-sided penetrating thoracoabdominal injuries that lacerate the liver can also be observed, provided there are no associated intraabdominal injuries. Patients with higher grade injuries fail nonoperative management more commonly than those with lower grade injuries, but these patients should still be offered nonoperative management so long as they remain hemodynamically stable. In general, patients who meet the criteria for the observation of liver injury but who require intervention to treat extra-abdominal injuries (eg, leg fracture stabilization) can also be observed. (See",
"      <a class=\"local\" href=\"#H462306215\">",
"       'Nonoperative management'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Surgical exploration is indicated in nonoperatively managed patients who continue to bleed (ongoing blood transfusion, hemodynamic instability), and in some patients who manifest a persistent systemic inflammatory response (ileus, fever, tachycardia, oliguria). The management of grade III injuries and higher often requires a combined angiographic and surgical approach. (See",
"      <a class=\"local\" href=\"#H631342355\">",
"       'Hepatic embolization'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29880?source=see_link\">",
"       \"Surgical techniques for managing hepatic injury\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H462306215\">",
"    <span class=\"h1\">",
"     NONOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonoperative management is the treatment of choice for hemodynamically stable patients with hepatic injury and consists of observation and supportive care with the adjunctive use of arteriography and hepatic embolization. Retrospective reviews of the National Trauma Data Bank and other observational studies have found that more than 80 percent of patients with blunt hepatic injury can be treated nonoperatively with success rates (defined as no need for operative intervention for the hepatic injury) in &gt;90 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/1,5,16,18,23-26\">",
"     1,5,16,18,23-26",
"    </a>",
"    ]. A review of the National Trauma Data Bank identified 35,510 hepatic injuries over a 10-year period from 1994 to 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/5\">",
"     5",
"    </a>",
"    ]. Of these, 91 percent of adults were successfully managed nonoperatively. Over the study period, the percentage of patients with liver injury managed nonoperatively rose from 75 to 82 percent, but the overall mortality associated with liver trauma remained unchanged at about 15 percent.",
"   </p>",
"   <p>",
"    Successful nonoperative management requires appropriate patient selection and the availability of resources including availability of intensive care unit beds, blood bank support, immediate operating room availability, and surgeons and interventional angiographers experienced in managing hepatic injury.",
"   </p>",
"   <p>",
"    Patients who are hemodynamically stable but demonstrate extravasation from the liver on computed tomography (CT) of the abdomen have higher failure rates with nonoperative management, and these patients should undergo arteriography and possible liver embolization followed by continued observation and serial hemoglobin determination. (See",
"    <a class=\"local\" href=\"#H631342355\">",
"     'Hepatic embolization'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631342348\">",
"    <span class=\"h2\">",
"     Contraindications to nonoperative management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contraindications to nonoperative management of liver injury include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/1,27,28\">",
"     1,27,28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemodynamic instability after initial resuscitation",
"     </li>",
"     <li>",
"      Other indication for abdominal surgery (eg, peritonitis)",
"     </li>",
"     <li>",
"      Gunshot injury (relative contraindication)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nonoperative management of gunshot wounds remains controversial even though nonoperative management of patients with isolated penetrating hepatic injuries due to abdominal stab wounds has been practiced routinely at many trauma centers for several years [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/29\">",
"     29",
"    </a>",
"    ]. Nonoperative management of these patients fails in up to one-third of patients due to ongoing bleeding, or the development of abdominal compartment syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/15,20,28,30\">",
"     15,20,28,30",
"    </a>",
"    ]. Missed injuries to the gastrointestinal tract are also a concern.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631342362\">",
"    <span class=\"h2\">",
"     Observation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonoperatively managed patients should be admitted to a monitored unit and initially placed on bed rest [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/1\">",
"     1",
"    </a>",
"    ]. Patients must be closely monitored by nursing and medical staff, and sufficient flexibility should be available to allow",
"    <span class=\"nowrap\">",
"     urgent/emergent",
"    </span>",
"    intervention (arteriography or surgery). (See",
"    <a class=\"local\" href=\"#H909582476\">",
"     'Failure of nonoperative management'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Large observational studies support the practice of discharging patients with liver injury who are being observed to home provided they have a normal abdominal examination and stable hemoglobin for at least 24 hours, regardless of the grade of injury. The length of observation is based solely on clinical criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with liver injury or other severe injuries who require hospitalization are at a high risk for thromboembolism and should receive thromboprophylaxis; however, chemical thromboprophylaxis may need to be delayed due to an increased risk of bleeding (eg, cerebral injury). Provided there are no other contraindications to pharmacologic prophylaxis, we typically initiate treatment when the hemoglobin has stabilized with less than 1 g hemoglobin decrement over a 24-hour period of time. Pharmacologic prophylaxis does not appear to increase nonoperative management failure rates or blood transfusion requirements [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31066?source=see_link&amp;anchor=H172458244#H172458244\">",
"     \"Overview of inpatient management in the adult trauma patient\", section on 'Thromboprophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631342355\">",
"    <span class=\"h2\">",
"     Hepatic embolization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic embolization requires special imaging facilities and a vascular interventionalist (ie, interventional radiology, vascular surgeon) experienced with celiac artery catheterization and embolization techniques. Success rates for embolization vary depending upon institution, embolization technique, arterial accessibility, operator skill, and the type of embolization material used. In some centers, hepatic embolization has replaced the need for initial operative intervention.",
"   </p>",
"   <p>",
"    Hepatic embolization appears to be most successful when used preemptively in hemodynamically stable patients who demonstrate extravasation of contrast on the initial abdominal CT scan. In retrospective reviews, technical success ranges from 68 to 87 percent and the incidence of recurrent hemorrhage is low [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/13,27,35-37\">",
"     13,27,35-37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hepatic embolization can also be used to treat patients who have failed observational management [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/13,38,39\">",
"     13,38,39",
"    </a>",
"    ], and adjunctively to manage patients with ongoing bleeding or rebleeding from the liver after surgical management (",
"    <a class=\"graphic graphic_algorithm graphicRef65194 \" href=\"UTD.htm?4/51/4912\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Depending upon the nature of the injury and technical factors, embolization coils, microspheres,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/4/18499?source=see_link\">",
"     absorbable gelatin sponge",
"    </a>",
"    , or endogenous clot can be used to interrupt blood flow in the main hepatic artery or branch vessels. Ischemic complications related to angioembolization are not uncommon and may lead to a need for surgical debridement or liver resection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7088099\">",
"     'Morbidity and mortality'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631342721\">",
"    <span class=\"h2\">",
"     Benefits and risks of nonoperative management",
"    </span>",
"    &nbsp;&mdash;&nbsp;When nonoperative management is successful, the risks inherent to surgery and anesthesia are eliminated. However, disadvantages associated with nonoperative management include an increased risk of missed intraabdominal injury, particularly hollow viscus injury, transfusion-related illness, and risks associated with embolization techniques, such as hepatic necrosis. (See",
"    <a class=\"local\" href=\"#H7088099\">",
"     'Morbidity and mortality'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with missed gastrointestinal hollow viscus injury present with worsening abdominal pain and peritoneal signs, generally by postinjury day four. These patients require operative intervention, and, during exploration, the liver injury should also be evaluated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26522?source=see_link\">",
"     \"Traumatic gastrointestinal injury in the adult patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29880?source=see_link\">",
"     \"Surgical techniques for managing hepatic injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Blood transfusion is associated with many complications that can include intravascular volume overload (Transfusion Associated Circulatory Overload [TACO]), transfusion-related acute lung injury (TRALI), hypothermia, coagulopathy, immunologic and allergic reactions as well as immunomodulation (Transfusion Related Immune Modulation, TRIM). Some clinicians feel these risks may outweigh the benefits of aggressive nonoperative management strategies, particularly in patients with high-grade liver injuries. The risks associated with blood transfusion are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/49/793?source=see_link&amp;anchor=H11#H11\">",
"     \"Use of blood products in the critically ill\", section on 'Complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42214?source=see_link&amp;anchor=H2#H2\">",
"     \"Transfusion reactions caused by chemical and physical agents\", section on 'Transfusional volume overload (TACO)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/39/28282?source=see_link\">",
"     \"Transfusion-related acute lung injury (TRALI)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=see_link&amp;anchor=H6#H6\">",
"     \"Leukoreduction to prevent complications of blood transfusion\", section on 'Immunosuppression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hepatic embolization is associated with additional risks that include bleeding, arterial access site complications, hepatic necrosis,",
"    <span class=\"nowrap\">",
"     liver/subdiaphragmatic",
"    </span>",
"    abscess, inadvertent embolization of other organs (eg, bowel, pancreas) or lower extremities, allergic reaction to contrast, and contrast-induced nephropathy. The risk of contrast-induced nephropathy may be greater when embolization is performed following contrast CT scan, particularly in patients who may already be volume depleted. Contrast-induced nephropathy and its prevention are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/13/10457?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of contrast-induced nephropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/42/35498?source=see_link\">",
"     \"Prevention of contrast-induced nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909582476\">",
"    <span class=\"h2\">",
"     Failure of nonoperative management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure of nonoperative management (observation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    embolization) is defined as the need for operative intervention, and is generally related to bleeding that becomes apparent by the need for ongoing fluid resuscitation or transfusion, or hemodynamic instability. Hypotension may be absolute or relative, or manifested as persistent tachycardia despite adequate fluid resuscitation.",
"   </p>",
"   <p>",
"    Failure rates for nonoperative management of hepatic injury are generally low [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/9,30,36\">",
"     9,30,36",
"    </a>",
"    ]. In a retrospective review of 591 patients managed nonoperatively for blunt liver injury, 6 percent failed nonoperative management with about half of these due to ongoing bleeding from other injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/35\">",
"     35",
"    </a>",
"    ]. Patients with grade IV or V injuries are more likely to fail nonoperative management.",
"   </p>",
"   <p>",
"    In one study, logistic regression found that blood transfusion &ge;3 units (odds ratio 10.8, 95% CI 1.6-72.2) was an independent risk factor for surgical intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/40\">",
"     40",
"    </a>",
"    ]. Most protocols allow for continued observation with up to 4 units of blood transfusion related to the hepatic injury.",
"   </p>",
"   <p>",
"    Patients who become hemodynamically unstable, by definition, have failed nonoperative management, and should be taken immediately to the operating room for abdominal exploration. Arteriography with embolization should not be pursued under these circumstances given the time needed to set up the interventional radiology suite, get personnel in place, and perform the embolization procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H631343002\">",
"    <span class=\"h2\">",
"     Follow-up care",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few data to guide the routine care and follow-up of patients with hepatic injury who have been managed nonoperatively. No definitive recommendations have been established regarding the need or timing of follow-up imaging, the need for or duration of bed rest, the timing of return to daily activities",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    exercise, or the timing to initiate prophylactic or therapeutic anticoagulation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/6,43\">",
"     6,43",
"    </a>",
"    ]. Although it is a common recommendation that patients avoid strenuous activities for several weeks, this remains intuitive with few data to support this practice [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/28\">",
"     28",
"    </a>",
"    ]. For patients with higher grade injuries, we restrict strenuous physical activity for a longer period of time, which, for Grade V injury, can be as long as three months. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H462306222\">",
"    <span class=\"h1\">",
"     SURGICAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The operative management of liver injuries that require surgical intervention can be a challenge even for experienced surgeons due to the complex nature of the liver, its size, vascularity, dual blood supply (portal, hepatic arterial), and its rich and difficult-to-access venous drainage. In hemodynamically unstable patients, damage control techniques provide temporary control of bleeding and allow anesthesia staff to resuscitate the patient. Definitive management of bleeding from the liver is accomplished using a variety of techniques. The surgical management of hepatic injury is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29880?source=see_link\">",
"     \"Surgical techniques for managing hepatic injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7088099\">",
"    <span class=\"h1\">",
"     MORBIDITY AND MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mortality rates for hepatic injury vary according to the grade of the injury and have improved over time with the introduction of nonoperative management strategies and the use of perihepatic packing [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/14\">",
"     14",
"    </a>",
"    ]. Since mortality is unusual with Grade I and II injuries, the greatest reduction in operative mortality has occurred for higher grade liver injuries (Grade III, IV, V). Overall mortality for these higher grade injuries ranges from 10 to 42 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/21,22,39,44,45\">",
"     21,22,39,44,45",
"    </a>",
"    ]. However, many studies do not include mortality related to juxtahepatic injury, for which mortality rates remain extremely high (77 percent in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complications are common following the management of liver injuries. The incidence of complications increases with the grade of liver injury [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/20,46\">",
"     20,46",
"    </a>",
"    ]. In a series of 669 patients, complications developed in 5, 22, and 52 percent of patients with grade III, IV, and V injuries, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/45\">",
"     45",
"    </a>",
"    ]. Complications associated with lower grade injuries (grade I, II) are rare.",
"   </p>",
"   <p>",
"    Biliary tree disruption with formation of biloma",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    persistent bile leak is a frequent complication of nonoperative management for liver injury. The incidence of bile leak ranges from 0.5 to 21 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/36,47,48\">",
"     36,47,48",
"    </a>",
"    ]. Bile leak manifests as abdominal pain or a persistent systemic inflammatory response syndrome (SIRS) with fever, tachycardia, and leukocytosis. Repeat abdominal CT scan establishes the diagnosis. Biliary tree disruption with persistent bilious drainage can often be successfully managed by endoscopic retrograde cholangiopancreatography and stent placement. However, findings on abdominal CT consistent with bile ascites",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    persistent hemoperitoneum warrant laparoscopic evaluation with abdominal irrigation and drainage to remove the bile, which is very irritating to the peritoneum. Findings consistent with perihepatic abscesses can usually be managed with antibiotics and percutaneous drainage techniques, but surgery may be needed if interventional techniques fail to provide adequate drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hepatic necrosis to some extent commonly occurs following angioembolization for hepatic injury, but may also be seen following laparotomy and hepatorrhaphy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/39,41\">",
"     39,41",
"    </a>",
"    ]. The combination of hepatic injury and ischemia induced by embolization may predispose to major hepatic necrosis, particularly in patients who have previously undergone surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/41\">",
"     41",
"    </a>",
"    ]. Major hepatic necrosis is managed surgically with repeated resectional debridement in conjunction with interventional drainage procedures, or hepatic lobectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Early lobectomy rather than repeated debridement may be associated with a lower overall complication rate and the need for fewer procedures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29880?source=see_link&amp;anchor=H909580667#H909580667\">",
"     \"Surgical techniques for managing hepatic injury\", section on 'Liver resection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H462306193\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hepatic injury can result from blunt or penetrating chest or abdominal trauma. Following blunt trauma, the liver is the most commonly injured organ. Penetrating injury to the liver is frequently associated with injuries to adjacent structures that can be associated with mortality rates exceeding 75 percent in some studies. (See",
"      <a class=\"local\" href=\"#H462306208\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H631340933\">",
"       'Associated injuries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We perform initial resuscitation, diagnostic evaluation, and management of the trauma patient based upon protocols from the Advanced Trauma Life Support (ATLS) program developed by the American College of Surgeons Committee on Trauma. Hemodynamically unstable patients with a positive Focused Assessment with Sonography for Trauma (FAST) exam or diagnostic peritoneal lavage or aspirate",
"      <span class=\"nowrap\">",
"       (DPL/DPA)",
"      </span>",
"      require operative surgical exploration to determine the source of life-threatening hemorrhage, which may be due to liver injury. (See",
"      <a class=\"local\" href=\"#H631340668\">",
"       'Trauma evaluation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H631340682\">",
"       'Approach to management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A suspicion of hepatic injury is increased with right upper quadrant",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      right chest trauma; however, the clinical history and physical examination are not sufficiently sensitive or specific for the presence of liver injury. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link&amp;anchor=H4#H4\">",
"       \"Management of splenic injury in the adult trauma patient\", section on 'Trauma evaluation'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H631340668\">",
"       'Trauma evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Computed tomography (CT) of the abdomen identifies the presence of liver injury and defines its severity in hemodynamically stable patients. Hepatic injury is graded (I through VI) depending upon the extent and depth of liver hematoma",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      laceration as identified on abdominal CT, or at the time of surgery. Higher grades of hepatic injury correlate with increasing morbidity and mortality. (See",
"      <a class=\"local\" href=\"#H631340675\">",
"       'Hepatic injury grading'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7088099\">",
"       'Morbidity and mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For hemodynamically stable patients with liver injury, we suggest nonoperative management over definitive surgical intervention, regardless of hepatic injury grade (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Observation involves monitored care, serial abdominal examination, and serial hemoglobin assessment and potentially hepatic embolization. Failure of nonoperative management (ongoing transfusion, hemodynamic instability) indicates the need for hepatic embolization or surgery. (See",
"      <a class=\"local\" href=\"#H631342362\">",
"       'Observation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For hemodynamically stable patients with liver injury who demonstrate pooling of intravenous contrast on initial or subsequent abdominal CT scan, we suggest hepatic embolization rather than nonoperative management without embolization (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Hepatic embolization requires specialized imaging facilities and an appropriately-trained interventionalist experienced with celiac artery catheterization. Failure of hepatic embolization to control bleeding indicates the need for surgery. (See",
"      <a class=\"local\" href=\"#H631342355\">",
"       'Hepatic embolization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mortality has decreased with the introduction of nonoperative management strategies and damage control techniques [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9497/abstract/14\">",
"       14",
"      </a>",
"      ]. Mortality for low-grade (I, II, III) injuries is rare, but for high-grade injuries ranges from 10 to 42 percent (IV, V, VI). Complications related to nonoperative management are common and include bile leak that can lead to ascites, biloma, or abscess, and hepatic necrosis related to angioembolization. (See",
"      <a class=\"local\" href=\"#H7088099\">",
"       'Morbidity and mortality'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/1\">",
"      Croce MA, Fabian TC, Menke PG, et al. Nonoperative management of blunt hepatic trauma is the treatment of choice for hemodynamically stable patients. Results of a prospective trial. Ann Surg 1995; 221:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/2\">",
"      Malhotra AK, Fabian TC, Croce MA, et al. Blunt hepatic injury: a paradigm shift from operative to nonoperative management in the 1990s. Ann Surg 2000; 231:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/3\">",
"      Tinkoff G, Esposito TJ, Reed J, et al. American Association for the Surgery of Trauma Organ Injury Scale I: spleen, liver, and kidney, validation based on the National Trauma Data Bank. J Am Coll Surg 2008; 207:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/4\">",
"      Kozar RA, Moore FA, Moore EE, et al. Western Trauma Association critical decisions in trauma: nonoperative management of adult blunt hepatic trauma. J Trauma 2009; 67:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/5\">",
"      Hurtuk M, Reed RL 2nd, Esposito TJ, et al. Trauma surgeons practice what they preach: The NTDB story on solid organ injury management. J Trauma 2006; 61:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/6\">",
"      Stassen, N, Bhullar, et al. Nonoperative management of blunt hepatic injury: An Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012; 73:S288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/7\">",
"      Becker CD, Mentha G, Terrier F. Blunt abdominal trauma in adults: role of CT in the diagnosis and management of visceral injuries. Part 1: liver and spleen. Eur Radiol 1998; 8:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/8\">",
"      S&aacute;nchez-Bueno F, Fern&aacute;ndez-Carri&oacute;n J, Torres Salmer&oacute;n G, et al. [Changes in the diagnosis and therapeutic management of hepatic trauma. A retrospective study comparing 2 series of cases in different (1997-1984 vs. 2001-2008)]. Cir Esp 2011; 89:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/9\">",
"      Fang JF, Chen RJ, Wong YC, et al. Classification and treatment of pooling of contrast material on computed tomographic scan of blunt hepatic trauma. J Trauma 2000; 49:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/10\">",
"      Fang JF, Wong YC, Lin BC, et al. The CT risk factors for the need of operative treatment in initially hemodynamically stable patients after blunt hepatic trauma. J Trauma 2006; 61:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/11\">",
"      Moore EE, Cogbill TH, Jurkovich GJ, et al. Organ injury scaling: spleen and liver (1994 revision). J Trauma 1995; 38:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/12\">",
"      Christmas AB, Wilson AK, Manning B, et al. Selective management of blunt hepatic injuries including nonoperative management is a safe and effective strategy. Surgery 2005; 138:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/13\">",
"      David Richardson J, Franklin GA, Lukan JK, et al. Evolution in the management of hepatic trauma: a 25-year perspective. Ann Surg 2000; 232:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/14\">",
"      Peitzman AB, Richardson JD. Surgical treatment of injuries to the solid abdominal organs: a 50-year perspective from the Journal of Trauma. J Trauma 2010; 69:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/15\">",
"      Jurkovich GJ. Selective non-operative management in 25 737 patients with penetrating abdominal injuries (Br J Surg 2011; 99(Suppl 1): 157-167). Br J Surg 2012; 99 Suppl 1:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/16\">",
"      Petrowsky H, Raeder S, Zuercher L, et al. A quarter century experience in liver trauma: a plea for early computed tomography and conservative management for all hemodynamically stable patients. World J Surg 2012; 36:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/17\">",
"      Meredith JW, Young JS, Bowling J, Roboussin D. Nonoperative management of blunt hepatic trauma: the exception or the rule? J Trauma 1994; 36:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/18\">",
"      Pachter HL, Knudson MM, Esrig B, et al. Status of nonoperative management of blunt hepatic injuries in 1995: a multicenter experience with 404 patients. J Trauma 1996; 40:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/19\">",
"      Velmahos GC, Toutouzas KG, Radin R, et al. Nonoperative treatment of blunt injury to solid abdominal organs: a prospective study. Arch Surg 2003; 138:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/20\">",
"      Zafar SN, Nabeel Zafar S, Rushing A, et al. Outcome of selective non-operative management of penetrating abdominal injuries from the North American National Trauma Database. Br J Surg 2012; 99 Suppl 1:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/21\">",
"      Pachter HL, Spencer FC, Hofstetter SR, et al. Significant trends in the treatment of hepatic trauma. Experience with 411 injuries. Ann Surg 1992; 215:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/22\">",
"      Pachter HL, Feliciano DV. Complex hepatic injuries. Surg Clin North Am 1996; 76:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/23\">",
"      Piper GL, Peitzman AB. Current management of hepatic trauma. Surg Clin North Am 2010; 90:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/24\">",
"      Letoublon C, Chen Y, Arvieux C, et al. Delayed celiotomy or laparoscopy as part of the nonoperative management of blunt hepatic trauma. World J Surg 2008; 32:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/25\">",
"      Lepp&auml;niemi AK, Mentula PJ, Streng MH, et al. Severe hepatic trauma: nonoperative management, definitive repair, or damage control surgery? World J Surg 2011; 35:2643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/26\">",
"      Kozar RA, McNutt MK. Management of adult blunt hepatic trauma. Curr Opin Crit Care 2010; 16:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/27\">",
"      Badger SA, Barclay R, Campbell P, et al. Management of liver trauma. World J Surg 2009; 33:2522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/28\">",
"      Richardson JD. Changes in the management of injuries to the liver and spleen. J Am Coll Surg 2005; 200:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/29\">",
"      Navsaria PH, Nicol AJ, Krige JE, Edu S. Selective nonoperative management of liver gunshot injuries. Ann Surg 2009; 249:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/30\">",
"      Demetriades D, Gomez H, Chahwan S, et al. Gunshot injuries to the liver: the role of selective nonoperative management. J Am Coll Surg 1999; 188:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/31\">",
"      Parks NA, Davis JW, Forman D, Lemaster D. Observation for nonoperative management of blunt liver injuries: how long is long enough? J Trauma 2011; 70:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/32\">",
"      London JA, Parry L, Galante J, Battistella F. Safety of early mobilization of patients with blunt solid organ injuries. Arch Surg 2008; 143:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/33\">",
"      Datta I, Ball CG, Rudmik LR, et al. A multicenter review of deep venous thrombosis prophylaxis practice patterns for blunt hepatic trauma. J Trauma Manag Outcomes 2009; 3:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/34\">",
"      Eberle BM, Schn&uuml;riger B, Inaba K, et al. Thromboembolic prophylaxis with low-molecular-weight heparin in patients with blunt solid abdominal organ injuries undergoing nonoperative management: current practice and outcomes. J Trauma 2011; 70:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/35\">",
"      Hoffer EK, Borsa JJ, Bloch RD, Fontaine AB. Endovascular techniques in the damage control setting. Radiographics 1999; 19:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/36\">",
"      Asensio JA, Demetriades D, Chahwan S, et al. Approach to the management of complex hepatic injuries. J Trauma 2000; 48:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/37\">",
"      Misselbeck TS, Teicher EJ, Cipolle MD, et al. Hepatic angioembolization in trauma patients: indications and complications. J Trauma 2009; 67:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/38\">",
"      Letoublon C, Morra I, Chen Y, et al. Hepatic arterial embolization in the management of blunt hepatic trauma: indications and complications. J Trauma 2011; 70:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/39\">",
"      Asensio JA, Rold&aacute;n G, Petrone P, et al. Operative management and outcomes in 103 AAST-OIS grades IV and V complex hepatic injuries: trauma surgeons still need to operate, but angioembolization helps. J Trauma 2003; 54:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/40\">",
"      Huang YC, Wu SC, Fu CY, et al. Tomographic findings are not always predictive of failed nonoperative management in blunt hepatic injury. Am J Surg 2012; 203:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/41\">",
"      Dabbs DN, Stein DM, Scalea TM. Major hepatic necrosis: a common complication after angioembolization for treatment of high-grade liver injuries. J Trauma 2009; 66:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/42\">",
"      Dabbs DN, Stein DM, Philosophe B, Scalea TM. Treatment of major hepatic necrosis: lobectomy versus serial debridement. J Trauma 2010; 69:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/43\">",
"      Cox JC, Fabian TC, Maish GO 3rd, et al. Routine follow-up imaging is unnecessary in the management of blunt hepatic injury. J Trauma 2005; 59:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/44\">",
"      Polanco P, Leon S, Pineda J, et al. Hepatic resection in the management of complex injury to the liver. J Trauma 2008; 65:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/45\">",
"      Kozar RA, Moore FA, Cothren CC, et al. Risk factors for hepatic morbidity following nonoperative management: multicenter study. Arch Surg 2006; 141:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/46\">",
"      Kozar RA, Moore JB, Niles SE, et al. Complications of nonoperative management of high-grade blunt hepatic injuries. J Trauma 2005; 59:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/47\">",
"      Singh V, Narasimhan KL, Verma GR, Singh G. Endoscopic management of traumatic hepatobiliary injuries. J Gastroenterol Hepatol 2007; 22:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9497/abstract/48\">",
"      Wahl WL, Brandt MM, Hemmila MR, Arbabi S. Diagnosis and management of bile leaks after blunt liver injury. Surgery 2005; 138:742.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15143 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-7C479FB97E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9497=[""].join("\n");
var outline_f9_17_9497=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H462306193\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462306208\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H631340690\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H631340668\">",
"      TRAUMA EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H631340912\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H631340933\">",
"      Associated injuries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H933016203\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H933016067\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H631340675\">",
"      HEPATIC INJURY GRADING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H631340682\">",
"      APPROACH TO MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462306215\">",
"      NONOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H631342348\">",
"      Contraindications to nonoperative management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H631342362\">",
"      Observation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H631342355\">",
"      Hepatic embolization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H631342721\">",
"      Benefits and risks of nonoperative management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909582476\">",
"      Failure of nonoperative management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H631343002\">",
"      Follow-up care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462306222\">",
"      SURGICAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7088099\">",
"      MORBIDITY AND MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462306193\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15143\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15143|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?4/51/4912\" title=\"algorithm 1\">",
"      Operative management of hepatic injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15143|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/53/37717\" title=\"diagnostic image 1\">",
"      Low grade liver laceration on computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/37/37459\" title=\"diagnostic image 2\">",
"      Grade II subcapsular liver hematoma on ultrasound and CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/7/5234\" title=\"diagnostic image 3\">",
"      Grade II liver hematoma CT scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/59/41904\" title=\"diagnostic image 4\">",
"      Traumatic liver laceration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/42/12964\" title=\"diagnostic image 5\">",
"      Grade III liver laceration and hematoma on ultrasound and CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/48/18181\" title=\"diagnostic image 6\">",
"      Grade IV traumatic liver injury on computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/57/23441\" title=\"diagnostic image 7\">",
"      Grade IV liver trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/25/403\" title=\"diagnostic image 8\">",
"      Grade V liver laceration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15143|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/51/7999\" title=\"figure 1\">",
"      Anterior view of upper abdominal structures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/35/13878\" title=\"figure 2\">",
"      Segmental anatomy of liver",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3943?source=related_link\">",
"      Initial evaluation and management of abdominal gunshot wounds in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12776?source=related_link\">",
"      Initial evaluation and management of abdominal stab wounds in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=related_link\">",
"      Initial evaluation and management of blunt abdominal trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=related_link\">",
"      Initial evaluation and management of blunt thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/21/23898?source=related_link\">",
"      Initial evaluation and management of penetrating thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=related_link\">",
"      Leukoreduction to prevent complications of blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=related_link\">",
"      Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22266?source=related_link\">",
"      Management of duodenal and pancreatic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=related_link\">",
"      Management of splenic injury in the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31066?source=related_link\">",
"      Overview of inpatient management in the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/13/10457?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of contrast-induced nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/42/35498?source=related_link\">",
"      Prevention of contrast-induced nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29880?source=related_link\">",
"      Surgical techniques for managing hepatic injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42214?source=related_link\">",
"      Transfusion reactions caused by chemical and physical agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/39/28282?source=related_link\">",
"      Transfusion-related acute lung injury (TRALI)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26522?source=related_link\">",
"      Traumatic gastrointestinal injury in the adult patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/49/793?source=related_link\">",
"      Use of blood products in the critically ill",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_17_9498="Overview of hysteroscopy";
var content_f9_17_9498=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of hysteroscopy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9498/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9498/contributors\">",
"     Linda D Bradley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9498/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9498/contributors\">",
"     Tommaso Falcone, MD, FRCSC, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/17/9498/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/17/9498/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/17/9498/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of hysteroscopy has provided a minimally invasive approach to common gynecologic problems, such as abnormal uterine bleeding. Increased clinician training, smaller diameter hysteroscopes, and increased emphasis on office-based procedures have led to a widespread use of this important technology.",
"   </p>",
"   <p>",
"    A hysteroscope is a telescope that is inserted into the uterus via the vagina and cervix to visualize the endometrial cavity, as well as the tubal ostia, endocervical canal, cervix, and vagina. Hysteroscopy can be performed for diagnostic or therapeutic indications.",
"   </p>",
"   <p>",
"    An overview of hysteroscopy is presented here. Vaginoscopy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22147?source=see_link\">",
"     \"Vaginoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hysteroscopy is performed for evaluation or treatment of the endometrial cavity, tubal ostia, or endocervical canal in women with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abnormal premenopausal or postmenopausal uterine bleeding",
"     </li>",
"     <li>",
"      Endometrial thickening or polyps",
"     </li>",
"     <li>",
"      Submucosal, and some intramural, fibroids",
"     </li>",
"     <li>",
"      Intrauterine adhesions",
"     </li>",
"     <li>",
"      M&uuml;llerian anomalies (eg, uterine septum)",
"     </li>",
"     <li>",
"      Retained intrauterine contraceptives or other foreign bodies",
"     </li>",
"     <li>",
"      Retained products of conception",
"     </li>",
"     <li>",
"      Desire for sterilization",
"     </li>",
"     <li>",
"      Endocervical lesions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are several approaches to evaluating women with abnormal uterine bleeding or intrauterine lesions (pelvic sonography, saline infusion sonography, endometrial sampling, hysterosalpingography). Using hysteroscopy for the initial evaluation offers the potential benefit of combining evaluation with treatment. Also, hysteroscopy avoids the risk of missing focal pathology, as may occur with blind endometrial sampling.",
"   </p>",
"   <p>",
"    Alternatively, hysteroscopy can be used to further evaluate or treat lesions identified on imaging studies (eg, normal endometrial echo detected with transvaginal ultrasound), or to confirm the absence of disease when symptoms persist and initial diagnostic tests are normal (eg, blind endometrial sampling). Using hysteroscopy to follow-up abnormal imaging findings helps to rule out ovarian or tubal pathology that may contribute to abnormal uterine bleeding.",
"   </p>",
"   <p>",
"    A detailed discussion of the choice between hysteroscopy and other methods of endometrial evaluation can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38744?source=see_link\">",
"     \"Evaluation of the endometrium for malignant or premalignant disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/131?source=see_link\">",
"     \"Endometrial sampling procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hysteroscopy cannot assess myometrial disease (eg, adenomyosis), tubal pathology, or the external uterine contour; thus, it is not sufficient for evaluation of these anatomic structures during an infertility evaluation. Additional procedures (eg, laparoscopy or hysterosalpingography) are necessary. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/56/17287?source=see_link\">",
"     \"Overview of infertility\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contraindications to hysteroscopy are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Viable intrauterine pregnancy",
"     </li>",
"     <li>",
"      Active pelvic infection (including genital herpes infection [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/1\">",
"       1",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Known cervical or uterine cancer",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While hysteroscopy should not be performed in a patient with a viable intrauterine pregnancy, postpartum or post-abortal hysteroscopy is sometimes useful for evaluation and treatment of retained products of conception [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Excessive uterine bleeding may limit visualization during hysteroscopy, but it is not a contraindication [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/4\">",
"     4",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"local\" href=\"#H31\">",
"     'Operative challenges'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Medical comorbidities (eg, coronary heart disease, bleeding diathesis) are also potential contraindications to hysteroscopic surgery. However, since this is a minimally invasive procedure, it is rarely contraindicated in few women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41735?source=see_link\">",
"     \"Overview of the principles of medical consultation and perioperative medicine\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INSTRUMENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rigid hysteroscope includes an outer sheath which surrounds channels for the telescope, distending media inflow and outflow, and operative instruments. Additional equipment is needed for infusing and monitoring uterine distending media.",
"   </p>",
"   <p>",
"    There are many different sizes and type of hysteroscopes. Some are better suited for diagnostic versus operative procedures, or for outpatient rather than operating room procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hysteroscopes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Outer diameter and working length",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Outer diameter &mdash; The total outer diameter (OD) of a hysteroscope refers to the diameter of the sheath, a metal tube which houses the telescope and instruments. Sheath ODs range from 3.1 to 10 mm.",
"      <br/>",
"      <br/>",
"      Smaller OD hysteroscopes cause less pain and decrease the need for mechanical dilation. Even reducing the sheath size from 5 to 3.3 mm can improve patient comfort [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. In general, inserting a hysteroscope with &gt;5 mm OD will require mechanical cervical dilation; most patients will experience discomfort and will require analgesia (eg, paracervical block, peri-procedural nonsteroidal agents). In addition, analgesia is typically required for operative procedures. Diagnostic procedures performed with smaller OD sheaths can usually be performed without dilation and in the office.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both diagnostic and operative sheaths are fitted with stopcocks or ports for the instillation of distending media. To clear blood and thus improve visualization of the uterine cavity, some operative sheaths have dual ports that provide continuous laminar flow of distending media. In addition, some operative sheaths aspirate pieces of tissue from the uterine cavity (ie, to remove debris or retrieve specimens for pathologic evaluation). This allows removal of large debris while maintaining cervical dilation (see",
"    <a class=\"local\" href=\"#H10\">",
"     'Distending media'",
"    </a>",
"    below).",
"    <br/>",
"    <br/>",
"    Selected diagnostic hysteroscopes permit targeted biopsies and retrieval of foreign bodies, as well as limited intrauterine surgery (removal of filmy adhesions or small endometrial polyps).",
"    <br/>",
"    <br/>",
"    Simple operative sheaths use the distending media channel for the insertion of instruments. Although this method is easy and allows one to use a small-diameter sheath, leaks of media are common.",
"    <br/>",
"    <br/>",
"    Advanced operative sheaths may have three channels: two for operative instruments and one for instilling distending media.",
"   </p>",
"   <p>",
"    Other operative sheaths contain permanently attached operative tools, such as biopsy instruments, forceps, or scissors.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Working length &mdash; The working length of a hysteroscope measures from the eyepiece to the distal tip, and can range from 160 to 302 mm. A longer working element permits the hysteroscopist to be further away from the vagina.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Rigid versus flexible",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most hysteroscopes are rigid, but narrow caliber scopes (&lt;5 mm) may also be semi-rigid or flexible. Rigid hysteroscopes cause more intraoperative pain, but offer better optical quality and are less costly. This was illustrated in a randomized trial that assigned 144 pre- and postmenopausal women undergoing outpatient diagnostic hysteroscopy to a 3.7 mm rigid or 3.6 mm flexible hysteroscope [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/7\">",
"     7",
"    </a>",
"    ]. Both groups received topical cervical anesthesia. Compared with flexible hysteroscopes, use of a rigid hysteroscope was associated with significantly more pain, but better optical quality and ease of insertion.",
"   </p>",
"   <p>",
"    Flexible hysteroscopy is especially useful for diagnostic or operative procedures in women with an irregularly shaped uterus, as the distal tip can be deflected upward or downward (eg, for tubal cannulation or lysis of adhesions near the tubal ostia) (",
"    <a class=\"graphic graphic_picture graphicRef59639 \" href=\"UTD.htm?41/17/42270\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Optics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Quality of visualization varies among hysteroscopic telescopes. In general, the higher quality cameras have larger ODs and are more costly. Thus, narrow caliber telescopes provide adequate quality for routine diagnostic procedures, while the high quality cameras are preferable for advanced operative hysteroscopy.",
"   </p>",
"   <p>",
"    The telescope consists of three parts: the eyepiece, barrel, and objective lens. The image depends upon characteristics of these components. Hysteroscopes are monocular (single eyepiece), and thus, provide little depth perception. The surgeon can look directly through the eyepiece or view the image via a video monitoring system. Use of a video monitoring system allows other operating room personnel and the patient to view the procedure and also allows still photographs and video recordings for documentation.",
"   </p>",
"   <p>",
"    Viewing angles range from zero to 70 degrees (",
"    <a class=\"graphic graphic_figure graphicRef58867 \" href=\"UTD.htm?5/54/5985\">",
"     figure 1",
"    </a>",
"    ). A zero degree hysteroscope provides a panoramic view in line with the sheath. Increasing viewing angles allow the surgeon to visualize areas to the left or right of midline without shifting the telescope from side to side (eg, to view the tubal ostia or a focal lesion in an irregularly shaped cavity).",
"   </p>",
"   <p>",
"    There are two main hysteroscopic optical systems: direct optical and contact. The direct optical hysteroscope, derived from the cystoscope, provides the surgeon with a global view of the uterine cavity. A distending medium is used and the image is well-illuminated and has excellent contrast and resolution.",
"   </p>",
"   <p>",
"    Conversely, contact hysteroscopes work without a distending medium and provide only a focal view of the endometrial cavity, since only tissue in direct contact with the scope can be viewed [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/8\">",
"     8",
"    </a>",
"    ]. Thus, unless the uterine cavity is explored in a slow, systematic fashion, significant pathology can be missed. This approach is rarely used.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Light source &mdash; Illumination for hysteroscopy is provided by a light source connected to the hysteroscope by a fiberoptic cable. Fiberoptics allow transmission of bright light without the transmission of significant heat.",
"      <br/>",
"      <br/>",
"      Most light sources are either halogen or xenon. Either type of lamp provides adequate illumination for operative procedures, photography, and videotaping; xenon lamps are more expensive than halogen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Operative instrumentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Operative hysteroscopes are used to remove endocervical or endometrial lesions (eg, submucosal myomas, endometrial polyps) or to perform an endometrial",
"    <span class=\"nowrap\">",
"     ablation/resection.",
"    </span>",
"    Some, but not all, operative hysteroscopes use electrocautery. Laser is rarely used in modern hysteroscopic procedures.",
"   </p>",
"   <p>",
"    The three types of operative hysteroscopes are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Operative sheath with instruments inserted through channels or fixed to the sheath",
"     </li>",
"     <li>",
"      Electrocautery resectoscope",
"     </li>",
"     <li>",
"      Hysteroscopic morcellator",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1572821\">",
"    <span class=\"h3\">",
"     Operative sheaths",
"    </span>",
"    &nbsp;&mdash;&nbsp;An assortment of flexible, semirigid, and rigid instruments have been developed or adapted for hysteroscopic surgery.",
"    <br/>",
"    <br/>",
"    Flexible and semirigid instruments range in diameter from 2 to 3 mm and are inserted through an operating channel in the sheath [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/9\">",
"     9",
"    </a>",
"    ]. These instruments include scissors, grasping forceps, biopsy forceps, and punctate electrodes (",
"    <a class=\"graphic graphic_picture graphicRef82008 graphicRef69759 \" href=\"UTD.htm?28/25/29080\">",
"     picture 2A-B",
"    </a>",
"    ). Semirigid or flexible instruments may be fragile, and must be handled with care to avoid damage.",
"    <br/>",
"    <br/>",
"    Rigid instruments may also be inserted through a channel, or may be fixed to the end of the hysteroscope. Fixed instruments are not commonly used, since they must be inserted, removed, and manipulated along with the entire hysteroscope.",
"    <br/>",
"    <br/>",
"    Some systems have sheaths which use suction to retrieve tissue fragments without removing the hysteroscope.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1572828\">",
"    <span class=\"h3\">",
"     Resectoscopes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resectoscopes typically consist of a 7 to 9 mm sheath [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/9\">",
"     9",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_picture graphicRef74123 \" href=\"UTD.htm?32/50/33572\">",
"     picture 3",
"    </a>",
"    ). They use electrocautery and may be monopolar or bipolar.",
"    <br/>",
"    <br/>",
"    When a monopolar resectoscope is used, the patient must be grounded and a nonconducting (ie, nonelectrolyte), distending medium must be used. Bipolar resectoscopes are a newer development and can be used with electrolyte distending media, eg,saline or Ringer's lactate [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/10\">",
"     10",
"    </a>",
"    ]. . (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Distending media'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/54/37737?source=see_link\">",
"     \"Overview of electrosurgery\"",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    Traditionally, electrodes for the resectoscope have included the loop and rollerball (",
"    <a class=\"graphic graphic_picture graphicRef55853 \" href=\"UTD.htm?14/35/14901\">",
"     picture 4",
"    </a>",
"    ). Newer vaporizing electrodes (eg, VaporTrode&reg;, Versapoint&trade;) have been introduced that vaporize lesions and thus obviate the need to remove floating pieces of tissue. Of course, they are not appropriate for procedures in which a specimen is needed for histology.",
"    <br/>",
"    <br/>",
"    Assembly of resectoscopes generally requires some practice and should be mastered before a surgical procedure is undertaken (",
"    <a class=\"graphic graphic_picture graphicRef69544 graphicRef50056 graphicRef62804 graphicRef75612 \" href=\"UTD.htm?10/57/11162\">",
"     picture 5A-D",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1572835\">",
"    <span class=\"h3\">",
"     Hysteroscopic morcellator",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hysteroscopic morcellator consists of a rotary blade that cuts lesions; tissue is then aspirated through the morcellator [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/11\">",
"     11",
"    </a>",
"    ]. The morcellator is inserted through the working channel of a 9 mm hysteroscope. The morcellator does not use electrocautery, and thus, is not able to coagulate bleeding vessels encountered during surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Distending media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hysteroscopy is performed using a distending medium to provide a global view of the endometrial cavity.",
"   </p>",
"   <p>",
"    The most commonly used distending media are low viscosity fluids and carbon dioxide. Carbon dioxide is used for diagnostic procedures. The management of fluid and gaseous distending media is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=see_link\">",
"     \"Hysteroscopy: Managing fluid and gas distending media\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SURGICAL PLANNING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Choosing an operative setting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Outpatient settings are increasingly common for diagnostic and some operative hysteroscopy (eg, hysteroscopic sterilization, removal of small lesions or adhesions). Ambulatory settings are acceptable to patients, time-saving, and cost-effective compared with operating room procedures, and should be used, whenever feasible [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Approach to outpatient hysteroscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common reasons for failure to complete an outpatient hysteroscopy are pain, cervical stenosis, and poor visualization [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/12\">",
"     12",
"    </a>",
"    ]. Thus, an approach to successful outpatient hysteroscopy includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patient counseling and selection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Exclude patients with cervical stenosis, limited mobility that impedes positioning, comorbidities that require intensive monitoring, or who cannot tolerate the procedure with a local anesthetic",
"     </li>",
"     <li>",
"      Provide anticipatory guidance about the degree and duration of discomfort",
"     </li>",
"     <li>",
"      Verbally reassure the patient during the procedure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Procedure selection and approach",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Choose procedures that are brief (&lt;30 minutes)",
"     </li>",
"     <li>",
"      Perform diagnostic or minor operative procedures",
"     </li>",
"     <li>",
"      Minimize intraoperative pain",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Minimizing cervical dilation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pre-treat with a prostaglandin the night before the procedure (eg, a single dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      200 mcg per vaginam)",
"     </li>",
"     <li>",
"      Use a narrow caliber hysteroscope (&le;4 mm)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Analgesia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Choice of analgesia should be specific to the patient and procedure (eg, procedures that include endometrial biopsy or use a larger diameter hysteroscope are more likely to require analgesia) (see",
"      <a class=\"local\" href=\"#H23\">",
"       'Anesthesia'",
"      </a>",
"      below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Choosing a hysteroscope",
"    </span>",
"    &nbsp;&mdash;&nbsp;Instrumentation choices for hysteroscopy must be tailored to the procedure and operative setting. Diagnostic hysteroscopy, particularly in the outpatient setting, relies upon a small outer diameter (OD) to minimize both the need for cervical dilation and patient discomfort.",
"   </p>",
"   <p>",
"    For minor procedures performed in the outpatient setting",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    under local anesthetic, it also makes sense to balance OD and optical quality. However, in general, a larger OD will be required to accommodate operative instruments compared with diagnostic hysteroscopy.",
"   </p>",
"   <p>",
"    Advanced operative procedures require an operative hysteroscope with one or two channels for instruments and also a high quality telescope.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Choosing a distending medium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic procedures can be performed using either carbon dioxide or normal saline. For operative procedures that use monopolar electrosurgical instruments, a nonconductive fluid (eg, glycine) is required to avoid thermal injury. Bipolar electrosurgical procedures may be performed using an isotonic fluid (eg, normal saline or lactated Ringer's), which avoids the risks of electrolyte and osmolar imbalances associated with nonconductive solutions.",
"   </p>",
"   <p>",
"    A detailed discussion of choosing a distending medium for hysteroscopy can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=see_link&amp;anchor=H8775396#H8775396\">",
"     \"Hysteroscopy: Managing fluid and gas distending media\", section on 'Choosing a distending medium'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION AND PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Informed consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women considering hysteroscopy should be counseled about alternative diagnostic or treatment approaches, and informed consent regarding expected treatment success and possible complications. Patients should be informed of possible need to abandon or prematurely stop a procedure due to fluid overload. Also, since uterine perforation is a possible complication, patients should consent to a possible laparoscopy or laparotomy if it becomes necessary to rule out visceral or vascular injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/55/39800?source=see_link\">",
"     \"Overview of preoperative evaluation and preparation for gynecologic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A medical history is taken, including: detailed questions regarding symptoms that relate to the indication for the procedure; obstetrical and surgical history; and medical comorbidities, medications, and allergies. A complete pelvic and general physical examination is performed, with particular attention to the size and mobility of the uterus and the patency of the cervix. Pregnancy testing is performed; cervical cultures are appropriate if cervicitis is suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Timing and endometrial preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;For premenopausal women with regular menstrual cycles, the proliferative phase is best for visualization of the uterine cavity. During the secretory phase, the thick endometrium can mimic endometrial polyps and lead to inaccurate diagnoses. Also, during menstruation, blood may interfere with visualization.",
"   </p>",
"   <p>",
"    In reproductive age women with irregular uterine bleeding, the ideal time for the procedure is unpredictable. Thus, patients should be counseled that a procedure may be attempted, but may need to be rescheduled if obscuring blood makes it impossible to evaluate the uterine cavity. Often, surgery is still feasible, because fluid pumps facilitate visualization by rapidly clearing debris and blood (see",
"    <a class=\"local\" href=\"#H31\">",
"     'Operative challenges'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Another approach is pharmacologic thinning of the endometrium. Thinning agents should be used only when the surgeon plans operative hysteroscopic resection of a leiomyoma or endometrial ablation. Thinning agents should not be used when diagnostic hysteroscopy alone is planned, as these hormones may influence the histology of the endometrium. The most commonly used agents are estrogen-progestin contraceptives or progestins alone (eg, oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    10 mg daily on cycle days 15 to 26) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/15\">",
"     15",
"    </a>",
"    ]. Gonadotropin releasing hormone agonists and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     danazol",
"    </a>",
"    are also effective, but are used infrequently due to adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. All of these agents require at least two months of therapy to effectively thin the endometrium. Regimens that require a shorter duration of therapy have been proposed (eg, desogestrel and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/15/6390?source=see_link\">",
"     raloxifene",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For postmenopausal women, hysteroscopy may be performed at any time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Cervical preparation and dilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Narrow caliber hysteroscopes (&le;5 mm) typically do not require cervical dilation, particularly in premenopausal women. If possible, mechanical cervical dilation should be avoided since it can be painful [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients who do require cervical dilation, cervical preparation with a prostaglandin (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    ) may be sufficient on its own or can facilitate mechanical dilation. A systematic review of 10 randomized clinical trials involving premenopausal women undergoing hysteroscopy compared preprocedure misoprostol versus placebo for cervical preparation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/21\">",
"     21",
"    </a>",
"    ]. Misoprostol was associated with a reduced need for further cervical dilation (RR 0.6; 95% CI 0.5-0.7), a lower rate of cervical laceration (RR 0.2; 95% CI 0.1-0.6), and greater cervical dilation (2.6 mm; 95% CI 1.73-3.54), but a higher rate of side effects (vaginal bleeding, cramping, fever). For every four women who received misoprostol prior to hysteroscopy, one woman avoided the need for further cervical dilation. For every 12 women receiving misoprostol, one cervical laceration was avoided.",
"   </p>",
"   <p>",
"    The vaginal route for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    may be more effective than oral. This was illustrated in a randomized trial of women undergoing hysteroscopy who were assigned to a preprocedure dose of 400 mcg of either vaginal or oral misoprostol [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/22\">",
"     22",
"    </a>",
"    ]. Post-treatment dilation (7 versus 6 mm) was greater and procedure duration (8 versus 15 minutes) was reduced significantly in the vaginal administration group. Also, the optimal misoprostol dose has not been established, but most studies used 200 to 400 mcg.",
"   </p>",
"   <p>",
"    In postmenopausal women, randomized trial data have not consistently demonstrated that preoperative",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    decreases the need for mechanical cervical dilation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/23-27\">",
"     23-27",
"    </a>",
"    ]. Pretreatment with vaginal estrogen for two weeks before surgery may augment the cervical dilation caused by misoprostol [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/24\">",
"     24",
"    </a>",
"    ]. A randomized trial of 67 postmenopausal women undergoing hysteroscopy were treated for two weeks with vaginal estradiol (25 mcg daily) and then received either vaginal misoprostol (1000 mcg) or placebo on the night before surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/9\">",
"     9",
"    </a>",
"    ]. Cervical dilation was significantly increased in the women treated with misoprostol versus placebo. Misoprostol also decreases intraoperative pain [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. We have found misoprostol to be useful in this population in our clinical practice.",
"   </p>",
"   <p>",
"    Given these data, we ask patients to self-administer oral or vaginal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    (200 to 400 mcg) the night before the procedure.",
"   </p>",
"   <p>",
"    Another option for cervical dilation prior to hysteroscopy is osmotic dilation (eg, laminaria). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19498?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of pregnancy termination\", section on 'Osmotic dilators'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Prophylactic antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics are not routinely administered during hysteroscopy for prevention of surgical site infection or endocarditis since posthysteroscopy infection occurs in less than 1 percent of women [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H45\">",
"     'Infection'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/55/39800?source=see_link\">",
"     \"Overview of preoperative evaluation and preparation for gynecologic surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Sterile preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/0/32768?source=see_link\">",
"     Povidone iodine",
"    </a>",
"    solution is typically used for sterile vaginal preparation. However, there are few studies evaluating the effect of vaginal preparation on the risk of surgical site infection prevention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/55/39800?source=see_link\">",
"     \"Overview of preoperative evaluation and preparation for gynecologic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anesthesia may be needed to improve patient comfort during hysteroscopy. Parts of the procedure that are potentially painful include placement of a tenaculum on the cervix, dilation of the cervix, insertion of the hysteroscope, uterine distension, and uterine biopsy; some women find uterine biopsy to be the most painful part of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ability to perform hysteroscopy using no anesthetic or local anesthesia allows use of outpatient settings and speeds recovery. Most diagnostic and brief or minor operative procedures can be performed without anesthetic or with a local anesthetic. Regional or general anesthesia is reserved for patients who cannot tolerate a procedure under local anesthesia, extensive operative procedures, or patients with comorbidities that necessitate intensive monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Managing pain or discomfort encompasses not just analgesia, but also patient counseling and selection of the type of procedure and instruments (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Approach to outpatient hysteroscopy'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Pre-procedure nonsteroidal antiinflammatory drugs reduce postoperative, but not intraoperative, pain, as shown in randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. Therefore, we do not premedicate with these drugs. Some surgeons pretreat selected patients with anxiolytics, but there are no data assessing this approach.",
"   </p>",
"   <p>",
"    Local anesthesia for hysteroscopy can be administered topically (cervical or intrauterine [transcervical]) or by injection (intracervical, paracervical, or uterosacral). We prefer paracervical block or, in selected cases, no anesthetic (eg, diagnostic hysteroscopy with a &lt;4 mm diameter hysteroscope). In a literature review, patients undergoing an outpatient hysteroscopy who received a paracervical block found the procedure to be more acceptable than other types of analgesia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/12\">",
"     12",
"    </a>",
"    ]. The percent of women who said they would prefer general anesthesia for a future procedure were: paracervical (2 percent), uterosacral (3 percent), intracervical (12 percent), no anesthetic (17 to 48 percent); there were no data for topical cervical or intrauterine administration. In addition, most randomized trials of paracervical block have shown a decrease in pain, while results from trials of other techniques have been inconsistent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/34-43\">",
"     34-43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One factor in deciding whether to use a paracervical block versus no anesthetic is the pain of the injection; some women find the injection of the anesthetic agent more painful than the procedure itself [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/29,35\">",
"     29,35",
"    </a>",
"    ]. Use of a paracervical block decreases pain compared with an injection of placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. However, no difference in pain was found in one trial that compared paracervical with uterosacral injection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/46\">",
"     46",
"    </a>",
"    ], and results from randomized trials comparing paracervical block to no anesthetic have been inconsistent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/29,47\">",
"     29,47",
"    </a>",
"    ]. Choice of agent and technique for paracervical block are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40439?source=see_link&amp;anchor=H17#H17\">",
"     \"Pudendal and paracervical block\", section on 'Paracervical block (Gynecologic)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For procedures that require additional pain control, a local agent can be combined with intravenous conscious sedation or other agents can be used in either the outpatient or operating room setting; intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42792?source=see_link\">",
"     tramadol",
"    </a>",
"    also appears to be effective for reducing procedure-related pain [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some surgeons advocate using no anesthetic [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Also, factors other than anesthetic may influence a patient's ability to tolerate a procedure without anesthesia. As an example, one trial found that when a 5 mm hysteroscope was used, women had less pain with a paracervical block than without anesthetic [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/29\">",
"     29",
"    </a>",
"    ]. However, women who underwent the procedure with a 3.5 mm hysteroscope and no anesthetic had significantly less pain than either 5 mm group. A multi-modal approach to optimal pain management for outpatient hysteroscopy is discussed above (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Approach to outpatient hysteroscopy'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    As noted above, general or regional anesthesia may be required for some patients or procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;General principles regarding performing hysteroscopy are reviewed here. A detailed discussion of specific operative procedures can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/7/31866?source=see_link\">",
"     \"An overview of endometrial ablation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15018?source=see_link&amp;anchor=H27#H27\">",
"     \"Surgical sterilization of women\", section on 'Hysteroscopic sterilization'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26101?source=see_link\">",
"     \"Intrauterine adhesions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/21/29014?source=see_link\">",
"     \"Surgical management of congenital uterine anomalies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A Foley urethral catheter is not necessary unless intensive monitoring of urine output is necessary (eg, prolonged procedure, excessive fluid absorption, or need to diuresis patient).",
"   </p>",
"   <p>",
"    Although a video monitor is not requisite, it greatly benefits the surgeon, trainees, and scrub and nursing personnel throughout the case.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Entry and cervical dilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial steps for all hysteroscopic procedures are the same as for other transcervical procedures (patient in dorsal lithotomy position, placement of speculum, use of tenaculum or mechanical dilation as needed). The cervix should not be dilated beyond the size of the hysteroscope, since this may cause leakage of distending medium.",
"   </p>",
"   <p>",
"    A removable obturator (rod within the sheath) is especially helpful for introduction of the sheath into the uterine cavity when entry is difficult. However, it is generally advisable to introduce the hysteroscope under direct visualization to be able to navigate through the cervical canal.",
"   </p>",
"   <p>",
"    Once the hysteroscope has been inserted, it is helpful to remove the speculum; using a bivalve speculum (open on one side) makes this possible. Insert the hysteroscope through the cervical os under direct endoscopic vision and remove the speculum.",
"   </p>",
"   <p>",
"    Some experts advocate an alternative approach to the classic initial entry (particularly for diagnostic procedures) technique, the vaginoscopic technique, which avoids the use of a speculum or tenaculum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Vaginoscopic technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vaginoscopic, or \"no touch,\" technique is performed without a speculum or tenaculum and without anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/48\">",
"     48",
"    </a>",
"    ]. Women with cervical stenosis are not candidates for this approach. A meta-analysis of six randomized trials found that use of the vaginoscopic versus traditional technique was associated with a significant decrease in operative pain [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/51\">",
"     51",
"    </a>",
"    ]. Failed procedures were infrequent for both techniques. Some, but not all, randomized trials have found that operative time was shorter for the vaginoscopic technique [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/52-55\">",
"     52-55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To perform the vaginoscopic technique, perform a bimanual pelvic examination with the patient in the dorsal lithotomy position. Prepare the vaginal introitus with saline or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/0/32768?source=see_link\">",
"     povidone iodine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/56\">",
"     56",
"    </a>",
"    ]. Without using a speculum, introduce a rigid or semi-rigid, narrow caliber (&lt;4 mm) hysteroscope into the vaginal introitus. Infuse normal saline at a pressure of 150 mmHg [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/57\">",
"     57",
"    </a>",
"    ]. Close the labia minora manually if needed to contain the distending medium. Visualize the cervix and direct the hysteroscope through the cervical canal into the uterine cavity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Evaluating the endocervix",
"    </span>",
"    &nbsp;&mdash;&nbsp;The endocervix can be easily inspected during insertion of the hysteroscope. Any lesions that warrant further evaluation can be visualized by withdrawing the hysteroscope to the lesion site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Evaluating the uterine cavity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the hysteroscope is within the endometrial cavity, the uterine cavity is distended. The entire cavity is inspected, including the tubal ostia and any pathology. It is often helpful to take photographs for documentation and communication with the patient.",
"   </p>",
"   <p>",
"    Whether using a gaseous or fluid medium, after initial uterine distension, deflate the endometrial cavity. This will prevent \"negative hysteroscopic view\" (ie, flattening of lesions by the pressure of distension, thereby making them difficult to see).",
"   </p>",
"   <p>",
"    In general, 1 to 3 percent of benign or malignant endometrial lesions are missed on hysteroscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/58\">",
"     58",
"    </a>",
"    ]. To avoid missing uterine pathology, endometrial sampling (hysteroscopic biopsies or blind sampling) should be performed in patients with global endometrial pathology or with persistent bleeding and no hysteroscopic findings.",
"   </p>",
"   <p>",
"    Women with focal pathology should undergo hysteroscopically directed removal of lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=see_link\">",
"     \"Endometrial carcinoma: Epidemiology and risk factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Management of distending media",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most important factors in performing operative hysteroscopy is maintenance of a clear operative field. For fluid media, this is most safely accomplished with a continuous flow hysteroscope and fluid pump. A complete discussion of the choice and management of distending media can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=see_link\">",
"     \"Hysteroscopy: Managing fluid and gas distending media\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Vasovagal reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasovagal syncope (also called neurocardiogenic syncope) is usually, but not always, associated with a prodrome of dizziness, nausea, bradycardia, pallor or diaphoresis. When these symptoms occur, useful measures are: stopping the procedure, placing the patient in supine position with her legs raised or in the Trendelenburg position, and administering intravenous fluid. Some patients may require",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    (0.5 to 1 mg IV every five minutes, not to exceed a total of 3 mg or 0.04",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    or \"smelling salts\" (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39873?source=see_link\">",
"     aromatic ammonia spirit",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     OPERATIVE CHALLENGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several reasons for hysteroscopic failure. As noted above, in the office setting, pain, cervical stenosis, and poor visualization are the most common reasons for terminating a procedure. In addition, advanced operative hysteroscopy may need to be halted due to excessive fluid absorption or uterine perforation (which precludes adequate uterine distension). In a systematic review of over 26,000 procedures, the overall rate of failure was 3.6 percent, and was similar in ambulatory and hospitalized patients and pre- and postmenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Cervical stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pre-procedure cervical ripening with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    and small diameter instruments can reduce the frequency of procedure failure due to cervical stenosis. In postmenopausal women with cervical stenosis, one option is to treat with two to four weeks or more of vaginal estrogen prior to the procedure to soften the cervix and thereby facilitate the action of misoprostol, although the efficacy of this approach has not been proven (see",
"    <a class=\"local\" href=\"#H25\">",
"     'Entry and cervical dilation'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    When dilation of the cervix is difficult, a flexible hysteroscope may be passed more easily than a rigid dilator or sound. Also, the direct view helps to navigate the canal.",
"   </p>",
"   <p>",
"    For women who fail these measures, intracervical injection of dilute vasopressin (4 units per 80 mL normal saline) has been reported to facilitate cervical dilation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/60\">",
"     60",
"    </a>",
"    ]. Although generally well tolerated, vasopressin injection must be performed with caution (by aspirating and confirming the absence of blood in the syringe prior to each injection), since intravascular injection or absorption has been associated with profound hypertension, bradycardia, and intraoperative mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If a small dilator cannot be easily inserted, hysteroscopy can be performed under ultrasound guidance to confirm correct passage of the dilator into the endometrial cavity and make sure a false passage is not created.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Uterine malposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extreme uterine retroversion or anteversion may be congenital or may be due to pelvic adhesions. Such malposition may limit the ability to introduce the hysteroscope. Traction with a tenaculum on the anterior lip of the cervix will often straighten the uterine axis. Also, use of a flexible hysteroscope may be helpful. Of note, malposition may increase the risk of uterine perforation.",
"   </p>",
"   <p>",
"    When the uterus is severely angulated, the tubal ostia must be visualized to confirm that the entire uterine cavity has been evaluated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Difficult uterine distention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the cervix has been dilated, it is unusual to have difficulty instilling a distention medium. If this difficulty is encountered, it is likely that there is an obstruction in the uterine cavity (eg, synechiae, malignancy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Obscuring blood",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bleeding can impair visualization either directly or, if carbon dioxide is used for distension, bleeding may cause gas bubbles to form. The gas bubbles can be cleared by switching to a fluid medium.",
"   </p>",
"   <p>",
"    For fluid media procedures, use of a continuous flow hysteroscope allows lavage of the endometrial cavity. When lavage is not possible, then dilation and curettage can be performed to remove endometrial debris and clots. Repeating the hysteroscopic procedure with a continuous flow hysteroscope can then be successful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/41/35480?source=see_link\">",
"     \"Dilation and curettage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients experience postoperative cramping or light bleeding and some complain of vaginal discomfort. Carbon dioxide distension can cause referred shoulder pain, but this typically resolves within 15 minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/62\">",
"     62",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    or nonsteroidal antiinflammatory drugs are usually adequate for postoperative pain control, if necessary.",
"   </p>",
"   <p>",
"    The patient may resume most normal activities within 24 hours and should follow standard postoperative instructions for gynecologic procedures. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?27/27/28083?source=see_link\">",
"     \"Patient information: Care after gynecologic surgery (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We see patients for a follow-up visit two weeks postoperatively to assess for further complications and review pathology results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications from hysteroscopy are rare, but some are potentially life threatening [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A multicenter study of 92 centers and over 21,000 operative hysteroscopic procedures reported a complication rate of 0.22 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/64\">",
"       64",
"      </a>",
"      ]. The most common complication was perforation of the uterus (0.12 percent), followed by fluid overload (0.06 percent), intraoperative hemorrhage (0.03 percent), bladder or bowel injury (0.02 percent), and endomyometritis (0.01 percent).",
"     </li>",
"     <li>",
"      Another multicenter study reported data from both diagnostic and operative procedures [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/65\">",
"       65",
"      </a>",
"      ]. The study involved 82 hospitals and 13,600 procedures; the overall complication rate was 0.28 percent. Diagnostic hysteroscopy had a significantly lower complication rate than operative hysteroscopy (0.13 versus 0.95 percent).",
"      <br/>",
"      <br/>",
"      The most common complication of both types of hysteroscopy was uterine perforation (0.13 for diagnostic; 0.76 percent for operative); 18 of 33 perforations occurred during entry (measuring the size of the uterus with the sound instrument, dilation problems, perforation by hysteroscope). Fluid overload occurred in operative (0.02 percent), but not diagnostic, procedures. The operative procedure with the highest frequency of complications was intrauterine adhesiolysis (4.5 percent complication rate); all of the other procedures had complication rates less than 1 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a systematic review of over 26,000 women who underwent diagnostic hysteroscopy, complication rates were reported by only 29 percent of studies, totaling 9413 procedures [",
"      <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/59\">",
"       59",
"      </a>",
"      ]. Among these procedures, there were only eight complications: four uterine perforations, one pelvic infection, one bladder perforation, and two medical complications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Uterine perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine perforation is the most common complication of hysteroscopy. In most studies, hysteroscopy is complicated by confirmed uterine perforation in 0.8 to 1.6 percent of operative procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/64-68\">",
"     64-68",
"    </a>",
"    ]. The perforation rate is less during diagnostic hysteroscopy (eg, 0.1 versus 1.0 percent with operative hysteroscopy percent in a series of 13,600 procedures) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A uterine perforation can occur during mechanical cervical dilation or insertion of the hysteroscope. Such a perforation may be recognized when an instrument passes beyond depth of the uterine fundus, when there is sudden loss of visualization, when omentum or bowel or peritoneal structures can be visualized at the uterine fundus, or when there is a sudden increase in the fluid deficit.",
"   </p>",
"   <p>",
"    If a uterine perforation occurs, all instruments should be removed from the uterus and the hemodynamic status of the patient should be assessed. A detailed discussion of the management of uterine perforation can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4408?source=see_link\">",
"     \"Uterine perforation during gynecologic procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Urinary tract or bowel injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bowel or bladder injury are rare, but may occur in association with uterine perforation or as a result of use of electrical current. Management of these injuries is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/27/7609?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Cervical laceration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical lacerations can occur, particularly in women with cervical stenosis. Lacerations that are large or are bleeding require sutures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Excessive fluid absorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications related to distending media vary according to the patient population and the media used. A complete discussion of management of distending media can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=see_link\">",
"     \"Hysteroscopy: Managing fluid and gas distending media\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8858?source=see_link\">",
"     \"Hyponatremia following transurethral resection or hysteroscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h2\">",
"     Embolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Embolism (air or carbon dioxide) can occur with any hysteroscopic technique and can cause cardiovascular collapse. A complete discussion of management of distending media and prevention of gas embolism can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=see_link\">",
"     \"Hysteroscopy: Managing fluid and gas distending media\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h2\">",
"     Hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potential sources of intraoperative bleeding include operative sites, uterine perforation, and cervical laceration.",
"   </p>",
"   <p>",
"    Bleeding from cervical lacerations that is recognized at surgery can be controlled using electrocautery or sutures.",
"   </p>",
"   <p>",
"    Bleeding from a specific site within the uterine cavity, with no suspicion of uterine perforation, can be controlled with electrosurgery is most cases. Women with diffuse bleeding should be evaluated for coagulopathy.",
"   </p>",
"   <p>",
"    If coagulation testing is normal and diffuse bleeding continues, it can be treated by placing a Foley catheter in the uterine cavity and then distending the bulb with 15 to 30 mL of water. In one series of 216 resectoscope procedures, four women (1.9 percent) developed postoperative uterine bleeding and were successfully treated with this procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/69\">",
"     69",
"    </a>",
"    ]. Postoperative bleeding (with no suspicion of uterine perforation), can also be managed with this technique.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h2\">",
"     Electrosurgical injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thermal effects of electrical (or laser) energy can cause injuries to the uterine cavity, as well as bowel, urinary bladder, and large pelvic vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/70\">",
"     70",
"    </a>",
"    ]. In particular, a significant risk of bowel injury has been reported from hysteroscopic coagulation of the tubal cornua for sterilization [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/71\">",
"     71",
"    </a>",
"    ]. One must be cautious if coagulating in the tubal recesses.",
"   </p>",
"   <p>",
"    The risk of electrosurgical injury can be minimized by always moving the electrical instrument when it is activated because the temperature of the uterine serosal surface does not rise appreciably if the instrument is not held stationary during coagulation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/72\">",
"     72",
"    </a>",
"    ]. Vaginal thermal injury may result from overdilation of the cervix or activation of current when the external sheath is less than 2 cms past the external cervical os [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/73\">",
"     73",
"    </a>",
"    ]. Electrode insulation defects can also cause thermal injury.",
"   </p>",
"   <p>",
"    Sepsis generally results from unrecognized thermal bowel injury; fistulae or urinary ascites can occur from an unrecognized bladder injury. Such complications require consultation with a colorectal surgeon, urologist, or infectious disease specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of infection after operative hysteroscopy is low. Studies of 2000 or more procedures report postoperative incidences of 0.1 to 0.9 percent incidence for endometritis and 0.6 percent for urinary tract infections [",
"    <a class=\"abstract\" href=\"UTD.htm?9/17/9498/abstract/64,65,74\">",
"     64,65,74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46\">",
"    <span class=\"h2\">",
"     Dissemination of tumor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concerns regarding the dissemination of malignant cells during hysteroscopy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38744?source=see_link&amp;anchor=H14#H14\">",
"     \"Evaluation of the endometrium for malignant or premalignant disease\", section on 'Risk of tumor dissemination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hysteroscopy is a procedure in which a telescope with a camera is used to evaluate or treat pathology of the endometrial cavity, tubal ostia, or endocervical canal. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hysteroscopy in outpatient settings is increasingly common. Advances in instrumentation, including narrow caliber hysteroscopes, decrease patient discomfort and have facilitated use of local anesthetic and ambulatory procedures. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Hysteroscopes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During hysteroscopy, the uterus is distended with a gas or fluid medium. Each medium has benefits and risks, including fluid overload or gas embolism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=see_link\">",
"       \"Hysteroscopy: Managing fluid and gas distending media\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      On the night before hysteroscopy, we recommend the use of vaginal",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      in premenopausal women (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ) and suggest its use in postmenopausal women (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ) rather than no preparation. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Entry and cervical dilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prophylactic antibiotics are not routinely administered during hysteroscopy since posthysteroscopy infection is rare. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Preoperative evaluation and preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most diagnostic and brief or minor operative procedures can be performed without anesthetic or with a local anesthetic. Regional or general anesthesia is reserved for patients who cannot tolerate a procedure under local anesthesia, extensive operative procedures, or patients with comorbidities that necessitate intensive monitoring. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Anesthesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In women undergoing hysteroscopy under local anesthetic, we suggest a paracervical block over other methods of administering local anesthesia (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Anesthesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The vaginoscopic technique for hysteroscopy avoids the use of a speculum and tenaculum. This may decrease patient discomfort in some procedures. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Vaginoscopic technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hysteroscopic complications are infrequent. Major complications include: uterine perforation, fluid overload, and gas embolism. (See",
"      <a class=\"local\" href=\"#H37\">",
"       'Complications'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=see_link\">",
"       \"Hysteroscopy: Managing fluid and gas distending media\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/1\">",
"      Price TM, Harris JB. Fulminant hepatic failure due to herpes simplex after hysteroscopy. Obstet Gynecol 2001; 98:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/2\">",
"      Hatfield JL, Brumsted JR, Cooper BC. Conservative treatment of placenta accreta. J Minim Invasive Gynecol 2006; 13:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/3\">",
"      Hinckley MD, Milki AA. 1000 office-based hysteroscopies prior to in vitro fertilization: feasibility and findings. JSLS 2004; 8:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/4\">",
"      Shalev J, Levi T, Orvieto R, et al. Emergency hysteroscopic treatment of acute severe uterine bleeding. J Obstet Gynaecol 2004; 24:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/5\">",
"      Cicinelli E, Parisi C, Galantino P, et al. Reliability, feasibility, and safety of minihysteroscopy with a vaginoscopic approach: experience with 6,000 cases. Fertil Steril 2003; 80:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/6\">",
"      De Angelis C, Santoro G, Re ME, Nofroni I. Office hysteroscopy and compliance: mini-hysteroscopy versus traditional hysteroscopy in a randomized trial. Hum Reprod 2003; 18:2441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/7\">",
"      Unfried G, Wieser F, Albrecht A, et al. Flexible versus rigid endoscopes for outpatient hysteroscopy: a prospective randomized clinical trial. Hum Reprod 2001; 16:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/8\">",
"      Barbot J, Parent B, Dubuisson JB. Contact hysteroscopy: another method of endoscopic examination of the uterine cavity. Am J Obstet Gynecol 1980; 136:721.",
"     </a>",
"    </li>",
"    <li>",
"     Baggish, MS, Valle, RF, Guedj, H. Hysteroscopy: Visual perspectives of uterine anatomy, physiology, and pathology, 3rd ed. Lippincott Williams, &amp; Wilkins 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/10\">",
"      Phillips DR, Milim SJ, Nathanson HG, et al. Preventing hyponatremic encephalopathy: comparison of serum sodium and osmolality during operative hysteroscopy with 5.0% mannitol and 1.5% glycine distention media. J Am Assoc Gynecol Laparosc 1997; 4:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/11\">",
"      Vilos GA, Abu-Rafea B. New developments in ambulatory hysteroscopic surgery. Best Pract Res Clin Obstet Gynaecol 2005; 19:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/12\">",
"      Readman E, Maher PJ. Pain relief and outpatient hysteroscopy: a literature review. J Am Assoc Gynecol Laparosc 2004; 11:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/13\">",
"      Marsh FA, Rogerson LJ, Duffy SR. A randomised controlled trial comparing outpatient versus daycase endometrial polypectomy. BJOG 2006; 113:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/14\">",
"      Kremer C, Duffy S, Moroney M. Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial. BMJ 2000; 320:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/15\">",
"      Grow DR, Iromloo K. Oral contraceptives maintain a very thin endometrium before operative hysteroscopy. Fertil Steril 2006; 85:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/16\">",
"      Vercellini P, Perino A, Consonni R, et al. Treatment with a gonadotrophin releasing hormone agonist before endometrial resection: a multicentre, randomised controlled trial. Br J Obstet Gynaecol 1996; 103:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/17\">",
"      Donnez J, Vilos G, Gannon MJ, et al. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study. Fertil Steril 1997; 68:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/18\">",
"      Fedele L, Bianchi S, Gruft L, et al. Danazol versus a gonadotropin-releasing hormone agonist as preoperative preparation for hysteroscopic metroplasty. Fertil Steril 1996; 65:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/19\">",
"      Marchini M, Fedele L, Bianchi S, et al. Endometrial patterns during therapy with danazol or gestrinone for endometriosis: structural and ultrastructural study. Hum Pathol 1992; 23:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/20\">",
"      Cicinelli E, Pinto V, Tinelli R, et al. Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study. Fertil Steril 2007; 88:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/21\">",
"      Crane JM, Healey S. Use of misoprostol before hysteroscopy: a systematic review. J Obstet Gynaecol Can 2006; 28:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/22\">",
"      Batukan C, Ozgun MT, Ozcelik B, et al. Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol. Fertil Steril 2008; 89:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/23\">",
"      da Costa AR, Pinto-Neto AM, Amorim M, et al. Use of misoprostol prior to hysteroscopy in postmenopausal women: a randomized, placebo-controlled clinical trial. J Minim Invasive Gynecol 2008; 15:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/24\">",
"      Oppegaard KS, Lieng M, Berg A, et al. A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial. BJOG 2010; 117:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/25\">",
"      Ngai SW, Chan YM, Ho PC. The use of misoprostol prior to hysteroscopy in postmenopausal women. Hum Reprod 2001; 16:1486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/26\">",
"      Fung TM, Lam MH, Wong SF, Ho LC. A randomised placebo-controlled trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women. BJOG 2002; 109:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/27\">",
"      Barcaite E, Bartusevicius A, Railaite DR, Nadisauskiene R. Vaginal misoprostol for cervical priming before hysteroscopy in perimenopausal and postmenopausal women. Int J Gynaecol Obstet 2005; 91:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/28\">",
"      ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 74. Antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 2006; 108:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/29\">",
"      Giorda G, Scarabelli C, Franceschi S, Campagnutta E. Feasibility and pain control in outpatient hysteroscopy in postmenopausal women: a randomized trial. Acta Obstet Gynecol Scand 2000; 79:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/30\">",
"      Bettocchi S, Ceci O, Di Venere R, et al. Advanced operative office hysteroscopy without anaesthesia: analysis of 501 cases treated with a 5 Fr. bipolar electrode. Hum Reprod 2002; 17:2435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/31\">",
"      Nagele F, Lockwood G, Magos AL. Randomised placebo controlled trial of mefenamic acid for premedication at outpatient hysteroscopy: a pilot study. Br J Obstet Gynaecol 1997; 104:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/32\">",
"      Tam WH, Yuen PM. Use of diclofenac as an analgesic in outpatient hysteroscopy: a randomized, double-blind, placebo-controlled study. Fertil Steril 2001; 76:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/33\">",
"      Mercorio F, De Simone R, Landi P, et al. Oral dexketoprofen for pain treatment during diagnostic hysteroscopy in postmenopausal women. Maturitas 2002; 43:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/34\">",
"      Cicinelli E, Didonna T, Ambrosi G, et al. Topical anaesthesia for diagnostic hysteroscopy and endometrial biopsy in postmenopausal women: a randomised placebo-controlled double-blind study. Br J Obstet Gynaecol 1997; 104:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/35\">",
"      Broadbent JA, Hill NC, Moln&aacute;r BG, et al. Randomized placebo controlled trial to assess the role of intracervical lignocaine in outpatient hysteroscopy. Br J Obstet Gynaecol 1992; 99:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/36\">",
"      Al-Sunaidi M, Tulandi T. A randomized trial comparing local intracervical and combined local and paracervical anesthesia in outpatient hysteroscopy. J Minim Invasive Gynecol 2007; 14:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/37\">",
"      Soriano D, Ajaj S, Chuong T, et al. Lidocaine spray and outpatient hysteroscopy: randomized placebo-controlled trial. Obstet Gynecol 2000; 96:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/38\">",
"      Davies A, Richardson RE, O'Connor H, et al. Lignocaine aerosol spray in outpatient hysteroscopy: a randomized double-blind placebo-controlled trial. Fertil Steril 1997; 67:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/39\">",
"      Stigliano CM, Mollo A, Zullo F. Two modalities of topical anesthesia for office hysteroscopy. Int J Gynaecol Obstet 1997; 59:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/40\">",
"      Wieser F, Kurz C, Wenzl R, et al. Atraumatic cervical passage at outpatient hysteroscopy. Fertil Steril 1998; 69:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/41\">",
"      Wong AY, Wong K, Tang LC. Stepwise pain score analysis of the effect of local lignocaine on outpatient hysteroscopy: a randomized, double-blind, placebo-controlled trial. Fertil Steril 2000; 73:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/42\">",
"      Clark, S, Vonau, B, Macdonald, R. Topical anaesthesia in out-patient hysteroscopy. Gynaecological Endoscopy 1996; 5:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/43\">",
"      Zullo F, Pellicano M, Stigliano CM, et al. Topical anesthesia for office hysteroscopy. A prospective, randomized study comparing two modalities. J Reprod Med 1999; 44:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/44\">",
"      Lau WC, Lo WK, Tam WH, Yuen PM. Paracervical anaesthesia in outpatient hysteroscopy: a randomised double-blind placebo-controlled trial. Br J Obstet Gynaecol 1999; 106:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/45\">",
"      Cicinelli E, Didonna T, Schonauer LM, et al. Paracervical anesthesia for hysteroscopy and endometrial biopsy in postmenopausal women. A randomized, double-blind, placebo-controlled study. J Reprod Med 1998; 43:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/46\">",
"      Finikiotis G, Tsocanos S. Outpatient hysteroscopy: a comparison of 2 methods of local analgesia. Aust N Z J Obstet Gynaecol 1992; 32:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/47\">",
"      Vercellini P, Colombo A, Mauro F, et al. Paracervical anesthesia for outpatient hysteroscopy. Fertil Steril 1994; 62:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/48\">",
"      Floris S, Piras B, Orr&ugrave; M, et al. Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy. Fertil Steril 2007; 87:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/49\">",
"      De Iaco P, Marabini A, Stefanetti M, et al. Acceptability and pain of outpatient hysteroscopy. J Am Assoc Gynecol Laparosc 2000; 7:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/50\">",
"      Kremer C, Barik S, Duffy S. Flexible outpatient hysteroscopy without anaesthesia: a safe, successful and well tolerated procedure. Br J Obstet Gynaecol 1998; 105:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/51\">",
"      Cooper NA, Smith P, Khan KS, Clark TJ. Vaginoscopic approach to outpatient hysteroscopy: a systematic review of the effect on pain. BJOG 2010; 117:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/52\">",
"      Sagiv R, Sadan O, Boaz M, et al. A new approach to office hysteroscopy compared with traditional hysteroscopy: a randomized controlled trial. Obstet Gynecol 2006; 108:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/53\">",
"      Guida M, Di Spiezio Sardo A, Acunzo G, et al. Vaginoscopic versus traditional office hysteroscopy: a randomized controlled study. Hum Reprod 2006; 21:3253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/54\">",
"      Garbin O, Kutnahorsky R, G&ouml;llner JL, Vayssiere C. Vaginoscopic versus conventional approaches to outpatient diagnostic hysteroscopy: a two-centre randomized prospective study. Hum Reprod 2006; 21:2996.",
"     </a>",
"    </li>",
"    <li>",
"     Sharma, M, Taylor, A, di Spiezio Sardo, A, Buck, L, Mastrogamvrakis, G, Kosmas I, Tsirkas P, Magos A. Outpatient hysteroscopy: traditional versus the 'no-touch' technique.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/56\">",
"      Comparative trial of tubal insufflation, hysterosalpingography, and laparoscopy with dye hydrotubation for assessment of tubal patency. World Health Organization. Fertil Steril 1986; 46:1101.",
"     </a>",
"    </li>",
"    <li>",
"     Data from Conceptus Incorporated, San Carlos, CA.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/58\">",
"      Loffer FD. Hysteroscopy with selective endometrial sampling compared with D&amp;C for abnormal uterine bleeding: the value of a negative hysteroscopic view. Obstet Gynecol 1989; 73:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/59\">",
"      Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002; 288:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/60\">",
"      Phillips DR, Nathanson HG, Milim SJ, Haselkorn JS. The effect of dilute vasopressin solution on the force needed for cervical dilatation: a randomized controlled trial. Obstet Gynecol 1997; 89:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/61\">",
"      Hobo R, Netsu S, Koyasu Y, Tsutsumi O. Bradycardia and cardiac arrest caused by intramyometrial injection of vasopressin during a laparoscopically assisted myomectomy. Obstet Gynecol 2009; 113:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/62\">",
"      Pellicano M, Guida M, Zullo F, et al. Carbon dioxide versus normal saline as a uterine distension medium for diagnostic vaginoscopic hysteroscopy in infertile patients: a prospective, randomized, multicenter study. Fertil Steril 2003; 79:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/63\">",
"      Bradley LD. Complications in hysteroscopy: prevention, treatment and legal risk. Curr Opin Obstet Gynecol 2002; 14:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/64\">",
"      Aydeniz B, Gruber IV, Schauf B, et al. A multicenter survey of complications associated with 21,676 operative hysteroscopies. Eur J Obstet Gynecol Reprod Biol 2002; 104:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/65\">",
"      Jansen FW, Vredevoogd CB, van Ulzen K, et al. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol 2000; 96:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/66\">",
"      Shveiky D, Rojansky N, Revel A, et al. Complications of hysteroscopic surgery: \"Beyond the learning curve\". J Minim Invasive Gynecol 2007; 14:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/67\">",
"      Agostini A, Cravello L, Bretelle F, et al. Risk of uterine perforation during hysteroscopic surgery. J Am Assoc Gynecol Laparosc 2002; 9:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/68\">",
"      Hulka JF, Peterson HB, Phillips JM, Surrey MW. Operative hysteroscopy. American Association of Gynecologic Laparoscopists 1991 membership survey. J Reprod Med 1993; 38:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/69\">",
"      Serden SP, Brooks PG. Treatment of abnormal uterine bleeding with the gynecologic resectoscope. J Reprod Med 1991; 36:697.",
"     </a>",
"    </li>",
"    <li>",
"     Vilos, GA, Brown S, Graham G, McCulloch S, Borg P. Genital tract electrical burns during hysteroscopic endometrial ablation: report of 13 cases in the United States and Canada.",
"    </li>",
"    <li>",
"     Darabi, K, Roy, K, Richart, RM. Collaborative studies on hysteroscopic sterilization procedures: final report. In Sciarra JJ, Zatuchni GI, Speidel JJ (eds): Risks, Benefits, and Controversies in Fertility Control. p. 81. Harper &amp; Row, Hagerstown, MD, 1978.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/72\">",
"      Duffy S, Reid PC, Sharp F. In-vivo studies of uterine electrosurgery. Br J Obstet Gynaecol 1992; 99:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/73\">",
"      Munro MG. Mechanisms of thermal injury to the lower genital tract with radiofrequency resectoscopic surgery. J Minim Invasive Gynecol 2006; 13:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/17/9498/abstract/74\">",
"      Agostini A, Cravello L, Shojai R, et al. Postoperative infection and surgical hysteroscopy. Fertil Steril 2002; 77:766.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3278 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-41.78.124.10-AD1D6AEAC5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9498=[""].join("\n");
var outline_f9_17_9498=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H47\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INSTRUMENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hysteroscopes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Outer diameter and working length",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Rigid versus flexible",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Optics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Operative instrumentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1572821\">",
"      - Operative sheaths",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1572828\">",
"      - Resectoscopes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1572835\">",
"      - Hysteroscopic morcellator",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Distending media",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SURGICAL PLANNING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Choosing an operative setting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Approach to outpatient hysteroscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Choosing a hysteroscope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Choosing a distending medium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PREOPERATIVE EVALUATION AND PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Informed consent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Timing and endometrial preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Cervical preparation and dilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Prophylactic antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Sterile preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Anesthesia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Entry and cervical dilation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Vaginoscopic technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Evaluating the endocervix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Evaluating the uterine cavity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Management of distending media",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Vasovagal reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      OPERATIVE CHALLENGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Cervical stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Uterine malposition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Difficult uterine distention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Obscuring blood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Uterine perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Urinary tract or bowel injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Cervical laceration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Excessive fluid absorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      Embolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      Hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      Electrosurgical injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H46\">",
"      Dissemination of tumor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H47\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/3278\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3278|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/54/5985\" title=\"figure 1\">",
"      Hysteroscopic viewing angles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3278|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/17/42270\" title=\"picture 1\">",
"      Flexible hysteroscope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/63/12277\" title=\"picture 2A\">",
"      Hysteroscopic instruments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/58/37793\" title=\"picture 2B\">",
"      Operative hysteroscope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/50/33572\" title=\"picture 3\">",
"      Resectoscope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/35/14901\" title=\"picture 4\">",
"      Resectoscope instruments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/13/31952\" title=\"picture 5A\">",
"      Resectoscope parts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/16/3329\" title=\"picture 5B\">",
"      Resectoscope assembly 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/61/20433\" title=\"picture 5C\">",
"      Resectoscope assembly 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/21/6481\" title=\"picture 5D\">",
"      Resectoscope assembly 3",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/7/31866?source=related_link\">",
"      An overview of endometrial ablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/41/35480?source=related_link\">",
"      Dilation and curettage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=related_link\">",
"      Endometrial carcinoma: Epidemiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/8/131?source=related_link\">",
"      Endometrial sampling procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38744?source=related_link\">",
"      Evaluation of the endometrium for malignant or premalignant disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8858?source=related_link\">",
"      Hyponatremia following transurethral resection or hysteroscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=related_link\">",
"      Hysteroscopy: Managing fluid and gas distending media",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26101?source=related_link\">",
"      Intrauterine adhesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/54/37737?source=related_link\">",
"      Overview of electrosurgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/56/17287?source=related_link\">",
"      Overview of infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19498?source=related_link\">",
"      Overview of pregnancy termination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/55/39800?source=related_link\">",
"      Overview of preoperative evaluation and preparation for gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41735?source=related_link\">",
"      Overview of the principles of medical consultation and perioperative medicine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/27/28083?source=related_link\">",
"      Patient information: Care after gynecologic surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40439?source=related_link\">",
"      Pudendal and paracervical block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/21/29014?source=related_link\">",
"      Surgical management of congenital uterine anomalies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15018?source=related_link\">",
"      Surgical sterilization of women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/27/7609?source=related_link\">",
"      Urinary tract injury in gynecologic surgery: Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4408?source=related_link\">",
"      Uterine perforation during gynecologic procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22147?source=related_link\">",
"      Vaginoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_17_9499="Indicator success NPPV";
var content_f9_17_9499=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Potential indicators of success in noninvasive positive pressure ventilation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Younger age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lower acuity of illness (APACHE score)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Able to cooperate, better neurologic score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Less air leaking, intact dentition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moderate hypercarbia (PaCO",
"        <sub>",
"         2",
"        </sub>",
"        &gt;45 mmHG, &lt;92 mmHG)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moderate acidemia (pH &lt;7.35, &gt;7.10)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Improvements in gas exchange and heart respiratory rates within first&nbsp;two hours",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: International Concensus Conferences in Intensive Care Medicine: Noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 2001; 163:288. Copyright &copy; 2001 American Thoracic Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9499=[""].join("\n");
var outline_f9_17_9499=null;
var title_f9_17_9500="High potassium food PI";
var content_f9_17_9500=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F67156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F67156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Foods with high levels of potassium",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       <strong>",
"        Grains",
"       </strong>",
"      </td>",
"      <td>",
"       Whole-grain breads, wheat bran, granola and granola bars",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Beverages",
"       </strong>",
"      </td>",
"      <td>",
"       Sports drinks (Gatorade, etc.), instant breakfast mix, soy milk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Snack foods/sweets",
"       </strong>",
"      </td>",
"      <td>",
"       Peanut butter (2 tablespoons), nuts or seeds (1 ounce), fig cookies, chocolate (1.5 to 2 ounces), molasses (1 tablespoon)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Fruits",
"       </strong>",
"      </td>",
"      <td>",
"       Apricots, avocado (&frac14; whole), bananas (&frac12; whole), coconut, melon (cantaloupe and honeydew), kiwi, mango, nectarines, oranges, orange juice, papaya, pears (fresh), plantains, pomegranate (and juice), dried fruits (apricots (5 halves), dates (5), figs, prunes, raisins), prune juice, yams",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Vegetables",
"       </strong>",
"      </td>",
"      <td>",
"       Bamboo shoots, baked or refried beans, beets, broccoli (cooked), Brussels sprouts, cabbage (raw), carrots (raw), chard, greens (except kale), kohlrabi, olives, mushrooms (canned), potatoes (white and sweet), parsnips, pickles, pumpkin, rutabaga, sauerkraut, spinach (cooked), squash (acorn, butternut, hubbard), tomato, tomato sauce, tomato juice, and vegetable juice cocktail",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Dairy products",
"       </strong>",
"      </td>",
"      <td>",
"       Milk and milk products, buttermilk, yogurt",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Proteins",
"       </strong>",
"      </td>",
"      <td>",
"       (3-ounce serving) Clams, sardines, scallops, lobster, whitefish, salmon (and most other fish), ground beef, sirloin steak (and most other beef products), pinto beans, kidney beans, black beans, navy beans (and most other peas and beans, serving size is &frac12; cup)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Soups",
"       </strong>",
"      </td>",
"      <td>",
"       Salt-free soups and low-sodium bouillon cubes, unsalted broth",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Condiments",
"       </strong>",
"      </td>",
"      <td>",
"       Imitation bacon bits, lite salt or salt substitutes (avoid completely)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Unless noted, one serving is &frac12; cup (4 ounces). These foods have greater than 250 mg of potassium per serving and should be avoided or eaten in very small portions if you have been told to eat a low-potassium diet.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9500=[""].join("\n");
var outline_f9_17_9500=null;
var title_f9_17_9501="Indications for posthumous reproduction";
var content_f9_17_9501=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F83086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F83086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for posthumous reproduction",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Scenario",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gamete provider(s)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Requester(s)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Techniques",
"       </td>",
"       <td class=\"subtitle1\">",
"        Considerations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Possibility of death is anticipated",
"       </td>",
"       <td>",
"        <p>",
"         Military personel in combat zones or other high risk occupations",
"         <sup>",
"          [2]",
"         </sup>",
"        </p>",
"        <p>",
"         Patients with potentially fatal illness (eg, cancer)",
"         <sup>",
"          [2]",
"         </sup>",
"        </p>",
"       </td>",
"       <td>",
"        The gamete provider and a surviving partner or family member",
"       </td>",
"       <td>",
"        Gamete/embryo cryopreservation",
"       </td>",
"       <td>",
"        Satisfies issues of informed consent from gamete provider prior to their death and respect for autonomy of the deceased",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Fertility preservation",
"       </td>",
"       <td>",
"        Patients are expected to survive a potentially gonadotoxic event, such as chemotherapy or radiation for cancer",
"       </td>",
"       <td>",
"        Usually a surviving partner or family member",
"       </td>",
"       <td>",
"        Cryopreservation of gametes, embryos, or reproductive tissues (eg, ovarian tissue)",
"       </td>",
"       <td>",
"        <p>",
"         Tissues are stored for future use in anticipation of probable cure",
"        </p>",
"        <p>",
"         Disposition of reproductive tissues should be decided at the time of their collection",
"         <sup>",
"          [1]",
"         </sup>",
"        </p>",
"        <p>",
"         Legal minors may not be able to give informed consent",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        General infertility",
"       </td>",
"       <td>",
"        Individuals/couples previously or currently using assisted reproductive technologies for routine indications",
"       </td>",
"       <td>",
"        <p>",
"         Usually a surviving partner or family member",
"        </p>",
"        <p>",
"         Possibly an unknown recipient (in the case of gamete or embryo donation)",
"         <sup>",
"          [3]",
"         </sup>",
"        </p>",
"       </td>",
"       <td>",
"        Gamete/embryo cryopreservation",
"       </td>",
"       <td>",
"        <p>",
"         Cryopreserved gametes or embryos already stored for use by the intended parents while living",
"         <sup>",
"          [3]",
"         </sup>",
"        </p>",
"        <p>",
"         Desire to reproduce while alive is explicit, but wishes concerning posthumous reproduction are not always considered",
"        </p>",
"        <p>",
"         Disposition of gametes/embryos in case of death should be determined prior to freezing",
"         <sup>",
"          [1]",
"         </sup>",
"        </p>",
"        <p>",
"         Full disclosure and 3rd party consent required in cases of anonymous gamete/embryo donation",
"         <sup>",
"          [1]",
"         </sup>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Sudden unexpected death or incapacitated state",
"       </td>",
"       <td>",
"        Patients suffering recent death, coma, or irrecoverable illness rendering them unable to provide consent for PAR",
"        <sup>",
"         [4]",
"        </sup>",
"       </td>",
"       <td>",
"        Surviving partner or family member",
"       </td>",
"       <td>",
"        Posthumous or perimortem gamete retrieval and cryopreservation",
"       </td>",
"       <td>",
"        <p>",
"         Often no opportunity to obtain consent from the prospective gamete donor",
"        </p>",
"        <p>",
"         Gamete retrieval can be invasive and is usually time-sensitive",
"        </p>",
"        <p>",
"         The act may be of emotionally therapeutic value for survivors even if the gametes are rarely if ever used",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <ol>",
"      <li>",
"       ESHRE Task Force on Ethics and Law, Pennings G, de Wert G, et al. ESHRE Task Force on Ethics and Law 11: Posthumous assisted reproduction. Hum Reprod 2006; 21:3050.",
"      </li>",
"      <li>",
"       Kindregan CP. Dead Dads: Thawing an Heir from the Freezer. William Mitchell Law Review 2009; 35:433.",
"      </li>",
"      <li>",
"       Ethics Committee of the American Society for Reproductive Medicine. Posthumous reproduction. Fertil Steril 2004; 82 Suppl 1:S260.",
"      </li>",
"      <li>",
"       Greer DM, Styer AK, Toth TL, et al. Case records of the Massachusetts General Hospital. Case 21-2010. A request for retrieval of oocytes from a 36-year-old woman with anoxic brain injury. N Engl J Med 2010; 363:276.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9501=[""].join("\n");
var outline_f9_17_9501=null;
var title_f9_17_9502="MPT for multiple myeloma";
var content_f9_17_9502=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Melphalan, prednisone, and thalidomide (MPT) for multiple myeloma",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td colspan=\"4\">",
"        Cycle length: 56 days (6 weeks).",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Melphalan",
"        </strong>",
"       </td>",
"       <td>",
"        0.25 mg/kg by mouth",
"       </td>",
"       <td>",
"        Take on an empty stomach (one hour prior to or two hours after meals).",
"       </td>",
"       <td>",
"        Days 1 through 4, every six weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Prednisone",
"        </strong>",
"       </td>",
"       <td>",
"        2 mg/kg by mouth",
"       </td>",
"       <td>",
"        Take with food (after meals or with food or milk) in the morning.",
"       </td>",
"       <td>",
"        Days 1 through 4, every six weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Thalidomide",
"        </strong>",
"       </td>",
"       <td>",
"        100 or 200 mg by mouth",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Take with water on an empty stomach at least one hour after the evening meal.",
"       </td>",
"       <td>",
"        Daily continuously, with the final dose on day 4 of the last cycle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        LOW or VERY LOW. Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for thrombosis:",
"        </strong>",
"        Without prophylaxis, the MPT regimen is associated with a 12 percent rate of thrombosis or embolism. As such, routine thromboprophylaxis is recommended for all patients",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topic on \"Thrombotic complications following treatment with thalidomide and its analogues\", section on Thalidomide plus melphalan and prednisone.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Primary prophylaxis with G-CSF is not indicated (rate of severe infection 13 percent)",
"        <sup>",
"         [1]",
"        </sup>",
"        . Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        Reduction in the initial dose of melphalan is required for patients with moderate to severe renal insufficiency",
"        <sup>",
"         [3,4]",
"        </sup>",
"        . If myelotoxicity does not occur, the dose may be increased in subsequent courses. No dose adjustments are needed for liver dysfunction. Refer to UpToDate topic on \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Pregnancy warning:",
"        </strong>",
"        Thalidomide can result in severe, life-threatening human birth defects. Strict birth control regulations are in place for all patients taking thalidomide. This drug is approved for marketing only under a special restricted distribution program approved by the US Food and Drug Administration (FDA) called the \"system for thalidomide education and prescribing safety\" (S.T.E.P.S.) program",
"        <sup>",
"         [5]",
"        </sup>",
"        . Pregnancy testing is required within 24 hours prior to initiation of thalidomide therapy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential, serum electrolytes, and serum uric acid.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess fluid status, blood pressure, and central nervous system status.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for signs of neuropathy monthly for the first three months, then periodically thereafter. Neuropathic complications commonly include constipation. As such, many clinicians provide a prophylactic bowel regimen for patients taking thalidomide.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Pregnancy testing should be performed weekly during the first four weeks, and then every two to four weeks, depending on menstrual cycle regularity.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose&nbsp;modifications for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        Melphalan should be administered with caution if the ANC is less than 3000/mm",
"        <sup>",
"         3",
"        </sup>",
"        or the platelet count is less than 100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        . Thalidomide should be withheld if the absolute neutrophil count falls below 750/mm",
"        <sup>",
"         3",
"        </sup>",
"        . Restart after ANC recovers to &gt;1500/mm",
"        <sup>",
"         3",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hypersensitivity:",
"        </strong>",
"        Hypersensitivity reactions are rare in patients receiving MPT. However, if they occur, especially if there are signs of anaphylaxis, they can recur with subsequent treatment. If a hypersensitivity reaction develops, MPT should not be administered again.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Rash:",
"        </strong>",
"        Thalidomide has been associated with rashes including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). If a rash develops, thalidomide should be discontinued and the rash further evaluated. Thalidomide should not be administered again if the rash is exfoliative, purpuric, bullous, or if SJS or TEN is suspected.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neuropathy:",
"        </strong>",
"        Thalidomide should be discontinued or dose reduced if a patient develops parasthesias accompanied by pain, motor deficit, or interference with activities of daily living.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, dose should be recalculated for all drugs",
"        </strong>",
"        .",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     G-CSF: granulocyte colony-stimulating factors; CBC: complete blood count; ANC: absolute neutrophil count.",
"     <br>",
"      * The dose of these medications is commonly rounded to the nearest tablet/capsule size.",
"      <br>",
"       &Delta; Overall survival with thalidomide doses &gt;200 mg per day (max 400 mg per day) were not different from doses &le;200 mg per day",
"       <sup>",
"        [1]",
"       </sup>",
"       .",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Facon T, et al. Lancet 2007; 370:1209.",
"       </li>",
"       <li>",
"        Lyman GH, et al. J Clin Oncol 2007; 25:5490.",
"       </li>",
"       <li>",
"        Alkeran (melphalan). FDAUS FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on January 6, 2012).",
"       </li>",
"       <li>",
"        Aronoff GR, Bennett WM, Berns JS, et al. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children, 5th ed. Philadelphia, PA: American College of Physicians; 2007, p.97, 170.",
"       </li>",
"       <li>",
"        Thalomid (thalidomide). US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on January 6, 2012).",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9502=[""].join("\n");
var outline_f9_17_9502=null;
var title_f9_17_9503="Spectrum of broad band and narrow band UVB lamps";
var content_f9_17_9503=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Spectrum of broad band and narrow band UVB lamps",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 354px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James Ferguson, Dundee, Scotland.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_17_9503=[""].join("\n");
var outline_f9_17_9503=null;
